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Osteoarthritis (OA) affects an estimated 250 million people worldwide, representing an enormous 
economic and social burden across demographic groups. While classically attributed to ‘wear and 
tear’ of the articular cartilage, there is a growing appreciation that OA is a whole-joint disease with 
a complex etiology involving the synovium and surrounding tissues. The synovium is a specialized 
connective tissue membrane that envelops the diarthrodial joint and maintains the synovial fluid 
environment through molecular secretion as well as bi-directional filtration of these constituents, 
nutrients, and cellular waste products. Moreover, synovium-derived cells have been directly 
implicated in both the native repair response as well as degradation of articular cartilage. 
Much of the existing research of synovium has been conducted in the context of rheumatoid 
arthritis (RA). And while synovitis is a key feature of both RA and OA, clinical reports have 
described OA synovium as distinct in its cellular and structural composition, molecular secretion, 
and chronic onset. However, literature studies have not adequately addressed the mechanisms by 
which alterations in synovium structure-function affect joint and cartilage health, particularly the 





work described in this dissertation addresses these knowledge gaps in the context of existing and 
emerging OA therapies, namely glucocorticoids and electrical stimulation.  
We anticipate that a more comprehensive characterization of changes to the synovium 
composition, secretion of key metabolic mediators, lubrication properties, as well as its ability to 
regulate solute transport in and out of the joint space will not only contribute to our basic science 
understanding of the synovium but also the development and modification of therapeutic strategies 
aimed at restoring and maintaining joint health. This characterization will be facilitated by our 
laboratory’s expertise in tissue engineering and explant culture, IL-1 and DEX stimulation, and 
electrical stimulation of joint tissues. The approach of using an engineered synovium model is 
attractive in that quantitative high throughput in vitro mechanistic studies can be performed on 
tissues that are fabricated from cells derived from normal and OA synovium of patients and 
corresponding immune cells at defined density and cell type ratios. It also facilitates isolating 
effects of certain cell types or starting composition that are found in explant specimens. 
Intra-articular glucocorticoid injections are commonly administered to patients in an effort 
to control inflammation and pain. And while these high dose injections are known to have 
significant detrimental local and systemic effects, comparatively low doses of dexamethasone 
(DEX), a synthetic glucocorticoid, are known to have pro-anabolic and anti-catabolic effects on 
cartilage cultures. Our laboratory has published extensively on the benefits of DEX stimulation in 
growth and maintenance of engineered and explanted cartilage as well as chondroprotection from 
pro-inflammatory cytokines (e.g interleukin-1; IL-1), both in juvenile bovine basic science and 
adult canine preclinical systems. However, the concomitant effects of DEX on synovium structure-





In Part I, we describe a functional tissue engineered synovium model that was validated 
against explant behavior. We were able to recapitulate many of the unique structural and functional 
characteristics of synovium, including protein expression, intimal lining formation, solute 
transport, and friction coefficient. Additionally, changes in engineered synovium structure-
function mirrored that of explants when treated with IL-1 or DEX. The engineered synovium 
model was then expanded to include resident macrophage-like synoviocytes (MLS), 
demonstrating the key role that these cells play in structural reorganization of synovium. The 
model was also translated to human cells, showing the potential of the system for personalized 
medicine. Finally, motivated by insights into solute transport in the synovium as well as its strong 
anti-inflammatory response to DEX, we developed a sustained low-dose DEX delivery platform 
for mitigating synovial inflammation while simultaneously stimulating cartilage growth. Utilizing 
a preclinical adult canine model, we showed that extended intra-articular delivery of DEX 
improved functional outcomes and cartilage tissue quality. 
In Part II, we evaluated synovium behavior and cartilage repair in response to modes of 
electrical stimulation. Electrical stimulation of cells and tissues has been a topic of interest for 
decades, owed in part to the knowledge that endogenous electric field (EF) gradients guide cell 
behavior during embryogenesis and wound healing. Pulsed electromagnetic fields (PEMFs) have 
been used in a clinical setting to stimulate bone repair and alleviate pain, however their use for OA 
and cartilage repair is controversial. Culture studied of PEMFs have shown anti-catabolic and pro-
anabolic effects on isolated FLS and cartilage, respectively. And previous work in our laboratory 
demonstrated directed 2D migration of synoviocytes and chondrocytes in response to direct current 





explants, so it is unclear to what extent the observed phenomena translate to the 3D tissue 
environment. 
For the first time, we characterized the biological response of both healthy bovine and OA 
human synovium explants, showing distinct anti-inflammatory behavior in bovine tissues and a 
highly variable response in arthritic human tissues, likely due to different inflammatory cell 
content. Motivated by the potent anti-inflammatory effect seen in normal tissue and previous work 
showing a pro-anabolic effect on cartilage, the PEMF system was then adapted for use with a 
preclinical adult canine model of engineered cartilage repair. In this model, PEMFs significantly 
enhanced functional outcomes and cartilage tissue quality. Finally, we investigated the potential 
for direct synovial cell-mediated cartilage repair via induced migration with DC EFs. By 
developing and validating a novel tissue-scale bioreactor capable of applying DC EFs in sterile 
culture conditions to three-dimensional constructs, we showed increased recruitment of synovial 
repair cells to the site of a cartilage wound. 
Taken together, the sum of the work builds on existing therapeutic strategies by developing 
models to understand the contribution of the synovium to joint maintenance and repair. By 
modeling dexamethasone- and electrical- induced changes to composition and function of 
synovium and cartilage, via complementary explant and engineered approaches, valuable 
mechanistic insights into osteoarthritis pathogenesis and cartilage repair were gathered. These 
findings lay the groundwork for more complex and personalized in vitro models of OA and 
motivate future work to capitalize on knowledge of the functional plasticity of the synovium to 
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Chapter 1 Introduction 
Introduction 
The synovium is a specialized connective tissue membrane that envelops the diarthrodial joint and 
maintains the composition of the synovial fluid. While the synovium has long been implicated in 
the etiology of rheumatoid arthritis (RA), and thus the subject of extensive research efforts in this 
context, there is comparatively little known about the role of synovium in post-traumatic and 
idiopathic osteoarthritis (OA). Our laboratory has vast experience in applying chemical, electrical, 
and mechanical stimuli to native and engineered cartilage tissues in order to better understand 
cartilage growth, healing, and OA progression. However, the concomitant and likely interactive 
effects of these stimuli on the synovium, as well as downstream consequences on cartilage and 
overall joint function, have largely been gleaned from culture studies of isolated cells or clinical 
reports. In order to provide a more complete understanding of synovium behavior that can be 
leveraged to improve on existing cartilage repair strategies and to inspire new treatments targeting 
synovial function, the motivation of the work in this dissertation is two-fold: 1) characterize 
synovium structure-function in response to pro-inflammatory cytokine insult and glucocorticoid 
treatment; 2) investigate electrotherapeutic strategies for modulating synovium behavior and 
cartilage repair. 
To guide this effort (Figure 1.1), two overarching hypotheses are presented, accompanied 
by specific aims and rationale. The broader clinical and societal significance of the work is then 
described, followed by an overview of the relevant literature, including diarthrodial joint structure-






Figure 1.1 Organizational structure of dissertation. 
 
1.1 Hypotheses and Specific Aims 
Global Hypothesis (Part I): Synovium structure-function, and by extension OA and cartilage 
repair, is modulated by interleukin-1 (IL-1) and dexamethasone (DEX). 
 
Specific Aim 1a: To develop a fibroblast-like synoviocyte (FLS)-based engineered 
synovium to facilitate evaluation of structure-function, and validate against baseline 
properties of native tissue explants. 
Specific Aim 1b: To evaluate the response of the engineered synovium described in SA1a 
and native tissue explants to IL-1 insult and DEX treatment. 
Specific Aim 1c: To incorporate tissue-resident macrophage-like synoviocytes (MLS) into 
the engineered synovium model and use cell tracking techniques to observe behavior. 
Specific Aim 1d: To translate the engineered synovium model to a human system, and 
evaluate the role of blood-derived T lymphocytes in synovium response to IL-1 and DEX. 
 
Despite the critical role of the synovium in joint and cartilage health, there is a striking lack of 
quantitative structure-function data. This is partly the result of a lack of adequate in vitro synovium 
models. Useful insights can be gleaned from in vivo monitoring of tracer molecules, however these 





and McDonald, 1989; Myers et al., 1995). For example, there is an apparent increase in synovium 
permeability that has been inferred from decreased HA content in the synovial fluid and increased 
HA in the serum (Scanzello and Goldring, 2012a). In contrast, a recent in vivo study reported that 
500 kDa dextran was retained in the arthritic joint longer than in the healthy joint, while 10 kDa 
was similar for both. This observation may be associated with changing composition and thickness 
of the synovium (Myers et al., 1995), however these conflicting findings highlight the need for 
more sophisticated synovium models. 
Explant studies are undoubtedly an important tool, but they have limited utility due to low 
supply of healthy human tissue. Specimens from clinical patients are highly damaged, 
contaminated with fat and capsular tissue, making them hard to manipulate and limiting the 
functional analysis that can be performed in vitro (McNamara et al., 2010). Studying the response 
of synovial explants to pro-inflammatory stimuli is further complicated by stark differences in cell 
and matrix content due to disease state, donor, and harvest site (Smith, 2011). Meanwhile, simpler 
2D monolayer studies of FLS from our laboratory (Estell et al., 2017; Silverstein et al., 2017) and 
others (Blewis et al., 2010b; Sun et al., 2003; Utomo et al., 2016), as well as those of 3D 
micropellet synovium culture (Kiener et al., 2010), are valuable tools for studying the biological 
changes to synovium cell secretion profiles. However, the former lacks normal tissue structure and 
organization, and the latter is a spherical microtissue rather than sheet-like membrane necessary 
for bulk characterization of composition, solute transport, and lubrication. 
Our laboratory has extensive experience evaluating the response of engineered and 
explanted cartilage to pro-inflammatory cytokine (i.e. IL-1) and anti-inflammatory drug (i.e. DEX) 
stimulation (Bian et al., 2010; Lima et al., 2008b). Intra-articular DEX injections have been used 





2017; Heard et al., 2015; Lu et al., 2011; Sherman et al., 2015), however evidence for their use 
remains inconclusive (American Academy of Orthopaedic Surgeons Board of Directors, 2013). In 
addition to the role that the synovium likely plays in drug clearance, these glucocorticoids are 
known to have a significant anti-inflammatory effect and modulate cell biosynthesis in the joint 
(Lu et al., 2011; Roach et al., 2016a), likely playing a role on FLS and local immune cells as well 
(Reyes et al., 2008). In better understanding synovium structure-function, especially in the context 
of current pharmaceutical treatments, researchers may be able to better predict and influence 
outcomes, perhaps by developing targeted synovium therapies (Jérémie Sellam and Berenbaum, 
2010; Sutton et al., 2009). 
To this end, these studies aim to build on this knowledge to develop complementary 
engineered and explanted synovium models to investigate how IL-1 and DEX alter synovium 
structure-function (Chapter 2). The approach of using a surrogate synovium model is attractive 
in that quantitative transport and lubrication measurements and other high throughput in vitro 
mechanistic studies can be performed on tissues that are fabricated from cells derived from small 
clinical biopsies and blood (Bondeson et al., 2010). Development of in vitro human models will 
be especially valuable due to limitations with translatability in animal systems (Bendele, 2001). It 
also facilitates isolating effects of certain cell types (i.e. FLS vs. MLS or T Lymphocytes) or 
starting composition (i.e. intima vs. sub-intima or fibrous vs. fatty) that are found in explant 
specimens. Building on a previous microtissue approach that demonstrates the unique ability of 
FLS to reconstitute many of the structural aspects of synovium (Kiener et al., 2006), we 
hypothesized that an engineered synovial membrane can recreate structure-function of native 
tissue. Further, cytokine- or glucocorticoid-induced changes to solute transport and lubrication 





Specific Aim 1e: To develop a sustained, low-dose, intra-articular DEX delivery platform, 
consisting of PLGA microspheres embedded within an acellular agarose implant, for 
improving joint repair. 
Specific Aim 1f: To evaluate the acellular DEX implant from SA1d in an adult canine 
preclinical model of osteochondral autograft transfer (OAT). Determine impact on 
cartilage repair tissue and synovium. 
 
Data from animal studies and early clinical trials suggest that early inhibition of the intra-articular 
inflammatory response post-traumatic injury of the knee may improve clinical outcomes (Olson et 
al., 2014). However, intra-articular glucocorticoid injection doses are necessarily high due to the 
high clearance rate of the steroid from the joint space (Armstrong et al., 1981; Habib, 2009). 
Repeated high-dose injections (Backes et al., 2013; Ikeuchi et al., 2014) have been associated with 
adverse effects on growth of articular and growth plate chondrocytes (Chrysis et al., 2003; Dragoo 
et al., 2012), synoviocytes (Sherman et al., 2015), and osteoblasts (Allen, 1996). Meanwhile, 
comparatively low doses of DEX serve as a critical pro-anabolic and anti-catabolic factor in 
chondrogenic cultures (Florine et al., 2013; Lima et al., 2007; Lu et al., 2011). An optimal delivery 
system for sustained low (therapeutic) dose of DEX to the synovial joint is not currently available 
for clinical use in cartilage restoration (Bajpayee et al., 2017). To this end, an intra-articular 
extended-release delivery system was developed and evaluated in a preclinical model of cartilage 
repair (Chapter 3). Motivated by the synovium response to DEX elucidated by SA1a-d, we 
hypothesized that sustained low-dose DEX delivery would support repair outcomes via dual pro-








Global Hypothesis (Part II): Electrical stimulation supports joint health and repair via anti-
catabolic, pro-anabolic, and galvanotactic effects on synovium and cartilage. 
 
Specific Aim 2a: To characterize the response of healthy and OA synovial explants to 
pulsed electromagnetic fields (PEMFs) in baseline, IL-1, and DEX-treated conditions. 
 
Aside from clinical evidence indicating a modulatory effect on pain (Betti et al., 1999; Zorzi et al., 
2007), little is known about how PEMF may alter the behavior of synovial tissue. Recently, much 
work has been done to characterize a potential anti-inflammatory effect of PEMF on isolated 
bovine and human OA FLS via the adenosine receptor complex (De Mattei et al., 2009; Ongaro et 
al., 2012; Varani et al., 2008). However the distribution and quantity of FLS, MLS, and non-
resident immune cells in the synovium changes dramatically based on stage of OA and donor 
(O’Brien et al., 2017; Utomo et al., 2016), potentially creating a more complex response to PEMF. 
Studies have evaluated the response of macrophage cell lines to PEMF, showing variable effects 
on inflammatory mediators (Akan et al., 2010; Kawczyk-Krupka et al., 2002; Ross and Harrison, 
2013). Moreover, cellular response is likely to be affected by cell-cell and cell-matrix interactions 
only present in native tissues. Motivated by results from studies in SA1a-d that showed IL, DEX, 
and OA-induced fluidity in cell phenotype, these studies aim to evaluate how chemical 
environment and disease state affect response to PEMF (Chapter 4). Specifically, we hypothesized 
that PEMFs would decrease markers of inflammation in healthy bovine tissues and have an 
inconsistent effect on human OA tissues. Further, we hypothesized that the effect of PEMF would 









Specific Aim 2b: To develop an optimal PEMF dosing strategy for improving joint repair. 
Specific Aim 2c: To evaluate the PEMF strategy in an adult canine preclinical model of 
engineered osteochondral repair. Determine impact on cartilage repair tissue and 
synovium. 
 
Clinical studies of PEMFs have shown improvements in function following microfracture, matrix-
assisted chondrocyte implantation (MACI®), bone marrow-derived stem cell transplantation, and 
osteochondral allograft (OCA) (Cadossi et al., 2014; Collarile et al., 2018; Iwasa and Reddi, 2018). 
However, while these initial studies were promising, PEMFs have remained controversial for 
cartilage repair due to inconclusive clinical evidence of robust efficacy and few mechanistic 
studies on the matter (Bjordal et al., 2007; Gobbi et al., 2014). We suspect that the conflicting data 
may stem from differences in methods and strengths/duty cycle of applied electric fields, anatomic 
geometry, repair type, and contributions from surrounding tissues. Informed by response of 
synovial tissue elucidated in SA2a and optimization of cartilage behavior in SA2b, these studies 
aim to provide a comprehensive analysis of clinical outcomes in conjunction with tissue level 
analyses of cartilage and synovium (Chapter 5). As engineered cartilage is especially susceptible 
to impacts from sub-optimal implantation properties and pro-inflammatory cytokines (Djouad et 
al., 2009; Hunter and Levenston, 2004; Obradovic et al., 2001b; Spalazzi et al., 2008), we 
hypothesized that a standardized and optimized PEMF strategy would serve a dual role of 
stimulating cartilage anabolism and suppressing synovial inflammation following joint repair. 
 
Specific Aim 2d: To investigate direct current electrical field (DC EF)-induced migration 
of adherent synovial immune cell populations. 






Specific Aim 2f: To design, build, and validate a bioreactor capable of applying DC EFs 
to three-dimensional tissue specimens. Evaluate migration of synovial repair cells within a 
model cartilage defect. 
 
FLS, which are sometimes referred to as synovium-derived stem cells (SDSCs), can be 
differentiated to make cartilage in vitro, making them an attractive target cell source for cartilage 
repair strategies (Bilgen et al., 2007; Rui et al., 2010; Sampat et al., 2011a). FLS are recruited to 
the site of partial thickness defects in vivo, however the efficiency of their migration into the wound 
site is generally insufficient for effective healing (Hunziker and Rosenberg, 1996). Meanwhile, 
proliferation of resident MLS and infiltration of peripheral blood mononuclear cells (PBMCs) 
contribute to the pro-inflammatory environment and further joint degeneration (O’Brien et al., 
2017; Utomo et al., 2016). 
DC EFs may allow the selective homing of repair cells and exclusion of immune cells. Our 
laboratory has shown that in 2D culture, both chondrocytes and FLS exhibit preferential cathodal 
or anodal migration, dependent on passage number (Chao et al., 2000; Finkelstein et al., 2007; Tan 
et al., 2011). Meanwhile, evidence suggests that macrophages preferentially migrate towards the 
anode (Orida and Feldman, 1982). Divergent galvanotactic behavior of fibroblasts and 
macrophages has been alluded to more recently as well (Douglas et al., 2019). However, 
galvanotaxis of FLS and MLS (or adherent PBMCs) has not been explored in a 3D repair model, 
either as a method to increase homing of FLS repair cells or to exclude inflammatory cells. Such 
an in vitro model will be crucial in translating culture findings to a preclinical system that will 
ostensibly require implanted electrodes. To this end, these studies aim to investigate galvanotaxis 
of adherent PBMCs and develop new methods to evaluate galvanotactic behavior in three-





and FLS exposed to DC EFs, in 2D and 3D, respectively, would exhibit directed migration. 
Furthermore, development of new bioreactor approaches would facilitate application of DC EFs 
to three-dimensional synovium and cartilage specimens in biomimetic configurations. 
 
1.2 Significance 
OA is a degenerative condition that affects an estimated 250 million people worldwide, 
representing an enormous economic and psychosocial burden for patients and their families 
(Hunter and Bierma-Zeinstra, 2019). While classically attributed to ‘wear and tear’ of the articular 
cartilage, there is a growing appreciation that OA is a whole-joint disease with complex etiology 
involving the synovium and surrounding tissues (Bhattaram and Chandrasekharan, 2016; Loeser 
et al., 2012; Scanzello and Goldring, 2012a). Pathologic changes to the synovium architecture and 
composition often precede the presence of cartilage damage (Hügle and Geurts, 2017), suggesting 
a potentially critical role in early disease pathogenesis. And while synovitis is a key feature of both 
rheumatoid arthritis (RA) and OA, clinical reports have described OA synovium as distinct in its 
cellular and structural composition, molecular secretion, and chronic onset (Bondeson, 2015; 
Furuzawa-Carballeda et al., 2008; Hitchon and El-Gabalawy, 2011; Penatti et al., 2017; Jeremie 
Sellam and Berenbaum, 2010; Sutton et al., 2009; Wenham and Conaghan, 2010). 
A better understanding of synovium transport and response to DEX may facilitate 
development of improved treatment strategies aimed at modulating synovium behavior and 
improving drug residence time. Furthermore, development of more effective pain treatments may 
help to mitigate the spread of opioid abuse (Goesling et al., 2016). In addition to drug clearance, 
the filtration and secretion function of the synovium defines the synovial fluid composition of 





molecular weight (MW) (1-6 MDa), which has shown anti-inflammatory (Cooper et al., 2008; Lee 
and Cowman, 1994), chondroprotective (Bauer et al., 2016), and lubricating (Blewis et al., 2010a) 
properties. HA is degraded in OA and these smaller fragments (e.g. <200kDa) promote a pro-
inflammatory phenotype (McKee et al., 1996) and reduce synovial fluid viscosity thereby 
increasing joint friction and tissue wear (Fam et al., 2009). 
While many OA cases are considered idiopathic, a large number arise secondary to a 
traumatic event. It has been reported that approximately 60% of knee arthroscopies find chondral 
lesions, 67% of which can be categorized as focal defects (Widuchowski et al., 2007). Improving 
cartilage repair and restoration surgeries via modulation of synovium structure-function may 
reduce rehabilitation times, costs, and the demand for total joint arthroplasty (TJA), as well as 
facilitate the adoption of engineered cartilage technologies. Electrotherapeutics hold potential as 
low-cost, low-risk, non-invasive adjunctive therapies for improving cartilage repair. Low intensity 
PEMFs have been shown to reduce joint inflammation and pain (Betti et al., 1999; Zorzi et al., 
2007) and are clinically-approved for treatment of arthritis (De Mattei et al., 2009; Ongaro et al., 
2012; Varani et al., 2008). Alternatively, DC EFs may enable selective homing of target cells to 
defect sites, thus augmenting natural repair processes (Katagiri et al., 2017). 
In understanding the complex interactions as well as individual cellular, biochemical, and 
functional changes that arise in OA synovium and cartilage, researchers may be able to better 
predict and influence outcomes (Attur et al., 2010; Scanzello and Goldring, 2012b). We believe 
that it is this lack of knowledge that contributes to the conflicting and inconclusive results of many 
current OA therapies, including glucocorticoid injections and electrotherapeutics (American 
Academy of Orthopaedic Surgeons Board of Directors, 2013). To this end, studies presented in 





compositional, structural, and functional properties of native tissue in both IL-1 and DEX-treated 
culture conditions (Chapter 2). We then elucidated the impact of sustained low-dose DEX on 
synovium and cartilage in a preclinical OAT repair model (Chapter 3). 
In Part II, investigation of the synovium was expanded to investigate the response to non-
invasive electrical stimulation modalities. We first determined the biological response of healthy 
or OA synovium explants to PEMF stimulation in both pro-inflammatory and anti-inflammatory 
culture conditions (Chapter 4) and then further evaluated the impact of PEMF on synovium and 
cartilage in a preclinical engineered cartilage repair model (Chapter 5). Finally, DC EFs were 
explored as a potential method of stimulating homing of synovial repair cells to a cartilage defect 
in a 3D culture system (Chapter 6). 
 
1.3 Background 
1.3.1 Diarthrodial Joint Structure and Function 
1.3.1.1 Normal Synovium 
The synovium envelops the diarthrodial joint and plays a key regulatory role in defining the 
composition of the synovial fluid through bi-directional filtration (Blewis et al., 2010a) as well as 
biosynthesis of critical boundary lubricants such as lubricin and hyaluronic acid (HA) (Blewis et 
al., 2010b; Schmidt and Sah, 2007). Characterized by a unique intima/sub-intima architecture, 
synovium is distinct from other barrier membranes found in the body (Kiener et al., 2010). The 
synovial intima is composed of a dense collagenous matrix (primarily type I and IV) (Smith, 2011) 
with cells interspersed, lacking a distinct basement membrane (Barland et al., 1962). The normal 
intimal lining (Figure 1.2A), which is in direct contact with the synovial fluid, is about 1-4 cells 





intimal layer of the synovium is ~5 mm thick and relatively acellular and heterogeneous. In 
addition to a sparse population of FLS and MLS, the tissue is highly vascularized with nerves in 
close proximity to the vessels (Haywood and Walsh, 2001; Levick and McDonald, 1995; Price et 
al., 1996; Smith, 2011). Depending on the depth and joint location, extracellular matrix (ECM) 
consists of a mixture of fibrous and collagenous (type I, III, IV, V and VI) dense connective tissue 
regions and adipose. 
FLS are key contributors to the articular cartilage niche, contributing molecules important 
for lubrication, ECM turnover, and inflammation (Kiener et al., 2010). In addition to expressing 
common MSC markers (Alegre-Aguarón et al., 2014), these cells can also be identified the surface 
expression of decay accelerating factor (CD55), vascular cell adhesion molecule-1 (VCAM-1), 
and calcium-dependent adhesion molecule-1 (cadherin-11) (Ospelt, 2017). FLS interact with the 
ECM and the sub-intima through integrins, such as the 11, 21, 41 integrins and intercellular 
adhesion molecule (ICAM-1) (Agarwal and Brenner, 2006; Bartok and Firestein, 2010; Kiener et 
al., 2010; Valencia et al., 2004). They have been shown to secrete lubricin and HA, both key 
components of joint lubrication (Jay, 1992; Jay et al., 2007, 2000a), and respond to and contribute 
to the secretion of inflammatory cytokines into the synovial fluid (Kiener et al., 2010). MLS also 
secrete catabolic factors and function to remove waste and pathogens from the joint (Jeremie 
Sellam and Berenbaum, 2010). MLS are identifiable by positive expression of CD11b, CD14, 
CD45, CD68 and CD163 (Bartok and Firestein, 2010; Edwards, 1982).  
The synovium is convoluted and known to come into contact with large portion of the 
articular surfaces (Palmer, 1967), ostensibly undergoing both fluid and tissue shear loading during 
normal daily activities. Synovial cells are highly responsive to shear loading, which is in part 





very large (1-6 MDa) and has anti-inflammatory (Cooper et al., 2008; Lee and Cowman, 1994), 
chondroprotective (Bauer et al., 2016), and lubricating (Blewis et al., 2010a) properties. The 
clearance of large molecules (i.e. HA and lubricin) from the joint is approximately one half every 
38 hours (Levick, J. R., et al., 1999). Water and smaller proteins (i.e. cytokines) in the synovial 
fluid are replaced about every two hours (Levick, J. R., et al., 1999). This leads to small molecules 
(MW<10kDa) quickly reaching equilibrium in plasma and synovial fluid (Gerwin et al., 2006). 
 
 
Figure 1.2 Relevant synovium anatomy. (A) Normal synovium is comprised of ~90% FLS and 
~10% MLS. (B) OA synovium composition and structure changes dramatically, coinciding with 
altered secretion of lubricants and inflammatory mediators.  
 
1.3.1.2 OA Synovium 
The OA synovium thickens into a pannus-like structure with an increase in intimal cellularity 
(hyperplasia), fibrosis, vascularity, and innervation (Figure 1.2B) (Mathiessen and Conaghan, 
2017; Shibakawa et al., 2003; Wenham and Conaghan, 2010; Yuan et al., 2004). The hyperplastic 





depending on the stage of OA (O’Brien et al., 2017; Utomo et al., 2016). There is a concurrent 
infiltration of macrophages, lymphocytes, and other immune cells from the vasculature and 
secretion of pro-inflammatory cytokines, all of which are thought to contribute to the progression 
of joint degeneration (Blewis et al., 2010b; Kiener et al., 2006; Scanzello and Goldring, 2012a; 
Sutton et al., 2009). Infiltrating mononuclear cells are predominately CD14+ 
monocytes/macrophages and CD4+ T lymphocytes (Moradi et al., 2015), estimated in one study 
to represent ~65% and 22% of the immune cells in the OA synovium, respectively (Pessler et al., 
2008). Meanwhile, other studies have found negligible quantities of T lymphocytes in OA 
synovium (Bondeson et al., 2010). 
Synovial inflammation is a key feature of OA, although distinct from that of rheumatoid 
arthritis RA (Ene et al., 2015; Hitchon and El-Gabalawy, 2011; Pelletier et al., 2001). Synovitis 
can be detected through imaging modalities such as MRI and ultrasound as the patients also have 
greater amount of synovial fluid volume with a total increase in lubricant content (although lower 
total concentration) (Blewis et al., 2010a; Mathiessen and Conaghan, 2017; Jeremie Sellam and 
Berenbaum, 2010). Normally large HA chains are degraded and these fragments promote a pro-
inflammatory phenotype (McKee et al., 1996) and reduced synovial fluid viscosity that increases 
joint friction and tissue wear (Fam et al., 2009). Additionally, decreased HA chain length 
exacerbates lubricant loss from the joint (Sabaratnam S. et al., 2005). Similar loss of lubricants has 
been observed following ACL injury, implicating this mechanism in secondary OA as well as 






1.3.1.3 Articular Cartilage and Repair Strategies 
Articular cartilage is a dense white connective tissue that covers our mobile joints and provides 
load-bearing support and lubrication (Lai et al., 1991). It has a highly specialized and organized 
structure, consisting of the superficial zone, middle zone, deep zone, and calcified zone (Carballo 
et al., 2017). The composition of each zone varies, however the primary ECM components are 
collagen (75% of tissue dry weight) and proteoglycan (20-30% of tissue dry weight) (Brocklehurst 
et al., 1984). The biomechanical behavior of articular cartilage is typically modeled as a biphasic 
mixture containing a liquid (80% of tissue wet weight) and a solid phase composed of porous 
matrix (Ateshian et al., 1997). It is the interaction of these phases that give cartilage its high 
compressive strength, mainly through fluid pressurization via charged proteoglycan molecules. 
The avascular nature of articular cartilage and dense extracellular matrix confer a poor 
healing capacity whereby localized regions of tissue damage can lead to joint degeneration and 
OA (Hehenberger et al., 1998; Kloth, 2005). Cartilage repair and restoration surgeries, such as 
microfracture, OAT, OCA, and cell-culture techniques (e.g. autologous chondrocyte implantation; 
ACI) are each limited by a number of factors, including availability of graft tissue, donor site 
morbidity, and difficulty in matching size and surface contours (Andrade et al., 2016; Bugbee et 
al., 2016; Nover et al., 2015; Shimozono et al., 2019). In attempts to overcome some of these 
issues, a number of engineered cartilage technologies (e.g. MACI) are progressing through the 
clinical pipeline (Iwasa et al., 2009; Pietschmann et al., 2009). 
The effectiveness and longevity of cartilage restoration treatments can also be limited by 
the impact of proinflammatory cytokines on graft incorporation and integrity (Djouad et al., 2009; 
Hunter and Levenston, 2004; Obradovic et al., 2001b; Spalazzi et al., 2008). Synovial fluid from 





specifically linked to adverse integrative repair (Wilusz et al., 2008). Iatrogenic cartilage injury 
can further hamper outcomes; chondrocyte death can occur due to osmolarity differences in saline, 
contact with blood, or drying during open procedures (Amin et al., 2017; Hooiveld et al., 2003; 
Sgaglione and Kerker, 2008). Furthermore, cartilage grafts often suffer from reduced viability and 
metabolic activity caused by extended preservation (Nover et al., 2015) or method of graft harvest 
and delivery (Sgaglione and Kerker, 2008). 
 
1.3.2 Osteoarthritis and Joint Repair Models 
1.3.2.1 Synovium-Based Models 
A number of models exist with which to study aspects of synovium structure-function, each with 
inherent strengths and limitations (Table 1.1). In vivo studies utilizing tracer molecules have 
offered important insights on solute transport across the synovium, but provide a challenge in 
resolving mechanisms below the whole-joint level (Levick, J. R., et al., 1999; Levick and 
McDonald, 1995, 1989) due to the inherent confounding variables of the in vivo environment 
including ill-defined boundary conditions arising from vasculature throughout the sub-intima 
(Bhattaram and Chandrasekharan, 2016). Studying the response of synovial explants to pro-
inflammatory stimuli is a complex task due to stark differences in cell and matrix content due to 
disease state, donor, and harvest site (Smith, 2011). The few studies that have cultured synovium 
explants have focused mainly on biochemical response to cytokine treatment (Fichadiya et al., 
2016; Labens et al., 2013). Human synovial explants treated with IL-1β or tumor necrosis factor-
α (TNFα) were shown to secrete increased concentration of inflammatory mediators such as 





 In an effort to work with a simpler and more reproducible system, some have opted to 
model synovium as a confluent FLS monolayer. This focus is facilitated by high proliferation in 
2D monolayers, whereby FLS exclude both the MLS and contaminating blood cells at early 
passage (Kiener et al., 2006). In response to IL-1β and TNFα, human OA FLS rapidly proliferate 
and secrete increased concentrations of lubricant molecules (e.g. HA and lubricin), cytokines, 
nitric oxide (NO), PGE2, and matrix metalloproteinases (MMPs) (Blewis et al., 2010a, 2010b; 
Furuzawa-Carballeda et al., 2008; Gitter et al., 1989; Hamilton et al., 1994; Pulkki, 1986). Similar 
synovium-like monolayers have been cultured on various substrates, including filter membranes 
(Blasioli et al., 2014; Blewis et al., 2010a), temperature responsive dishes (Mitani et al., 2014), 
and suspension (Warnock et al., 2014, 2013). Systems consisting of filter membranes enable 
functional transport measurements (Blewis et al., 2010a) and the dual compartments of 
Transwells® are especially useful for co-culture with cells or tissues such as macrophages (Blasioli 
et al., 2014; Peck et al., 2018) or cartilage (Peck et al., 2018; Pretzel et al., 2009). However, simple 
cell layers lack the dense ECM and three-dimensional architecture of the intima and sub-intima 
that play an integral role in the function of native tissue. 
 Some have described engineered models of synovium, each demonstrating varying levels 
of complexity to closer resemble native tissue while avoiding the pitfalls of explant tissue. One 
research group created an engineered model of RA synovium consisting of 25 µl microtissues 
seeded with 5.0 × 106 FLS per ml. These tissues demonstrated an ability to reorganize into the 
intimal lining architecture, secrete lubricin, support macrophage survival, and create a hyperplastic 
tissue in response to TNFα exposure (Kiener et al., 2010, 2006; Kiener and Brenner, 2005; 
Valencia et al., 2004). Yet despite reproducing synovial cell behavior in this engineered synovium 





measurements, and not in a biomimetic membrane configuration necessary for bulk functional 
measures. 
 
Table 1.1 Comparison of in vitro synovium models. 
 
Cell Monolayer 
(Blewis et al., 2010a) 
TE RA Micropellet 
(Kiener et al., 2010) 
Native Explants                     
(Swärd et al., 2017; van Buul et al., 2012) 
TE Synovial Membrane 
(Stefani et al., 2018) 
Gross Morphology X X ✓ ✓ 
Structural organization X ✓ ✓ ✓ 
ECM content X ✓ ✓ ✓ 
Cell content X ✓ ✓ ✓ 
Molecular secretion ✓ ✓ ✓ ✓ 
Solute transport 
measurements 
✓ X ✓/X ✓ 
Friction and lubricant 
measurements 
✓ X ✓/X ✓ 
Defined geometry and 
initial content 
✓ ✓ X ✓ 
Clinical specimen 
availability 
✓ ✓ X ✓ 
High throughput 
mechanistic studies 
✓ ✓ X ✓ 
 
1.3.2.2 Cartilage-Based Models 
IL-1 and DEX stimulation of engineered and explanted cartilage tissues have been widely used to 
model the OA and post-injury joint environment (Lima et al., 2008c; Andrea R Tan et al., 2015). 
Behavior of engineered adult cartilage has been validated against explanted tissues (Lima et al., 
2008c; Ng et al., 2010). Engineered tissues are useful for in vitro modeling due to their consistent 





assessments with higher sample size.  
There is currently a limited understanding of the inter-relationship between the synovium 
(including FLS and MLS) and cartilage explants in OA, particularly in the presence of 
inflammatory mediators. Co-culture of bovine, canine, or human cartilage and synovium explants 
from healthy and OA donors exposed to injurious compression or cytokine insult (IL-1 or TNFα) 
resulted in increased tissue degradation (decreased collagen and proteoglycan content) and 
increased levels of inflammatory mediators such as MMPs, NO and PGE2 (Beekhuizen et al., 
2011; Cook et al., 2007; Hardy et al., 2002; Lee et al., 2009; Swärd et al., 2017; van Buul et al., 
2012). Similarly, co-culture of OA synoviocytes with alginate encapsulated OA chondrocytes 
resulted in decreased proteoglycan synthesis and increased PGE2 expression, an effect that was 
only further magnified by treatment with IL-1β (Huch et al., 2001). However, co-culturing injured 
cartilage with healthy FLS had a protective effect on cartilage (Lee et al., 2013). Overall, many 
co-culture studies only looked at the effects of co-culture on cartilage tissue, generally ignoring 
reciprocal changes to the synovium (Cook et al., 2007; Patwari et al., 2009). 
 
1.3.3 Dexamethasone 
1.3.3.1 Clinical Use 
Intra-articular glucocorticoid injections have been used for decades to treat joint inflammation and 
pain (Cederlöf and Jonson, 1966; Grodzinsky et al., 2017; Heard et al., 2015; Lu et al., 2011; 
Sherman et al., 2015). However, injection doses are necessarily high (4 mg per knee) due to the 
high clearance rate of the steroid from the joint space, where serum levels can peak within hours 
to a couple of days after administration (Armstrong et al., 1981; Habib, 2009). Repeated high-dose 





growth of articular and growth plate chondrocytes (Chrysis et al., 2003; Dragoo et al., 2012), 
synoviocytes (Sherman et al., 2015), and osteoblasts (Allen, 1996). Impairment of healing or 
infections can be other undesired side effects of glucocorticoids (Sherman et al., 2015). These side 
effects, as well as risks of systemic absorption, typically limit patients to 2-4 injections per year 
(Armstrong et al., 1981; Berthelot et al., 2013; Habib, 2009; McAlindon et al., 2017; Neustadt, 
2006; Younes et al., 2007). As a result, current guidance does not recommend for or against the 
use of intraarticular glucocorticoids (American Academy of Orthopaedic Surgeons Board of 
Directors, 2013). 
To provide extended low-dose glucocorticoid delivery, an intra-articular microsphere 
injection of triamcinolone acetonide (TA) has recently been approved by the FDA. In advanced 
OA patients, these TA-MS injections provided better pain relief and longer joint residence time 
than bolus TA injection (Bodick et al., 2015; Kraus et al., 2018; Spitzer et al., 2019). However, 
TA-loaded MS did not affect cartilage pathology in this clinical trial (Spitzer et al., 2019) or an in 
vivo rat model of OA (Rudnik-Jansen et al., 2017). The product was not evaluated for cartilage 
repair. 
 
1.3.3.2 In Vitro Use 
DEX, a synthetic glucocorticoid, is a common media supplement for chondrogenic and osteogenic 
cultures. Used at relatively low doses (100 nM), it stimulates anabolism in immature tissues and 
contributes to maintenance of mature tissues in vitro (Bian et al., 2010; Lima et al., 2008c, 2007). 
Lu and co-workers have reported that DEX concentrations as low as 1 nM were sufficient to protect 
cartilage explants against TNF-, and concentrations of 100 nM to 10 µM enhanced cartilage 





been reported to inhibit collagen degradation of cartilage explants in response to IL-1 and 
plasminogen (Saito et al., 1999). Although typically administered via bolus dose, it has been 
demonstrated that in vitro sustained DEX release from poly(lactic-co-glycolic acid) (PLGA) 
microspheres (MS) promotes development of functional engineered cartilage and confers 
protection from pro-inflammatory cytokine-induced tissue degradation (Roach et al., 2016b). 
 
1.3.4 Electrotherapeutics 
1.3.4.1 Pulsed Electromagnetic Fields 
Historically, PEMFs have been used in a clinical setting to treat delayed unions of bone fractures 
(Becker et al., 1977). Low intensity PEMFs have also been used to reduce joint inflammation and 
pain (Betti et al., 1999; Zorzi et al., 2007) and is clinically-approved for treatment of arthritis (De 
Mattei et al., 2009; Gobbi et al., 2014; Ongaro et al., 2012; Ryang We et al., 2013; Trock et al., 
1993; Varani et al., 2008). More recently, PEMFs were shown to improve function following 
microfracture, MACI, bone marrow-derived cell transplantation, and OCA (Cadossi et al., 2014; 
Collarile et al., 2018; Iwasa and Reddi, 2018). However, while these initial clinical studies were 
promising, PEMFs have remained controversial for arthritis and cartilage repair due to limited 
clinical evidence of robust efficacy and few mechanistic studies on the matter (American Academy 
of Orthopaedic Surgeons Board of Directors, 2013; Bjordal et al., 2007; Gobbi et al., 2014). 
Controlled laboratory experiments have suggested several potential mechanisms of action. 
In vitro studies have established PEMFs as a modulator of inflammatory signaling in isolated 
chondrocytes and FLS (De Mattei et al., 2009; Vincenzi et al., 2013). Specifically, it has been 
shown that PEMF may attenuate inflammation through the adenosine pathway (De Mattei et al., 





chondrocyte proliferation and matrix production (Mattei et al., 2001; Ongaro et al., 2011) as well 
as chondro-differentiation of MSCs (Esposito et al., 2013). Enhanced proteoglycan synthesis was 
also observed in bovine and human OA cartilage explants (De Mattei et al., 2007; Ongaro et al., 
2011). Nevertheless, in vivo studies have struggled to reproduce positive culture results in 
synovium and cartilage. In autologous cartilage repair in sheep, enhancement of subchondral bone 
integration was observed, however cartilage and synovium were not significantly affected 
(Benazzo et al., 2008). 
 
1.3.4.2 Direct Current Electrical Fields 
Endogenously generated EF gradients are known to guide cell migration in developing embryos 
(Robinson, 1985). Analogous to their role in development, both pulsed and continuous DC EF 
gradients of 1-10 V/cm guide cell migration in regeneration following connective tissue injuries 
in adult animals (Baker et al., 1974; Lippiello et al., 1990; Nessler and Mass, 1987; Soong et al., 
1990). Pulsed DC EFs have been used therapeutically in humans (Kloth, 2005), especially for 
promoting healing of non-joining bone fractures and dermatological wounds, including diabetic or 
pressure-induced ulcers (Braddock et al., 1999). The use of DC EFs of strengths ranging from 0.1-
10 V/cm is known to induce directed movement (galvanotaxis) and shape change (galvanotropism) 
in a number of musculoskeletal cells in vitro, such as chondrocytes, ligament fibroblasts, meniscal 
fibrochondrocytes, and FLS (Table 1.2) (Chao et al., 2007, 2000; Finkelstein et al., 2007; Gunja 
et al., 2011; Tan et al., 2011). Exposed to a DC EF of 6 V/cm, FLS exhibited anodal migration at 
P1 and cathodal migration at P4 and directed velocity of up to 5 µm/hr (A. R. Tan et al., 2015a).  
The translation of these findings to biomimetic and/or 3D configuration is unclear, 





systems. Most 2D galvanotaxis systems have the advantage of simple and repeatable 
measurements that also allow real-time microscopic analysis (Chao et al., 2007, 2000; O’Connell 
et al., 2015; Tan et al., 2011). Cell phenotype and behavior is known to change drastically based 
on substrate and 3D environment (Sun et al., 2006). In order to better model how cells might 
migrate in vivo, others have created pseudo-3D culture systems capable of applying pulsed and 
continuous DC EFs to cells (Sun et al., 2004; Wu et al., 2014; Yuan et al., 2014; Zhao et al., 1996). 
These set-ups are typically unable to accommodate irregularly sized explants and/or TE constructs, 
instead examining single cells on an acellular substrate. 
 
Table 1.2 Summary of in vitro galvanotaxis studies. 





2D Glass Slide Chondrocytes 6 V/cm DC, 
5% FBS 
6.21 µm/hr Cathode (P2) or anode (P4) (O’Connell et 
al., 2015) 
2D Glass Slide Chondrocytes 10 V/cm DC, 
5% FBS 
17.59 µm/hr Cathode (P1) (Chao et al., 
2000) 
2D Glass Slide Synovial 
Fibroblasts 
6 V/cm DC, 
5% FBS 
~5 µm/hr Anode (P1) or Cathode (P4) (A. R. Tan et al., 
2015b) 
3D Confluent Cell 
Sheets 
Epithelial cells 1.5 V/cm DC, 
10% FBS 
~15 µm/hr Cathode (Zhao et al., 
1996) 




0.1 V/cm DC, 
10% FBS 
13.74 µm/hr Perpendicular to EF (Sun et al., 
2004) 




3 V/cm pulsed 
(2ms and 1 
Hz), 10% FBS 
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Chapter 2 Explanted and Engineered Synovium: Complementary Approaches to Evaluate Structure-
Function in Response to Chemical Stimuli 
Explanted and Engineered Synovium: 
Complementary Approaches to Evaluate Structure-
Function in Response to Chemical Stimuli 
 
2.1 Introduction 
In both OA and acute joint injury, architectural and compositional changes to the synovial 
membrane affect secretion, lubrication, and transport behavior in the synovium, contributing to an 
altered joint homeostatic environment (Elsaid et al., 2008; Mwangi et al., 2018; Smith, 2011). Yet, 
despite the appreciation for the role that the synovium plays in cartilage and joint health, 
quantitative structure-function data for this tissue remain incomplete. We anticipate that through 
development of a functional tissue engineered synovium model, limitations of explant culture 
systems can be overcome while also avoiding the pitfalls of simpler monolayer culture systems 
(Table 1.1). Our laboratory has extensive experience evaluating the response of engineered and 
explanted cartilage to pro-inflammatory cytokine (i.e. IL-1) and anti-inflammatory drug (i.e. DEX) 
stimulation (Bian et al., 2010; Lima et al., 2008b). DEX, a glucocorticoid, is widely used in joint 
applications, both clinically and in culture (1.3.3), however it is unclear how it affects synovium 
behavior. 
To this end, we aimed to build on this knowledge by developing complementary 





synovium structure-function. Here, we modified an existing Matrigel-based micropellet approach, 
where FLS-only constructs were able to reorganize in an intimal lining architecture that became 
hyperplastic in the presence of TNFα, secrete lubricin, and support blood monocyte survival 
(Kiener et al., 2010, 2006; Kiener and Brenner, 2005; Valencia et al., 2004). Matrigel shares many 
ECM constituents of native synovium and supports synovial cell assays for studying pro-
inflammatory cytokine effects on proliferation and cell infiltration (Kiener et al., 2010; Kiener and 
Brenner, 2005; Lee et al., 2007; Valencia et al., 2004). Building on this approach, we hypothesized 
that an engineered synovial membrane can recreate structure-function of native tissue. Further, 
cytokine- or glucocorticoid-induced changes to solute transport and lubrication properties can be 
related to changes in architecture and composition. 
To this end, we first describe the development of a juvenile bovine FLS-based engineered 
synovium, cultured as a flat, disk-shaped membrane in a Transwell insert (SA1a). Second, the fully 
formed engineered synovium was subjected to IL-1 and DEX treatment, and changes to structure-
function were compared to explant tissue (SA1b). The bovine model was then expanded to include 
labeled MLS in order to track cell response (SA1c). Finally, engineered synovium was prepared 
using passaged human FLS and co-cultured with human T lymphocytes in IL-1 and DEX treated 
conditions (SA1d). 
 
2.2 Bovine FLS-based Engineered Synovium Responds Similarly to 
Interleukin-1 and Dexamethasone as Explants in Culture 
2.2.1 Introduction 
In this section, studies are described to characterize and validate the FLS-based engineered 
synovium in baseline as well as IL-1 and DEX-treated conditions (SA1a-b). A basic science bovine 





exhibited by engineered constructs and ease of procurement of synovial explants, which facilitated 
model validation by comparing engineered and native tissues. Engineered constructs were 
prepared by encapsulating FLS in Matrigel (Kiener and Brenner, 2005; Lee et al., 2007) and 
allowing gelation directly in a Transwell to create a flat, disk-shaped construct. Constructs were 
then pre-cultured to allow cellular reorganization into an intimal lining layer with underlying sub-
intimal layer. First, key baseline features of native synovium structure-function were assessed. 
Tissue behavior was then compared in response to IL and DEX stimulation. This included ECM 
and cell content, and for the first time, quantitative measurements of solute transport and 
lubrication function. 
 
2.2.2 Materials and Methods 
2.2.2.1 Synovium Explant Harvest 
Fresh synovial tissue was harvested from discarded (IACUC-exempt) bovine calf knee joints (2-4 
weeks old). Explants were collected from the region adjacent to the medial and lateral femoral 
condyles (Figure 2.1). For subsequent in vitro experiments, tissue was pooled from 4 donor 
animals and diced into consistent ~5 mm  5 mm pieces. Prior to studies, explants were maintained 
for up to two weeks in serum-free basal media (BM) consisting of DMEM supplemented with 
50 μg/mL L-proline (Cat. No. P5607; Sigma), 100 μg/mL sodium pyruvate (Cat. No. S8636; 
Sigma), 1% ITS™+ Premix (contains insulin, transferrin, selenous acid, BSA, and linoleic acid; 







Figure 2.1 Bovine synovium explant harvest. Synovium (arrow) was harvested from the 
medial and lateral femoral condyles of juvenile bovine knees.  
 
2.2.2.2 Formation of Tissue Engineered Synovium Constructs 
Synovium was digested in collagenase type II (Cat. No. LS004177; Worthington Biochemical 
Corporation) for 2 hours with stirring at 37°C. Digested synovial cells were filtered through a 70 
µm porous nylon mesh. Viable cells were counted and plated at a density of 1.76103 cells/cm2 
for expansion. The mixed population of primary synovial cells was expanded for two passages in 
α-Minimum Essential Medium (αMEM; Cat. No. 12000022; ThermoFisher) containing 10% fetal 
bovine serum (FBS; Cat. No. S11550; Atlanta Biologicals), 1% antibiotic-antimycotic (Cat. No. 
15240062; ThermoFisher), and 5 ng/ml fibroblast growth factor-2 (FGF-2; Cat. No. PHG0264; 
ThermoFisher) (Alegre-Aguarón et al., 2014; Sampat et al., 2011b; A. R. Tan et al., 2015a). The 
resulting population of FLS was suspended at 5106 cells/ml in 7 mg/ml Matrigel (Cat. No. 
354234; Corning) (Figure 2.2A). For biochemical and histological analyses, constructs were cast 
in 6.5 mm Transwells with 3 m polyester filter membranes (Cat. No. 3472; Corning), resulting 
in disk-shaped specimens attached to the underlying filter (volume = 100 µl, diameter = 6.48 mm, 





geometry. Transport analyses were conducted using a parallel set of TE specimens cast in a scaled-
down (volume = 25 µl, diameter = 4.27 mm, height = 1.70 mm) 4.26 mm Transwell system (Cat. 
No. 3385; Corning). To induce ECM deposition and the stratified intimal/subintimal organization, 
constructs were initially cultured in Dulbecco’s Modified Eagle’s Medium (DMEM; Cat. No. 
12100046; ThermoFisher) supplemented with 10% FBS, 1% antibiotic-antimycotic, and 50 µg/ml 
ascorbic acid-2-phosphate (Cat. No. A8960; Sigma) for 21 days in the upper compartment of the 
Transwell only (Figure 2.2B). During this period, the basolateral compartment was left empty and 
media in the luminal compartment was changed three times per week. Luminal media volumes 
were 100 µl and 300 µl for 4.26 mm and 6.5 mm Transwells, respectively. 
 
 
Figure 2.2 Schematic of engineered synovium formation. (A) The construct is initially cast in 
the luminal compartment of a Transwell insert. Cells are suspended within the Matrigel matrix in 
a random orientation. Representative day 0 histology (left) and gross morphology (right). (B) 
During the 21-day pre-culture period, media is only supplemented in the luminal compartment. 
This induces cellular reorganization into a stratified architecture (intima and sub-intima). Matrix 
deposition also occurs during this period, resulting in a membranous construct. Representative day 






2.2.2.3 In Vitro Chemical Stimulation 
TE constructs and explants (EXP) were individually cultured for two weeks in one of four 
conditions: serum-free BM (CTL), 100 nM DEX, 10 ng/ml IL-1, or both DEX and IL-1 (ILDEX) 
(Lima et al., 2008b; Roach et al., 2016a). For TE constructs, media was introduced to both luminal 
and basolateral compartments, and media was changed three times per week. Basolateral media 
volumes were 200 µl and 700 µl for 4.26 mm and 6.5 mm Transwells, respectively. Individual 
EXP specimens were cultured in 1 ml media each, again with media changes three times per week. 
TE synovium was harvested at day 21 (initial maturity, start of treatment) and day 35 (end of two-
week treatment) for biochemical, histological, and transport analyses. Synovium explants were 
harvested at day 0 (initial harvest, start of treatment) and day 14 (end of two-week treatment). 
 
2.2.2.4 Functional Assessment of Tissue Permeability 
Three different solutions were prepared, each containing a different FITC-labeled dextran diluted 
in PBS (10 kDa, 0.5 mg/ml, Cat. No. D1820; 70 kDa, 0.5 mg/ml, Cat. No. D1822; 500 kDa, 0.2 
mg/ml, Cat. No. D7136; ThermoFisher). Small dextrans were selected to resemble the MW of the 
pro-inflammatory cytokines IL1α (17 kDa) and TNFα (17 kDa), as well as TGFβ3 (27 kDa), 
MMP-2 (72 kDa), and small MW HA. Lubricin (200-400 kDa) concentrations are 0.3-0.4 mg/ml 
(Levick, J. R., et al., 1999) and 0.11-0.18 mg/ml (Levick, J. R., et al., 1999) in healthy and OA 
knees, respectively, whereas HA (27-10,000 kDa) concentrations are on the order of 1-4 mg/ml, 
depending on disease state (Levick, J. R., et al., 1999).  
At time zero, 50 µl of FITC-labeled dextran in PBS solution was added to the upper 
(luminal) compartment of the Transwell (n=7-8 per media-solute size pairing) (Figure 2.3C). PBS 





PBS at 0, 1, 2, 4, 8, 24, 48, and 72-hour time points. The basolateral solute concentration was 
quantified for each time point using a fluorescent plate reader (SpectraFluor Plus, Tecan) at an 
excitation and emission wavelength of 495 nm and 519 nm, respectively. Clearance, defined as 
the amount of dextran collected from the basolateral compartment as a function of the starting 
amount of dextran in the luminal compartment, was plotted as a function of time. Apparent 
permeability (Pd) was computed as a function of solute flux (Js), area of the filter (S), and solute 
concentration difference in the luminal and basolateral compartment (ΔC): Pd = Js/(SΔC) (Garcia 
et al., 2011; Yuan and Rigor, 2010). For this computation, it was assumed that solute flux was 
determined entirely by diffusion. In a similar manner, permeability of 70 kDa dextran was assessed 
in CTL and IL-treated bovine explants (n=3-4) by affixing a piece of tissue to a larger 6.5 mm 
Transwell using a silicone gasket (Figure 2.3B, D). The DEX group was omitted from explant 
transport analysis due to sample size limitations related to the large amount of explant tissue 
required to make these measurements. However, solute transport in native explants was visualized 







Figure 2.3 Schematic of solute transport studies in TE synovium and explants. (A) TE 
synovium (arrow) was cultured and tested in situ on a 4.26 mm Transwell insert. (B) Synovium 
explant (arrow) was secured to the underside of a 6.5 mm Transwell insert using a rubber gasket 
(red); Change in permeability of FITC-labeled dextran in (C) TE and (D) explant synovium (I) 
was assessed using a Transwell system. The dextran suspension (II) was placed in the luminal 
compartment (i.e. the synovial cavity). PBS (III) was added to the basolateral compartment (i.e. 
the fibrous capsule and associated vasculature) and sampled at time points to quantify joint 
clearance.  
 
2.2.2.5 Functional Assessment of Tissue Friction 
Baseline minimum friction coefficient of bovine TE and explant synovium (n=3) was determined 
using a custom loading device, as described in (Estell, 2018). Briefly, a multiaxial load cell made 
continuous measurements of normal and friction forces during reciprocal sliding of synovium 
against a glass platen at 1 mm/s with 25 kPa contact pressure applied. Friction coefficients were 
calculated for each cycle from the ratio of the two forces and averaged over a 1 hr test. During 





 Separately, spatially-varying modulus of the synovium was measured using atomic force 
microscopy (AFM, Asylum MFP 3D Bio Infinity). At each of 5 different “local test regions” (100 
μm × 100 μm) synovium specimens were subjected to 5 elastic modulus indentation tests 
(Krishnan et al., 2004). 
 
2.2.2.6 Biochemistry 
Bovine TE constructs (n=8-10) and explants (n=9-10) were frozen at -20 °C. Lyophilized samples 
were weighed to obtain specimen dry weight (DW) prior to digestion. Samples were solubilized 
by incubating for 16 hours at 56 °C in 0.5 mg/mL proteinase K (Cat. No. 193504; MP Biomedicals) 
in 50 mM Tris buffered saline containing 1 mM EDTA, 1 mM iodoacetamide (Cat. No. 12227-
1000; Acros), and 10 mg/mL pepstatin A (Cat. No. BP2671100; Fisher) (Riesle et al., 1998). DNA 
and collagen content were analyzed using the Picogreen (Cat. No. P11496; ThermoFisher) and 
orthohydroxyproline (OHP) assays, respectively. The OHP assay was performed as previously 
described (Hollander et al., 1994). 
 
2.2.2.7 Media Analyses 
Media samples were assayed using a HA Quantikine ELISA Kit (Cat. No. DHYAL0; R&D 
Systems). To account for variations in size of the specimens, HA values were normalized to the 
final dry weight of the associated specimens. Additionally, NO was assayed using a Griess Reagent 
Kit (Cat. No. G7921; ThermoFisher). Agarose gel (0.5% w/v in TAE buffer) electrophoresis (~2.3 
V/cm for 6 hours) and subsequent staining with 0.005% Stains-All (Cat. No. E9379; Sigma) in 
50% ethanol was used to determine relative MW distributions for pooled TE and EXP samples 





ThermoFisher) and ~1.5-1.8 MDa HA (Cat. No. 53747; Sigma) were used as approximate MW 
standards. A solution of 50% (v/v) juvenile bovine synovial fluid in PBS was added as an 
additional comparison. ImageJ was used to generate size distribution histograms from imaged gels 
and quantify peak location and area under curve. 
 
2.2.2.8 Histological and Immunohistochemical Characterization 
4% paraformaldehyde-fixed samples (TE and EXP) were embedded in paraffin wax and sectioned 
in 8 μm slices. Deparaffinized sections were stained with hematoxylin and eosin (H&E) to 
determine cell distribution and picrosirius red to determine collagen distribution. Samples were 
immunohistochemically stained for collagen type I (Smith, 2011) (1:200; rabbit polyclonal; Cat. 
No. ab34710; Abcam), collagen type IV (Smith, 2011) (1:500; rabbit polyclonal; Cat. No. ab6586; 
Abcam), lubricin (Jay et al., 2000b) (1:250; rabbit polyclonal; Cat. No. ab28484; Abcam), CD-14 
(Zimmermann et al., 2001) (1:200; rabbit polyclonal; Cat. No. ab203294; Abcam), and cadherin-
11 (Lee et al., 2007) (1:40; goat polyclonal; Cat. No. AF1790; R&D Systems) using a 
3,3'Diaminobenzidine (DAB) Substrate Kit (Cat. No. ab64238; Abcam). Briefly, heat mediated 
epitope retrieval was performed for 10 minutes at 98 °C in citrate buffer (pH 6) prior to 
commencing the DAB protocol. The sections were counterstained with hematoxylin. Isotype 
controls were prepared to rule out non-specific staining. 
 
2.2.2.9 Statistics 
Data sets were tested for normality and homogeneity using the Kolmogorov-Smirnov Test and 
Bartlett's test, respectively. If possible, non-normal data was log-transformed to achieve normal 





data were analyzed using the Kruskal Wallis test and Dunn’s post-hoc test. Normal and 
homogeneous data sets were analyzed using one- or two-way analysis of variance (ANOVA) with 
Tukey honest significant difference (HSD) post-hoc test. A Pearson (r) or Spearman (rs) 
correlation coefficient was computed for relevant comparisons with α=0.05. All statistical tests 




2.2.3.1 Baseline Comparison of TE and Explant Synovium 
Mature day 21 TE synovium exhibited structural characteristics of native synovium. TE synovium 
exhibited an opaque, flat morphology, reminiscent of the membranous appearance of native tissue 
explants (Figure 2.4A-B). The formation of the intimal lining, a key characteristic of synovium, 
was confirmed with H&E (Figure 2.4C-D). Three-dimensional z-stack reconstructions of confocal 
images showed similar patterns of cellular organization in each tissue (Figure 2.4E-F). 
Additionally, TE synovium expressed critical proteins of interest in the native synovium. Lubricin 
(Figure 2.4G-H), cadherin-11 (Figure 2.4I-J), collagen type I (Figure 2.4M-N), and collagen 
type IV (Figure 2.4O-P) were highly expressed in the intimal lining layer, but also throughout the 
sub-intima. CD14 expression (Figure 2.4K-L), indicative of MLS or monocyte phenotype, was 
low in each tissue. TE and explant synovium had statistically similar baseline permeability and 
minimum friction coefficient (Figure 2.5A-B). Furthermore, a similar distribution of elastic 
modulus was observed in the two tissue types, however a higher proportion of EXP regions had 

















Figure 2.4 Structure and composition of bovine 
explant and TE synovium. (A) Explant and (B) TE 
synovium displayed an opaque, flat, membranous 
morphology. (C, D) A 1-4 cell thick intimal lining 
layer was observed using H&E. (E, F) 3D z-stack 
reconstruction with cells labeled with calcein-AM 
(green) showed similar cellular localization to the 
surface of the tissue with fewer subintimal cells. 
Positive immunohistochemical staining was 
visualized with DAB Peroxidase and cells were 
counterstained with hematoxylin. Both tissues 
showed (G and H) lubricin and (I and J) cadherin-
11 expression. (K) CD14 expression was extremely 
low in EXP synovium, as expected for “healthy” 
synovium containing primarily FLS, whereas (L) TE 
synovium had negative staining. (M and N) Type I 
and (O and P) type IV collagen were also present in 
both tissues. (Q and R) Corresponding isotype 






Figure 2.5 Baseline permeability and mechanical properties of explant and TE synovium. (A) 
Mean permeability of 70 kDa FITC-dextran was similar in EXP (n=3) and TE (n=7) synovium. 
(B) Minimum equilibrium friction coefficient was similar in EXP (n=3) and TE (n=3) synovium 
(Estell, 2018). (C) Histogram of AFM elastic modulus measurements for EXP and TE synovium, 
inset: tip of AFM probe on explant. 
 
2.2.3.2 Lubricant Secretion 
Robust lubricin staining was observed in EXP and TE synovium for both CTL and IL groups, with 
comparatively weaker staining in DEX groups (Figure 2.6A). HA secretion in IL groups was 
significantly higher than CTL in TE synovium and bovine explants (p<0.05) with a near twofold 
increase, and to a lesser extent in TE synovium treated with DEX (p<0.05) (Figure 2.6B). Gel 
electrophoresis of pooled specimens (Figure 2.6C, D) showed that both CTL and DEX-treated 





counterparts. The 1.5 MDa HA standard and bovine synovial fluid contained predominantly high 
(>460 kDa) MW HA, although a large size range with multiple peaks was observed in each (Figure 
2.6D). Further, of the high MW HA (>460 kDa) in explant specimens, CTL and DEX-treated 







Figure 2.6 Lubricin and HA secretion in bovine TE and EXP synovium. (A) Robust lubricin 
expression (reddish brown) was observed in CTL and IL groups for both EXP and TE synovium, 
with comparatively weaker staining in DEX groups. (B) Overall, bovine TE and EXP synovium 





DEX. (C) Agarose gel electrophoresis (HA, blue; ladder, purple) showed approximate HA size 
distribution of (D) pooled experimental groups and standard molecules of interest. In both EXP 
and TE synovium, wide HA MW distributions were observed, with the highest proportion of high 
MW HA (lower relative mobility) being estimated in CTL and DEX-treated groups. Peaks 
(arrows) represented mobility of the predominant high MW HA for a given group. The upper size 
limit of the ladder was 460 kDa (dotted line), which was used as a cut-off point to approximate the 
relative amounts of small and large MW HA in the given sample. Lower MWs could not be 
accurately resolved in the given gel conditions (low agarose concentration and high voltage) that 
were otherwise necessary for HA mobility. 
 
2.2.3.3 Structure-Function Response 
Total collagen content, normalized to average initial collagen content in the given tissue type, was 
significantly lower in DEX-treated TE synovium compared to CTL (p<0.05) (Figure 2.7A). A 
similar trend was observed in IL-treated TE synovium (p=0.270). No significant differences were 
observed in collagen of bovine explants (Figure 2.7B). DNA content, normalized to initial DNA 
content, was elevated in IL-treated TE (p=0.163) and bovine explant (p=0.136) synovium relative 
to their CTL counterparts (Figure 2.7C, D). When comparing the relative change in ratio of 
collagen to DNA, COL/DNA was significantly lower in TE DEX and TE IL relative to TE CTL 
(p<0.05) (Figure 2.7E). A similar trend of decreased COL/DNA in bovine EXP IL was seen 
compared to CTL (p=0.104) (Figure 2.7F). 
Similarities were observed in structural changes undergone by TE and EXP synovium, as 
visualized with H&E and picrosirius red histology (Figure 2.8). CTL specimens were especially 
fibrous, with strong picrosirius red staining and associated large gaps present in the ECM. DEX 
specimens had increased intimal cellularity and slightly denser matrix. IL specimens had further 







Figure 2.7 Total collagen and DNA content in bovine TE and explant synovium. (A) Change 
in total collagen was significantly lower in DEX-treated TE synovium relative to CTL (p<0.05), 
and a similar trend was observed in IL-treated TE synovium (p=0.2698). (B) Total collagen was 
statistically unchanged in all bovine explant groups. Change in DNA was elevated with IL 
treatment relative to CTL for (C) bovine TE synovium (p=0.163) and (D) EXP synovium 
(p=0.136). DNA significantly decreased compared to initial values in TE CTL and increased 
compared to initial values in EXP IL (p<0.05). Change in COL/DNA was significantly lower in 
DEX- and IL-treated groups compared to CTL for (E) bovine TE synovium (p<0.05), and similar 







Figure 2.8 H&E and picrosirius red histology of bovine TE and EXP synovium. Similarities 
were observed in structural changes undergone by TE (upper) and EXP (lower) synovium, as 
visualized with H&E and picrosirius red staining. CTL specimens were especially fibrous, with 
strong picrosirius red staining and associated large gaps present in the ECM. DEX specimens had 
increased intimal cellularity and slightly denser matrix staining. IL specimens had further 





For solute transport analysis, the two separate fluid reservoirs modeled different 
compartments within the joint. The luminal compartment modeled synovial fluid while the 
basolateral compartment modeled the extra-capsular space. Total clearance over 72 hours (Figure 
2.9A, C, E) mimicked differences in permeability (Figure 2.9B, D, F) in each group, with higher 
clearance correlating to higher permeability values, as expected. Cell-free Matrigel controls (not 
plotted) consistently had significantly higher clearance than TE constructs over the 72-hour 
measurement period (p<0.05). Cell-free controls vs. TE constructs had 72-hour dextran clearances 
of (~56% vs. ~25%) for 10 kDa, (~24% vs. ~13%) for 70 kDa, and (~17% vs. ~5%) for 500 kDa. 
Overall, permeability in TE synovium (Figure 2.9A-F) was significantly decreased with 
increasing solute MW (p<0.05). Both DEX and IL resulted in decreased permeability of the 70 
kDa solute (p<0.05), with approximate decreases of 28% and 26%, respectively (Figure 2.9D). In 
TE synovium, decreased collagen to DNA ratio (COL/DNA) was strongly correlated with 
observed decreases in permeability of 70 kDa dextran (r(2) = 0.9736, p = 0.0264). Specifically, 
DEX and IL specimens had lower COL/DNA compared to CTL (Figure 2.7E) and similarly had 
lower permeability (Figure 2.9D). No significant differences or correlations were observed with 
the 10 kDa and 500 kDa solutes.  
Total 72-hour clearance of 70 kDa dextran was significantly higher in EXP compared to 
TE specimens (p<0.05), however variance was quite high compared to TE constructs. Permeability 
of 70 kDa dextran was statistically similar in TE synovium and bovine explants, with coefficients 
of 4.3  10-4 ± 1.1  10-4 cm/hr and 4.9  10-4 ± 2.1  10-4 cm/hr, respectively. Permeability of 70 
kDa dextran in CTL bovine explants increased twofold (p=0.0941), while IL-treated explants 
remained unchanged (p=0.88) (Figure 2.9H). No significant correlation between permeability 









Figure 2.9 Cumulative clearance of dextran and corresponding permeability values were 





in bovine EXP specimens (G-H). (D) Both DEX- and IL-treated TE groups exhibited decreased 
permeability relative to CTL with 70 kDa dextran only. Permeability of 70 kDa dextran in CTL 
did not differ significantly from native tissue (dotted line, value from 7H), whereas DEX and IL 
specimens were significantly lower (*p<0.05 vs. CTL, †p<0.05 vs. native). (G-H) In EXP 
synovium (N=3-4), permeability in CTL increased over time and was higher than IL-treated tissue, 
but neither observation was statistically significant (p=0.0941 and p=0.3448, respectively). (I) 
Representative 3D confocal image of 70 kDa FITC-Dextran (green) and resident cells (red-orange) 
within a living synovium explant showed diffusion occurring in intercellular spaces. 
 
2.2.3.4 Inflammatory Response 
NO secretion per DNA was elevated in IL-treated TE synovium and bovine explants compared to 
corresponding DEX groups (p<0.05) (Figure 2.10A, C). Day 0 bovine TE synovium and explants 
consisted primarily of CD14- cells (Figure 2.10B, D). In both tissue types, relatively intense CD14 
staining (reddish-brown) was observed in CTL and IL specimens. DEX-treated tissues had 
relatively less intense staining compared to CTL and IL, however elevated compared to initial. 
 
 
Figure 2.10 Nitric oxide secretion and CD14 expression in TE synovium and explants. NO 





*p<0.05 vs. CTL, †p<0.05 vs. DEX. Elevated CD14 expression (reddish brown) was observed in 
(B) TE and (D) explant tissue treated with IL. An increase was also seen in CTL groups, but CD14 
staining was less intense for DEX specimens. 
 
2.2.4 Discussion 
The findings of these studies support the specific hypothesis linked to SA1a-b and, by extension, 
the global hypothesis of Part I. Similarities in baseline structural, biochemical, solute transport, 
and friction properties were observed in bovine TE synovium and native synovium explants. 
Furthermore, similar IL-1 and DEX-induced changes in structure-function were observed. 
Specifically, engineered synovium allowed quantitative correlations between structure and solute 
transport function that are not possible with other culture techniques. 
The FLS-only TE synovium exhibited a defined intimal lining layer and expressed lubricin 
and cadherin-11, among other markers of native synovium (Figure 2.4). TE and explant synovium 
also had similar baseline permeability to 70 kDa dextran and minimum friction coefficient (Figure 
2.5). Increased HA secretion in response to IL and DEX was characteristic of TE and native tissue 
(Figure 2.6). Relative size determination by gel electrophoresis showed a shift to lower MW HA 
in IL-treated specimens compared to CTL and DEX (Figure 2.6). A similar trend has been 
observed in OA patients, where the proportion of pro-inflammatory, low MW HA in the joint 
(Jiang et al., 2011) tends to increase due to the breakdown of larger MW HA (Stern, 2004). 
Synovium explants from healthy and OA donors exposed to cytokine insult have increased 
concentration of pro-inflammatory mediators such as MMPs, NO and PGE2 (Beekhuizen et al., 
2011; Cook et al., 2007; Hardy et al., 2002; Lee et al., 2009; Swärd et al., 2017; van Buul et al., 





and to modulate cell biosynthesis in the joint (Roach et al., 2016a), likely influencing FLS as well 
(Reyes et al., 2008). Similar trends in NO secretion were observed in our specimens (Figure 2.10). 
The concentration of lubricin, another lubricant molecule, was decreased in the ECM of 
DEX-treated and control bovine explants, whereas it was maintained or increased in IL-treated 
groups (Figure 2.6). It is possible that greater levels of secreted lubricants in the media for DEX 
groups are correlated to lower levels within the tissue itself; however, additional studies will be 
required to confirm this. OA synovial fluid contains decreased concentrations of lubricin (Blewis 
et al., 2010a; Elsaid et al., 2008; Mathiessen and Conaghan, 2017; Jeremie Sellam and Berenbaum, 
2010), despite reports that human OA FLS rapidly proliferate and secrete increased concentrations 
of lubricant molecules (e.g. HA and lubricin) when treated with IL-1β and TNF-α in vitro (Blewis 
et al., 2010a, 2010b; Furuzawa-Carballeda et al., 2008; Gitter et al., 1989; Hamilton et al., 1994; 
Pulkki, 1986). Overall, it is presumed that the relative balance between aberrant cytokine and 
lubricant production in the joint and altered transport properties determines synovial fluid content 
of lubricant molecules. 
Permeability of 500 kDa dextran was ~1.6-1.9  10-4 cm/hr in TE synovium, which is 
similar to that of lubricin and HA (~0.36-1.8  10-4 cm/hr) in membranes of physiologic pore size 
(50 nm) (Blewis et al., 2007). Permeability of 70 kDa dextran was statistically similar in TE 
synovium and bovine explants, with coefficients of 4.3  10-4 ± 1.1  10-4 cm/hr and 4.9  10-4 ± 
2.1  10-4 cm/hr, respectively. Furthermore, the observed relationship between increasing solute 
size and decreased permeability parallels in vivo findings of the rabbit knee, which showed 
increased clearance of low MW HA (≤500 kDa) compared to high MW HA (~2,200 kDa) 
(Coleman P. J. et al., 2004a; Sabaratnam S. et al., 2005). As 10 kDa dextran permeability was 





spaces. On the other hand, molecules of 500 kDa and above diffuse very slowly. Future studies 
can investigate whether more accurate modeling, including computational analyses of the transport 
can resolve differences in behavior of higher MW solutes. 
Under the conditions of the current studies, treating TE synovium with DEX or IL resulted 
in a ~20% reduction in 70 kDa dextran permeability (Figure 2.9). A similar decrease in 
permeability was observed in IL vs CTL bovine explant tissues, however there was a high degree 
of statistical variance arising from the inherent challenges in harvesting uniform synovium samples 
from the joint (Figure 2.9). This functional change was related to lower collagen in DEX-treated 
TE synovium and greater DNA in TE synovium treated with IL. In fact, the relative ratio of 
COL/DNA (i.e. ECM vs. cells) in DEX- and IL-treated groups for both TE synovium and bovine 
explants was lower than CTL (Figure 2.7). In TE synovium, this lower COL/DNA was strongly 
correlated with observed lower permeability of 70 kDa dextran (r2 = 0.97, p = 0.0264). Though for 
bovine explant synovium, no significant correlation was detected, so it is unclear to what extent 
the ECM contributes to native tissue transport behavior. 
Others have described similar transport mechanisms in the synovium, which are facilitated 
by ECM volume fractions (primarily collagen fibrils and GAGs) and limited by the space occupied 
by cells (Blewis et al., 2007). A similar mechanism was observed here, with solute diffusion in 
native synovium occurring primarily around cells and through the interstitial ECM (Figure 2.9). 
This potential mechanism is further supported by histological findings (Figure 2.8), which showed 
intimal hyperplasia in both DEX and IL-treated TE specimens. This structural change was 
mirrored in explanted tissue, as well as increased collagen compaction in IL-treated groups relative 
to CTL. Future studies will be necessary to assess the relative importance of these structural 





Despite the similarity between transport characteristics of native and engineered synovium 
presented herein, it should be noted that the results of our in vitro solute transport are seemingly 
in contrast with reports of increased HA clearance from arthritic joints (Coleman P. J. et al., 2004b; 
Fraser et al., 1993), as well as elevated degradative enzymes associated with tissue breakdown and 
possible increased permeability (Marks and Donaldson, 2005). Notably, IL-1 is known to induce 
breakdown of endothelial layers and thereby increase permeability in blood-brain barrier models 
(Labus et al., 2014). Aside from the increased complexity of interpreting solute transport in the 
synovial joint, a living organ at the tissue level, it is speculated that this difference may be due to 
the competing contributions of higher clearance due to breakdown of HA and the thickening of 
the intimal layer, which may hinder transport. A recent study of dextran clearance in destabilized 
rat knees supports this hypothesis, showing slower transport of 500 kDa dextran and an apparent 
thickening of synovium in the destabilized joints (Mwangi et al., 2018). The downward shift in 
HA MW was recreated in our EXP and TE synovium experiments in response to interleukin 
(Figure 2.6). 
It is also likely that dextran does not fully recreate the complex tertiary structure of large 
MW HA or exhibit the same binding characteristics. Future work should examine various sizes of 
HA, however endogenous HA synthesis/breakdown in cultures and the high polydispersity of 
commercially available HA products may confound results. Furthermore, as additional variables 
are added to increase the complexity of our TE model, such as to examine the effects of vascular-
mediated clearance (Bhattaram and Chandrasekharan, 2016; Levick, J. R., et al., 1999), synovial 
fluid shear, hydrostatic pressure, and strain-dependent permeability, there may be more 





While correlations between structure and function may be limited by the different size 
Transwells used, it was necessary to fabricate engineered synovium of dimensions better suited 
for a particular target measurement. The larger 6.5 mm Transwell system was used to grow 
specimens that produced measurable levels of matrix and lubricants. A scaled down 4.26 mm 
system was adopted for the transport analyses to enable the high throughput necessary to test 
multiple dextran sizes with sufficient replicates. Importantly, comparisons between TE constructs 
subjected to different treatments were performed on engineered synovium derived from the same 
size Transwell. While it is possible that tissue properties may be somewhat dependent on the 
Transwell size, similar structural and chemical changes were observed in response to pro-
inflammatory cytokines to those reported for other configurations, such as engineered synovial 
microtissues (Kiener and Brenner, 2005) and FLS monolayers (Blewis et al., 2010b). For 
comparisons of TE synovium, initial construct dimensions as well as cell and Matrigel 
concentrations were kept consistent. Nevertheless, future studies will incorporate additional 
ELISAs and sensitive measurement techniques to allow all measurements in the scaled-down, 
high-throughput version of the system. 
Interestingly, an apparent phenotypic shift was seen in bovine explant cultures (Figure 
2.10) and may help to explain the similarity in the biological response of the FLS-based TE 
synovium and native tissues. CTL and IL-treated bovine TE synovium and explants had an 
increase in CD14+ cells and decrease in CD14- cells, whereas treatment with DEX maintained 
lower CD14 expression levels. This is striking due to the lack of MLS in the engineered synovium 
model. There is precedent for human fibroblasts to express and secrete soluble CD14 (Sugawara 
et al., 1998) and other markers of M1-activated macrophages (Manferdini et al., 2017) when 





to trans-differentiation of FLS (Fell, 1978; Graabaek, 1984). The following section examines this 
phenomenon further. 
 
2.3 MLS Content Changes Dramatically in Bovine Synovium Explant 
Culture and Modulates Structural Changes in Engineered Synovium 
2.3.1 Introduction 
The normal intimal lining is about 1-4 cells thick and composed of approximately 90% FLS and 
10% MLS (Valencia et al., 2004). FLS, the primary cells in the synovium, are largely responsible 
for ECM production (Kiener et al., 2010; Lee et al., 2007), lubricant secretion (Jay, 1992; Jay et 
al., 2007, 2000a), and contribute to the cascade of inflammatory cytokines in OA synovial fluid 
(Kiener et al., 2010). Hence, most biological studies of isolated synoviocytes have focused on 
solely on this cell type. However, the hyperplastic response includes a drastically changing 
distribution and quantity of FLS, MLS, and other immune cells depending on the stage of OA 
(O’Brien et al., 2017; Utomo et al., 2016). There is a concurrent increase in polarized macrophage 
infiltration from the vasculature and secretion of pro-inflammatory cytokines, all of which are 
thought to contribute to the progression of joint degeneration (Blewis et al., 2010b; Kiener et al., 
2006; Scanzello and Goldring, 2012a; Sutton et al., 2009). 
Motivated both by this knowledge and the apparent phenotypic shift observed in both the 
FLS-only TE synovium and explants in the preceding section (2.2), we sought to incorporate MLS 
into the engineered synovium model and track their role in structural reorganization of the intima 
(SA1c). It is anticipated that this added level of complexity will be necessary in order to decouple 
the roles of different cell types within the synovium, especially as its composition and structure 





or DEX, followed by co-culturing physiologically relevant quantities of MLS to mimic structural 
changes at different disease states and evaluate phenotypic stability. 
 
2.3.2 Materials and Methods 
2.3.2.1 Isolation and Expansion of MLS 
Synovial explant tissue from juvenile bovine (n=2-4) or human OA (n=3) knees was digested in 
collagenase type II for 2 hours at 37 °C. Isolated cells were counted using a hemocytometer before 
and after performing a CD14 Dynabeads™ (Cat. No. 11149D; ThermoFisher) selection protocol. 
Briefly, the mixed cell population of synovial cells was incubated in Dynabeads and magnetically 
separated based on CD14 expression. Dynabeads were removed from CD14+ cells prior to culture 
via trypsinization. 
For passaging, viable MLS (CD14+) were plated at a density of 1.76  103 cells/cm2 and 
expanded for two passages in αMEM containing 10% FBS, 1% antibiotic-antimycotic, and 10 
ng/ml macrophage colony stimulating factor (MCSF; Cat. No. PHC9504; ThermoFisher) 
(Gonçalves and Mosser, 2001). FLS were passaged as previously described (2.2.2.1). 
 
2.3.2.2 Cell Ratio Determination 
For quantification of initial CD14+ (i.e. MLS) and CD14- (i.e. FLS) content in explant tissues, 
parallel groups were counted with Dynabeads (to determine relative ratio) and quantified using the 
Picogreen DNA assay (to determine total cell content per dry weight). The resulting ratio and total 






2.3.2.3 Formation and Cytokine Treatment of TE Synovium with FLS and MLS 
P2 bovine MLS were pre-labeled using DiI lipophilic membrane dye (Cat. No. V22885; 
ThermoFisher) while P2 bovine FLS remained unlabeled. TE constructs were created as described 
previously (2.2.2.2), with the addition of three different FLS to MLS ratios: 100% FLS, 50% FLS 
+ 50% MLS, or 100% MLS. Each group had a total combined initial cell concentration of 5  106 
cells/ml. Pre-culture followed by treatment in CTL or IL conditions (N=2), as described earlier, 
was conducted. 
 
2.3.2.4 Histology and Immunohistochemistry 
TE specimens were processed for immunofluorescence. Briefly, sections were deparaffinized and 
heat mediated epitope retrieval was performed for 10 minutes at 98 °C in citrate buffer (pH 6). 
Sections were incubated overnight in CD14 primary antibody (1:200; rabbit polyclonal; Cat. No. 
ab203294; Abcam) followed by a 1-hour incubation in Alexa Fluor 488 secondary antibody 
(1:200, goat anti-rabbit, Cat. No. ab150077; Abcam). The sections were counterstained with DAPI. 
 
2.3.2.5 Statistics 
Statistical analyses were performed as previously described (2.2.2.9). 
 
2.3.3 Results 
2.3.3.1 CD14 Ratio Determination in Explants 
Day 0 bovine explants consisted primarily (>90%) of CD14- cells (Figure 2.11). This ratio of 
CD14+ to CD14- was did not significantly change over 14 days with DEX treatment. In CTL and 





(p<0.05). Concurrently, CD14- content decreased significantly in both groups, dropping to 
approximately 30% and 13% of total cells, respectively. Meanwhile, human OA explants 
contained less DNA per dry weight than bovine explant specimens; however, CD14+ constituted 
over 50% of the total cell population. 
 
 
Figure 2.11 Quantification of CD14+ and CD14- cells in explant synovium. The phenotype 
ratio of MLS (CD14+) to FLS (CD14-) in EXP tissue was maintained by DEX. In CTL and IL-
treated tissue, MLS content increased and FLS content decreased. Total cell content increased with 
IL treatment; *p<0.05 (total DNA), †p<0.05 (FLS), ‡p<0.05 (MLS). 
 
2.3.3.2 TE Synovium Co-culture of FLS and MLS 
The DiI membrane dye (red) robustly labeled MLS, and initial FLS to MLS ratios were 
qualitatively maintained over 14 days in CTL culture (Figure 2.12A). Furthermore, the CD14 
phenotype appeared to be stable, with red-labeled MLS also exhibiting strong positive expression 
of CD14 (green), while non-labeled FLS did not strongly express CD14. When treated with IL, 





MLS to FLS ratios resulting in a thicker intima (Figure 2.12B). Intimal layer formation was visible 
in all groups. 
 
 
Figure 2.12 CD14 immunohistochemistry of TE synovium containing MLS and FLS. Pre-
labeled MLS (DiI, red) and varying ratios of un-labeled FLS were cultured for two weeks in (A) 
CTL or (B) IL-supplemented media and all cells subsequently counterstained with DAPI (blue). 
In both CTL and IL groups, DiI (red) was co-localized with intense CD-14 expression (green). 
Intimal lining formation was apparent in all groups, regardless of cell type, with intimal 
hyperplasia apparent in groups treated with IL. 
 
2.3.4 Discussion 
The findings of these studies support the specific hypothesis linked to SA1c and, by extension, the 
global hypothesis of Part I. Specifically, these results highlight a strength of the engineered 
synovium model, where it is anticipated that the ability to define initial FLS to MLS ratios of the 
TE synovium may be important for modeling different stages of disease as well as understanding 





explants. The hyperplastic response to IL-1 was exacerbated by the presence of MLS (Figure 
2.12), which may have significant implications for transport and friction properties. Co-
localization of FLS and MLS in the hyperplastic intima is characteristic of native OA tissues, as 
well (O’Brien et al., 2017). 
A similar dual contribution to hyperplasia was observed in micropellet cultures, where FLS 
and monocytes “cooperated” in the TNFα-induced intimal formation (Byrne et al., 2014b, 2014a; 
Calvo et al., 2017). This is likely a product of both cell-cell and cell-ECM adhesive interactions in 
synovial remodeling (Agarwal and Brenner, 2006). FLS have been shown to play an important 
role in the regulation of macrophage phenotype (Donlin et al., 2014), and the reverse is likely also 
true. It will be informative to observe relative M1/M2 phenotype of resident and non-resident 
immune cells and correlating this to NO and PGE2 concentration, as well as transport and 
lubrication function. 
CTL and IL-treated bovine synovium explants had a significant increase in CD14+ cells 
and decrease in CD14- cells, whereas treatment with DEX maintained CD14 expression levels 
(Figure 2.11). This confirmed the qualitative observations made in both engineered and explanted 
tissues in Chapter 2.2. Meanwhile, human OA explants were predominantly composed of CD14+ 
cells, which was similar to the distribution observed in CTL and IL-treated explants. It is likely 
that a significant portion of CD14+ cells in the OA human tissue were blood-derived cells, rather 
than resident MLS (Bhattaram and Chandrasekharan, 2016). However, there is precedent for 
human fibroblasts to express and secrete soluble CD14 (Sugawara et al., 1998) and other markers 
of M1-activated macrophages (Manferdini et al., 2017) when exposed to an inflammatory 
environment, so it remains possible that a phenotypic shift is partially due to transdifferentiation 





2.4 T Lymphocytes Modulate Engineered Human Synovium Response to 
Interleukin-1 and Dexamethasone 
2.4.1 Introduction 
The approach of using a surrogate synovium model is attractive in that quantitative transport and 
lubrication measurements and other high throughput in vitro mechanistic studies can be performed 
on tissues that are fabricated from cells derived from clinical biopsies and human blood specimens 
(Bondeson et al., 2010). In clinical OA specimens, infiltrating mononuclear cells are 
predominately CD14+ monocytes/macrophages and CD4+ T lymphocytes (Moradi et al., 2015), 
estimated in one study to represent ~65% and 22% of the immune cells in the OA synovium, 
respectively (Pessler et al., 2008). Meanwhile, other studies have found negligible quantities of T 
lymphocytes in OA synovium (Bondeson et al., 2010). Therefore, it is anticipated that the ability 
to define initial FLS to T lymphocyte ratios of the TE synovium may be important for modeling 
different stages and presentations of disease as well as understanding interactions between these 
cell types which is not possible in vivo or with native synovium explants. For example, differences 
in immune cell content may be a factor in the inconclusive evidence of intra-articular 
glucocorticoid effectiveness (American Academy of Orthopaedic Surgeons Board of Directors, 
2013). Motivated by data validating the native-like behavior of engineered bovine synovium (2.2, 
2.3), in this section we explore translation of the bovine system to an in vitro human model (SA1d). 







2.4.2 Materials and Methods 
2.4.2.1 Isolation and Expansion of T Lymphocytes  
A fresh leukocyte-enriched blood sample (Leukopak; New York Blood Center, New York, NY) 
was obtained from a healthy blood donor (n=1, Type O+). The Leukopak was stored at 4°C and 
processed the day following collection. Briefly, a purified population of T lymphocytes was 
obtained using a Dynabeads FlowComp Human CD3 Kit (ThermoFisher; Cat. No. 11365D). 
Isolated T lymphocytes were then activated using a Dynabeads Human T-Activator CD3/CD28 
Kit (ThermoFisher; Cat. No. 11131D) and expanded in Iscove’s Modified Eagle Medium (IMDM) 
supplemented with 10% FBS and 30 units/ml interleukin-2 (IL-2; ThermoFisher, Cat No. 
PHC0026) for 1 week. 
 
2.4.2.2 Optimization of T Lymphocyte 3D Culture 
Activated T lymphocytes were encapsulated in 7 mg/ml Matrigel GFR (Corning; Cat No. 354230) 
at a concentration of 1 million cells/ml. Constructs (100 µl each) were then cultured for 1 week in 
one of four conditions: IMDM with 10% FBS and 30 units/ml IL-2, αMEM with 10% FBS, BM 
with 10 ng/ml IL-1β, or BM with 100 nM DEX. T cell-Matrigel constructs were collected at Day 
0 (n=6) and 7 (n=2-4) for biochemical assessment. 
 
2.4.2.3 Isolation of Normal Human FLS and Formation of Human TE Synovium 
Normal human synovium (n=1, 33y/o white male) was obtained from the Musculoskeletal 
Transplant Foundation (Edison, NJ). FLS were isolated, passaged, and formed into engineered 
synovium constructs according to the procedure outlined in section 2.2.2.2 (96-well Transwell 





cells/ml (instead of 5 million cells/ml) and pre-cultured for 3 months (instead of 21 days) with 
20% bovine synovial fluid (Animal Technologies, Tyler, TX) supplemented media (instead of 
FBS). The modifications were made in response to slow tissue maturation compared to previous 
bovine constructs and to more closely mimic the in vivo environment. Following the 3-month pre-
culture and maturation period, “day 0” specimens were collected and weighed prior to biochemical 
(n=6) and histological (n=1) analyses. 
 
2.4.2.4 Co-Culture and Stimulation of T Lymphocytes with TE Synovium 
Activated T lymphocytes were encapsulated in 7 mg/ml Matrigel GFR (Corning; Cat No. 354230) 
at a concentration of 1 million cells/ml. T Cell-Matrigel constructs (100 µl each) were then layered 
on top of TE synovium constructs in the luminal compartment of the Transwell. Co-cultures were 
treated in parallel with T cell-free controls for two weeks in one of three media conditions: BM 
(CTL), BM with 100 nM DEX, and BM with 10 ng/ml IL-1β. Specimens were collected at day 14 
(n=3-6) for biochemical and histological assessments. 
 
 
Figure 2.13 Schematic of T lymphocyte construct layered on engineered synovium. T 
lymphocytes (dark purple) were encapsulated within a Matrigel matrix (light purple). This 





2.4.2.5 Biochemical Analyses 
Lymphocyte-Matrigel layers were removed from co-cultures prior to weighing and assaying, so 
only cells that may have migrated to the engineered synovium would contribute to measured DNA 
content. Specimens were weighed to obtain wet weights (WW). After freezing and lyophilizing, 
specimens were again weighed to obtain dry weights (DW). Finally, samples were digested and 
assayed for DNA, as previously described (2.2.2.6).  
 
2.4.2.6 Media Analyses 
Media was collected and replaced 2x per week and subsequently assayed for HA as previously 
described (2.2.2.7). 
 
2.4.2.7 Histology and Immunohistochemistry 
Lymphocyte-Matrigel layers were removed from TE constructs prior to fixation, so that only T 
cells that had migrated or attached to TE constructs would be visible in resulting images. TE 
constructs were processed for H&E (n=1), as described in section 2.2.2.8, and also processed for 
immunofluorescence. Briefly, sections were deparaffinized and heat mediated epitope retrieval 
was performed for 10 minutes at 98 °C in citrate buffer (pH 6). Sections were incubated for 2 hours 
at 4°C in CD3 (Nakamura et al., 1999) primary antibody (1:150; rabbit monoclonal [SP7]; Cat. 
No. ab16669; Abcam) followed by a 1-hour incubation in Alexa Fluor 488 secondary antibody 
(1:200, goat anti-rabbit, Cat. No. ab150077; Abcam). The sections were counterstained with DAPI. 
 
2.4.2.8 Statistics 






2.4.3.1 T Lymphocyte 3D Optimization 
T lymphocytes cultured in BM+IL conditions had similar DNA content to those cultured in 
standard IMDM conditions (p=0.33) (Figure 2.14). Meanwhile, DNA content was significantly 
decreased in BM+DEX and αMEM conditions compared to both BM+IL and IMDM (p<0.0001). 
 
 
Figure 2.14 DNA content of T lymphocytes cultured in Matrigel. Basal media with 10 ng/ml 
IL-1 (BM+IL), basal media with DEX (BM+DEX), αMEM with 10% FBS (αMEM), and IMDM 
with 10% FBS and 30 units/ml IL-2 (IMDM); *p<0.0001 compared to BM+IL and IMDM. 
 
2.4.3.2 TE Synovium with FLS±T Lymphocyte Co-Culture 
Co-culture with T lymphocytes had a significant overall effect on DEX- and IL-mediated changes 
to DNA content in TE synovium (p=0.026) (Figure 2.15). Specifically, in -T cell groups, DNA 
content was elevated relative to CTL in both DEX (p=0.20) and IL (p=0.024) conditions. However, 
in +T cell groups, DNA content was unchanged in those same media conditions (p=0.50 and p=1.0, 
respectively). Additionally, DNA in IL-treated specimens was elevated compared to DEX in T cell 





 TE synovium wet weight was not significantly affected by media or T cell condition 
(Figure 2.15). Tissue dry weight significantly increased compared to day 0 in CTL+T cells 
(p<0.001) and IL+/-T cells (p<0.01 and 0.049, respectively). Meanwhile, in +T cell groups, dry 
weight was elevated in CTL (p=0.0018) and IL (p=0.029) compared to DEX. Overall, co-culture 
with T lymphocytes decreased HA secretion by approximately 28% (p=0.093) (Figure 2.16).  
 
 
Figure 2.15 DNA content and weights of TE synovium co-cultured with T cells. *p<0.05 







Figure 2.16 Total hyaluronan (HA) secretion of TE synovium ±T lymphocytes; (n=3-6). 
 
Robust intimal linings (arrows) were observed in -T cell groups, with marked hyperplasia 
(i.e. thickened intimal cell layer) in the DEX sample (Figure 2.17). Co-culture with T lymphocytes 
led to less of a hyperplastic response across media groups. Meanwhile immunostaining for T 
lymphocytes (CD3) showed that a number of these cells integrated with the intima in +T cell 
groups (Figure 2.18). 
 
 
Figure 2.17 H&E of human TE synovium co-cultured with T lymphocytes. Arrows show 







Figure 2.18 CD3 staining of human TE synovium co-cultured with T lymphocytes. (A-C) No 
T lymphocyte groups and (D-F) +T lymphocyte co-culture groups for (A, D) CTL, (B, E) DEX, 
and (C, F) IL treated specimens. Arrows show adherence and integration of T cells within the 
intimal lining of +T cell samples. 
 
2.4.4 Discussion 
The presented studies highlight a strength of the TE synovium model; with the ability to add 
increasing degrees of complexity, now with human-derived FLS and T lymphocytes, this model 
allows investigation of the role that different synovial cell populations contribute to structure-
function in a more clinically relevant system (SA1d). Without T cells, human engineered synovium 
had similar structural characteristics to explant tissue, however HA content was not similarly 
modulated by IL-1 or DEX. Meanwhile, co-culture with a layer of T lymphocytes significantly 
altered the structural and lubricant response to IL-1 or DEX. Overall, these findings are supportive 
of the global hypothesis outlined for Part I, however further characterization of the human 
engineered synovium model and additional validation with human explant tissues need to be 





In the initial analysis of T lymphocyte culture in Matrigel matrix, IL stimulation supported 
significantly greater cell proliferation compared to CTL or DEX conditions (Figure 2.14). This is 
consistent with literature studies, where activation of the glucocorticoid receptor induced apoptosis 
in T lymphocytes (Jamieson and Yamamoto, 2000) and an activated state is required to support 
proliferation (Sarin et al., 1996). 
In the absence of T cells, DNA content in human engineered synovium was elevated 
relative to CTL in both DEX and IL conditions (Figure 2.15). This trend was consistent with DNA 
changes in bovine explant culture (Figure 2.7D). Meanwhile, co-culture of engineered synovium 
with T lymphocytes led to the disappearance of this trend. Although T cell layers were removed 
from constructs prior to analysis, it was anticipated that T cells with proper cytokine stimulation 
(i.e. IL group) would readily proliferate, attach, and integrate with the matrix (Rocha et al., 1984; 
Schor, 1983), thereby contributing to overall DNA content. However, DNA content was elevated 
in both IL and CTL relative to DEX. T cells have been shown to bind to FLS in vitro (Haynes et 
al., 1988) and form two-way interactions with MSCs (Pober et al., 1983), and this interaction may 
have contributed to T cell survival in the absence of IL. This theory is supported by CD3 
immunohistochemistry, which showed T cells present in the intimal lining of all three media 
groups (Figure 2.18). However, this needs to be further evaluated, as RA models have shown that 
FLS do not directly affect T lymphocyte behavior and proliferation (Ohyama et al., 2002).  
The human engineered synovium matured over a 3-month period, due to the lower metabolic 
activity of adult human cells compared to bovine. However, robust intimal linings were observed 
in -T cell groups, with marked hyperplasia (i.e. thickened intimal cell layer) in the DEX sample 
(Figure 2.17). Co-culture with T lymphocytes led to a dampened hyperplastic response across 





cell content and distribution within the pannus structure is highly variable in native tissues 
(Scanzello and Goldring, 2012a). As lymphocytes are not always present in OA synovitis, it is 
possible that multiple mechanisms of synovial thickening exist. FLS driven hyperplasia was 
observed absent T cells, and T cells partially suppressed this mode of hyperplasia. At the same 
time, T cells integrated in the intimal lining regardless of media treatment.  
Tissue dry weight significantly increased in culture for CTL+T cells and IL±T cells 
(Figure 2.15), suggesting that although T cells were observed on DEX specimens, they likely did 
not contribute to a pannus-like formation. A concomitant increase in wet weight was not observed, 
indicating that the increased dry weight likely caused a greater degree of matrix compaction. The 
influence of T cell incorporation on solute transport was not evaluated here, however the 
engineered synovium model will facilitate these studies in the future. 
Evaluating lubricant function, co-culture with T lymphocytes decreased HA secretion by 
approximately 28% overall, however this was unaffected by media treatment (Figure 2.16). Our 
studies presented earlier in this chapter showed increased HA secretion in bovine tissues with both 
DEX and IL treatment, but MW distribution was markedly different based on media treatment 
(Figure 2.6). It is possible that this divergence in behavior was due to the lack of HLA matching 
in this study, however previous work has not considered this factor (Byrne et al., 2014a; Lee et al., 
2007). Both FLS and MLS express HLA-DR (Shiozawa et al., 1983), which is recognized by T 
cells and other leukocytes. However, HLA-DR expression may be lost in culture, as has been 
observed in skin fibroblasts (Branchet et al., 1992). As we observed significant proliferation in all 
groups, it is likely that FLS within engineered synovium also exhibited this phenotypic change and 







In this chapter, complementary engineered and explanted synovium models for evaluating changes 
to structure-function induced by IL-1 or DEX were described (SA1a-d). Together, we accept the 
hypothesis that engineered synovium can recreate structure-function of native tissue both in 
baseline as well as in IL-1 and DEX stimulated culture conditions. By extension, the results also 
support the Global Hypothesis for Part I of this dissertation (1.1). First, a FLS-based engineered 
synovium was developed and shown to recapitulate the gross morphological, biological, and bulk 
functional properties of native bovine tissue (2.2). This system elucidated a potential mechanism 
of altered solute transport in synovium; IL-1 and DEX treatment both reduced solute permeability, 
and this change was correlated with FLS-mediated hyperplasia and ECM synthesis. This relatively 
simple yet biomimetic synovium model allowed robust investigation of cellular mechanisms and 
macroscale tissue behavior in a controlled and repeatable system that was modified to incorporate 
MLS (2.3). An exaggerated IL-1-induced hyperplastic response and co-localization of FLS and 
MLS was observed in a co-culture version of the model, highlighting the importance of MLS in 
synovium structure-function. Finally, the model was translated to a human system with co-cultured 
T lymphocytes (2.4). We observed reduced intimal hyperplasia in engineered synovium co-
cultured with T lymphocytes that correlated with increased specimen dry weight, suggesting an 
alternative T cell-mediated mechanism of hyperplasia and/or pannus formation. Overall, these 
studies highlight the complexity of the synovium response to IL-1 and DEX as well as the 
interaction of various cell types present at different stages and presentations of OA, with specific 






Chapter 3 Sustained Low-Dose Dexamethasone Delivery Via a PLGA 
Microsphere-Embedded Agarose Implant for Enhanced Osteochondral 
Repair 
Sustained Low-Dose Dexamethasone Delivery Via a 
PLGA Microsphere-Embedded Agarose Implant for 
Enhanced Osteochondral Repair 
 
3.1 Introduction 
Motivated by current limitations in osteochondral repair (1.3.1.3) and intra-articular DEX delivery 
(1.3.3), as well as insights into synovium structure-function in response to IL-1 and DEX 
elucidated in Chapter 2, we sought to develop and evaluate an improved intra-articular DEX 
delivery strategy (SA1e-f). An optimal delivery system for sustained low (therapeutic) dose of 
DEX to the synovial joint is not currently available for clinical use in cartilage restoration. Toward 
this goal, our laboratory has demonstrated that in vitro local sustained DEX release from PLGA 
MS promotes development of functional engineered cartilage and confers protection from pro-
inflammatory cytokine-induced tissue degradation (Roach et al., 2016b). Therefore, the present 
study was designed to provide preclinical data towards addressing a critical unmet need in 
orthopaedic surgery. The adult canine preclinical model was selected for its similarities to humans 
in patellofemoral joint pathology and presentation of pain and discomfort via changes to gait 
(Bendele, 2001). 
To facilitate targeted drug delivery to the joint, an acellular agarose (copolymer in phase 





microspheres (DLMS) was developed (SA1e). Drug penetration and activity was first assessed; 
DLMS carriers were co-cultured with engineered cartilage constructs and evaluated for p57Kip2 
expression, an indicator of glucocorticoid binding (Samuelsson et al., 1999) (Study 1a). Separately, 
to evaluate chondroprotection, carriers and engineered cartilage constructs were co-cultured for 
two weeks ± IL-1 (Study 1b). We then moved to clinically relevant osteochondral autograft 
transfer (OAT) for in vivo study (Study 2, SA1f), as it is an established procedure that may benefit 
from expedited host integration, support of chondrocyte growth, and reduced donor site morbidity 
(Sgaglione and Kerker, 2008). DLMS implants were combined with a clinically-relevant bone 
substrate to aid in integration (Hung et al., 2003) and press-fit into the autograft donor site and 
compared to intra-articular DEX injection and standard-of-care controls. The 6-month study end 
point was selected as the critical window for healing, integration, and cartilage restoration needed 
for successful functional outcomes in this preclinical model. Overall, we hypothesized that 
sustained low-dose DEX delivery would have a dual anti-catabolic and pro-anabolic effect, 
preventing synovitis and further cartilage degeneration while simultaneously supporting the 
functional integrity of osteochondral autografts.  
 
3.2 Materials and Methods 
3.2.1 Microsphere Fabrication, Characterization, and Dosing 
Dexamethasone sodium phosphate (DSP; MW 516.4; Sigma D1159), a solubilized 1:1 molar 
equivalent of DEX (MW 392.5), was encapsulated in PLGA (75:25 lactide:glycolide, MW: 
66,000-107,000; Sigma P1941) as previously described to create DLMS (Roach et al., 2016b; 
Rubin et al., 2009). Unloaded PLGA microspheres (ULMS) were fabricated similarly without the 





Briefly, DLMS and ULMS had mean diameter of 46 ± 17 µm (n=543) and 25 ± 15 µm (n=411), 
respectively. The theoretical drug loading of DLMS was 9.1% (w/w). The actual loading capacity, 
determined via complete polymer hydrolysis and spectrophotometric analysis at 242 nm, was 6.3% 
(w/w).  
To estimate proper dosing, the release profile of the microsphere formulation in agarose 
was characterized (Roach, 2017). Briefly, DLMS were encapsulated in 2% (w/v) agarose (Sigma; 
A9414) and punched into cylindrical (∅ 6 mm × 2.34 mm thickness) constructs (5.33 mg MS/ml; 
350 µg MS per carrier). Constructs (n=4) were placed in individual microcentrifuge tubes with 1 
ml PBS (pH 7.4), which was replaced at regular time points over 100 days. Supernatant was 
assayed spectrophotometrically at 242 nm and absorbance compared to a standard curve. There 
was an initial burst release of approximately 9.2% of the total encapsulated drug in the first 24 
hours. Fitting the subsequent release data to a line over the next 99 days (R2=0.99), an average 
release rate of approximately 0.9% per day was determined. 
Synovial fluid volume in the canine knee (stifle) can range from <1 ml in normal animals 
to 3 ml or more with induced synovitis (Myers et al., 1995). Therefore, we estimated that ~1 ng 
DSP would be sufficient to meet the 1 nM critical threshold for chondroprotection and ~10 µg 
DSP to reach the upper threshold for a pro-anabolic effect (10 µM). Dosing for subsequent 
experiments was chosen to target this specific therapeutic window identified by Lu, et al (Lu et 
al., 2011). 
 
3.2.2 Preparation and Culture of Engineered Cartilage Constructs 
Articular cartilage was harvested from the knees of adult dogs (~1-year-old; n=4 joints) 





and pooled passage 2 (P2) cells were encapsulated in agarose (2% (w/v) Type VII Agarose, Sigma 
A4018) to form cylindrical constructs (∅ 4 mm × 2.23 mm thickness) with an initial composition 
of 30 x 106 cells/ml (Ng et al., 2010). Constructs were initially cultured to maturity (Day 42, 
Young’s modulus (EY) ~ 200kPa) in chondrogenic medium (CM) supplemented with 10 ng/ml 
TGFβ3 (R&D Systems #243B3200), 100 nM DEX (Sigma D4902), and 50 µg/ml ascorbic acid-
2-phosphate (Sigma A8960). 
At culture maturity, constructs were concentrically cored and replaced with a 2% (w/v) 
agarose hydrogel carrier (∅ 1.5 mm × 2.23 mm thickness) containing DLMS or ULMS (3.3 mg 
MS/ml) (Figure 3.1A). Engineered cartilage ring-implant core (ring-core) pairs were cultured for 
3 days in CM supplemented with 10 ng/ml TGFβ3 and 50 µg/ml ascorbic acid-2-phosphate (Study 
1a). 
For Study 1b, 2% (w/v) agarose hydrogel carriers (∅ 10 mm × 2.23 mm thickness) were 
encapsulated with DLMS (5.0 mg MS/ml; approximately 880 µg MS and 55 µg DSP per carrier). 
Mature cartilage constructs were co-cultured with the DLMS carriers for two weeks with or 
without application of 10 ng/ml IL-1 (recombinant human interleukin-1β; ThermoFisher 
PHC0816) (n=6) (Figure 3.1B). To achieve the desired dosage, four hydrogel carriers were placed 
in a total of 25 ml media, resulting in an estimated burst delivery of 20. µg DSP (1.6 µM DEX) in 
the first 24 hours followed by 1.9 µg DSP (150 nM DEX) per day. 
Negative DEX control carriers contained ULMS (5.0 mg MS/ml; 880 µg MS). Separately, 
positive controls were supplemented with 100 nM soluble DEX, which is a standard concentration 
for confirming chondroprotection (Lima et al., 2008c; Ng et al., 2010; Roach et al., 2016b).  In 
each group, half of the media was replaced with fresh media 3x per week. All constructs were 







Figure 3.1 Schematic of in vitro dexamethasone microsphere delivery. (A) Following a 42-
day maturation period, engineered cartilage constructs (~200 kPa) were cored and implanted with 
DLMS or ULMS carriers for 3 days (Study 1a). (B) Mature engineered cartilage constructs were 
divided into six experimental groups for a 14-day IL-1 stimulation period where they were co-
cultured with DLMS or ULMS carriers. 
 
3.2.3 In Vitro Evaluation of Delivery to Engineered Cartilage 
Study 1a specimens were fixed in formalin, paraffin embedded, and sectioned (20 μm). Heat 
mediated epitope retrieval was performed in citrate buffer at 60°C overnight, followed by 
incubating in rabbit monoclonal [EP2515Y] to p57Kip2 (Abcam; ab75974) and then goat anti-rabbit 
IgG secondary antibody (Alexa Fluor 488; ThermoFisher; A11034). Pixel intensity was analyzed 
to quantify cell DEX uptake radially away from the core (ImageJ). 
For Study 1b, Young’s (EY) and dynamic (G) moduli were measured under unconfined 
compression conditions (Mauck et al., 2000). Following mechanical testing, individual specimens 
were processed and assayed for DNA, GAG, and collagen, as previously described (2.2.2.6). 
Values were normalized to specimen wet weight (ww). Half of each specimen was fixed in 





Resulting images were processed in ImageJ (convert to 8-bit, invert black and white) and relative 
pixel intensity quantified using the “plot profile” function. 
 
3.2.4 Preclinical Canine Osteochondral Autograft Model 
In preparation for the Study 2 procedure, devitalized bovine trabecular bone cores (∅ 8 mm x 5 
mm thickness) were infused with 2% (w/v) agarose hydrogel mixed with DLMS (33 mg MS/ml; 
3.3 mg MS and 210 µg DSP per carrier) to produce multilayered acellular osteochondral implants 
(1 mm gel-only region, 1 mm gel bone interface, and 4 mm bone-only) (Figure 3.2, iii). From 
release studies, this was expected to deliver a 24-hour burst of 19 µg DSP (15-75 µM DEX; 
assuming 0.5-2.5 ml volume (Nade and Newbold, 1983)) per implant followed by 1.8 µg DSP 
(1.4-7.0 µM DEX; assuming 0.5-2.5 ml volume) per implant per day. To confirm expected release, 
extra implants (n=4) were placed in PBS and supernatant was collected and assayed (3.2.1). 
On the day of surgery, adult mongrel dogs (10 ± 1 months, 25.3 ± 3.5 kg, all female) were 
premedicated, anesthetized and prepared for aseptic surgery of the right knee (University of 
Missouri-Columbia IACUC #9167; complied with ARRIVE guidelines). Briefly, 2 doses of 
cefazolin (antibiotic) were given perioperatively and 2 morphine intramuscular doses plus 2 doses 
of oral tramadol were given for pain management. Post-operatively, a soft padded bandage was 
kept on the operated right hindlimb for 1 week with oral cefpodoxime (antibiotic) for 10 days. 
Osteochondral autografts (∅ 8 mm diameter) (Figure 3.2, ii) were obtained from the 
trochlear ridge and sulcus terminalis and transferred to size-matched recipient defects on the 
neighboring trochlea or medial/lateral femoral condyle of the same knee (n=3 grafts per knee) 
using the Osteochondral Autograft Transfer System® (OATS®; Arthrex, Naples, FL). The empty 





n=6 animals, n=3 implants per animal). Dogs receiving this implant were compared to those for 
which there was one post-surgical DEX injection of 4 mg/knee (OATS-INJ; n=5 animals, n=3 
grafts per animal; no implant) or no DEX injection (OATS-CTL; n=5 animals, n=3 grafts per 
animal; no implant). 
Possible systemic effects of dexamethasone were assessed by daily monitoring by 
veterinarians, animal weights, and post mortem examination (necropsy). 
 
 
Figure 3.2 Schematic of in vivo OATS procedure with DEX implant. (A) Autograft donor site 
(i.), autograft repair site (ii.), DLMS implant (iii.), and dexamethasone-PLGA microsphere release 
(iv.); (B) cartilage autograft (ii.) and DLMS implant (iii.); (C) autograft donor (i.) and repair (ii.) 
sites; (D) Repair (ii.) and DLMS implant (iii.) sites. 
 
3.2.5 Clinically Based Assessments 
Animals were examined by a board-certified veterinary orthopaedic surgeon (JLC). Clinical 
lameness, functional gait, comfortable range of motion (CROM), pain, and effusion (Bozynski et 
al., 2015) were assessed both pre-surgery (T=0) and at the conclusion of the study period (T=6 





a Luminex Multiplex Assay for IL-6 (Stannus et al., 2010), IL-8 (Lotz et al., 1992), MMP-2 (Duerr 
et al., n.d.), and MMP-3 (Okada et al., 1992) (ThermoFisher). 
 
3.2.6 Histological Scoring 
At the terminal time point (T=6 months), animals were sacrificed and tissue harvested for 
histopathology assessment. Osteochondral treatment sites including adjacent cartilage and bone 
were collected, fixed in formalin, and stained with H&E, picrosirius red, and toluidine blue. 
Synovium was harvested from four separate locations (medial/lateral trochlea and medial/lateral 
femoral condyle), fixed in formalin, and stained with H&E. 
A modified osteochondral (OC) scoring system was used to evaluate the autograft recipient 
sites (Chang et al., 2014). The scoring consisted of evaluating cartilage fill, cartilage edge 
integration at host-graft junction, cartilage surface congruity of construct and host-construct 
junction, fibrosis, and inflammation. 
A modified OARSI method was used to evaluate surrounding cartilage structure, 
chondrocyte pathology, proteoglycan staining, collagen integrity, tidemark, and  subchondral bone 
plate (Cook et al., 2010). The OARSI method was also used to evaluate synovial pathology through 
microscopic examination of the lining cell, lining, and cell infiltration characteristics (Cook et al., 
2010). All scoring was performed by two blinded board-certified veterinary pathologists. 
DLMS implants were scanned using Micro-CT at T=0 and T=6 months to assess changes 







Data sets were tested for normality (Kolmogorov-Smirnov Test) and homogeneity (Bartlett’s 
Test). When necessary, data was log-transformed to achieve normality or evaluated using 
equivalent nonparametric tests. For in vitro studies, one-way ANOVA with Tukey post hoc test 
(α=0.05) was used. For the in vivo study, functional and synovial fluid measures were compared 
using two-way ANOVA or corresponding mixed-effects analysis (group, time) with time as a 
repeated measures factor and Tukey post-hoc test (α=0.05). This data was presented as mean and 
standard deviation, unless otherwise noted. Analyses were performed using GraphPad Prism 8. 
Ordinal scores (OARSI and OC) were analyzed using a Generalized Linear Model. 
Specifically, data was fit to an ordinal multinomial probability distribution and cumulative logit 
link function with generalized estimating equations correction for repeated measures (location, 
scorer). The dependent (response) variable was the score and the independent variables 
(predictors) were the categorical factors: group and/or repair location. Total OARSI scores were 
grouped into ordered categories for regression analysis to increase the number of observations per 
level of the dependent variable. Odds ratios (OR) and corresponding 95% CI were computed from 
the model’s parameter estimates. Averages of non-normal datasets were presented as median (95% 
CI). Ordinal regression analyses were performed using IBM SPSS Statistics 25. The results of a 
pilot study were used to determine the sample size needed in Study 2 to achieve at least 80% power 







3.3.1 In Situ Evaluation of DEX Receptor Binding (Study 1a) 
Cells in the surrounding cartilage ring were exposed to a radially-dependent concentration of DEX, 
with cartilage immediately adjacent to the DLMS-laden core expressing the most intense staining 
for p57Kip2 that declined toward the edge of the construct (Figure 3.3). In contrast, for ULMS 
constructs, mean intensity of the stain remained at baseline levels. 
 
 
Figure 3.3 Dexamethasone penetration indicated by p57Kip2 expression. Representative 
immunohistochemical stain for p57Kip2 expression (green) counterstained with DAPI. Inner core 
containing either (A) DLMS or (B) ULMS marked with * and boundary outlined with dotted line; 
(C) Relative pixel intensity of immunohistochemical stain expression as a function of distance 
away from the microsphere-embedded core (n=1). 
 
3.3.2 In Vitro Chondroprotection (Study 1b) 
At day 42, Young’s modulus (EY) of the engineered cartilage constructs was 213 ± 29 kPa (Figure 
3.4A). Following the 14-day treatment period (day 56), EY of ULMS+IL specimens was 





Meanwhile, EY was not significantly affected by IL insult in DLMS (256 vs. 197 kPa; between-
group difference, 59.0 kPa; p=0.92). No significant between-group differences were observed in 
dynamic modulus (G) (Figure 3.4B). 
GAG/ww reached 5.5 ± 0.6% by day 42 (Figure 3.4C). Following the 14-day treatment 
period, GAG/ww of ULMS+IL specimens was significantly lower than ULMS (5.8 vs. 4.3%; 
between-group difference, 1.5%; p<0.001). GAG distribution was markedly more diffuse in the 
periphery of ULMS and IL groups (Figure 3.5). Safranin-O intensity was similar between groups 
at depths greater than ~150 µm. Meanwhile, GAG/ww was not significantly affected by IL insult 
in DLMS (6.1 vs. 5.9%; between-group difference, 0.2%; p=1.0) (Figure 3.4C). GAG/ww in the 
DLMS+IL group was significantly greater than ULMS+IL (p<0.0001). 
COL/ww was not significantly affected by IL insult, however DLMS had significantly 
lower content than ULMS (p=0.022) and day 42 (p<0.001) (Figure 3.4D). 
Positive controls for DEX protection (i.e. soluble DEX) confirmed maintenance of EY, G, 







Figure 3.4 Mechanical and biochemical properties of engineered cartilage. (A) Young’s 
modulus (EY); (B) Dynamic modulus (G); (C) GAG/ww (%); (D) COL/ww (%); *p<0.05. (bars 







Figure 3.5 Representative safranin-o (saf-o) histology of cartilage construct cross-section at 
the surface (arrow) and corresponding relative staining intensity.  
 
3.3.3 Confirmation of DLMS Implant Release Profile (Study 2) 
A burst release of 64 µg DSP was observed in the first 48 hours. Fitting the subsequent release 
data to a line (R2=0.98) over the next 8 days, a daily release rate of 1.4 µg DSP per day (95% CI, 






3.3.4 Clinically Based Assessments of In Vivo OATS Repairs (Study 2) 
Gait was significantly worse at 6 months compared to baseline in OATS-CTL (p=0.031) and INJ 
(p=0.008) groups (Table 3.1). Meanwhile, gait score was similar to baseline in DLMS specimens 
(p=0.39). Lameness was elevated in CTL compared to both DLMS (1.8 vs. 1.3; between-group 
difference, 0.5; p=0.099) and INJ (1.8 vs. 1.4; between-group difference, 0.4; p=0.20). 
We did not observe significant between-group differences in animal’s change in weight at 
the 6-month time point.  
 
Table 3.1 Clinical outcome scores of OATS repairs at 6 months; *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001 
 Mean (95% CI)  Mean Difference from Baseline (95% CI) 
Measurement Baseline  OATS-CTL (N=5) OATS-DLMS (N=6) OATS-INJ (N=5) 
Gait 10.0 (10.0 to 10.0)  -2.9 (-5.5 to -0.2)* -1.3 (-3.7 to 1.1) -3.6 (-6.2 to -0.9)** 
CROM (°) 108 (107 to 109)  -12 (-20 to -4)** -8 (-15 to -0.0)* -9 (-17 to -1)* 
Lameness 0.0 (0.0 to 0.0)  1.8 (1.2 to 2.4)**** 1.3 (0.8 to 1.9)**** 1.4 (0.8 to 2.0)**** 
Pain 0.0 (0.0 to 0.0)  1.3 (0.2 to 2.4)* 1.1 (0.2 to 2.1)* 1.0 (0.0 to 2.1) 
Effusion 0.0 (0.0 to 0.0)  2.0 (0.9 to 3.0)*** 1.8 (0.9 to 2.8)*** 1.3 (0.3 to 2.4)* 
OATS, osteochondral autograft transfer system; CTL, no dexamethasone supplementation group; DLMS, 
dexamethasone-loaded microsphere implant group; INJ, dexamethasone injection group 
 
3.3.5 Histological Assessment of OATS Repairs (Study 2) 
Cartilage was visually intact in each group, with some evidence of lesions in OATS-INJ specimens 
(Figure 3.6A-C). The combined OARSI cartilage score of DLMS specimens were more than twice 
as likely to be improved compared to CTL (p=0.003), but there was not a significantly increased 
likelihood compared to the INJ group (p=0.47) (Table 3.2). OC scores, which specifically 





Examining sub-scores (Table 3.2), DLMS were nearly three times more likely to have 
better chondrocyte scores and more than three times more likely to have better proteoglycan sub-
scores than both CTL (p=0.001 and 0.005, respectively) and INJ (p=0.078 and 0.048, respectively). 
Meanwhile, INJ was not significantly likely to differ from CTL in chondrocyte or proteoglycan 
score (p=0.92 and 0.95, respectively). Superior proteoglycan deposition in DLMS samples was 
evident from toluidine blue staining as well (Figure 3.6G-I). 
DLMS were more than twice as likely to have a better collagen sub-score than both CTL 
(p=0.001) and INJ (p=0.068), which was further evidenced in picrosirius red staining (Figure 3.6J-







Figure 3.6 Gross imaging and histological staining for selected graft sites. (A-C) Gross 
morphology; (D-F) H&E; (G-I) Toluidine blue; (J-L) Picrosirius red; (M-O) Polarized light 
microscopy; OATS-CTL (A, D, G, J, M; 92-FCL), OATS-DLMS (B, E, H, K, N; 88-FCL), OATS-











Table 3.2 OARSI cartilage scores and sub-scores; *p<0.05, **p<0.01, ***p<0.001 
 
Median (95% CI) 
 









INJ vs. CTL DLMS vs. CTL DLMS vs. INJ 
OARSI (Cartilage, 
combined) 12 (9 to 17) 12 (7 to 15) 8 (6 to 12) 
 
1.3 (0.6 to 2.7) 2.2 (1.3 to 3.6)** 1.6 (0.7 to 3.7) 
Structure 2 (2 to 3) 2 (1 to 3) 2 (1 to 3) 
 
1.8 (0.9 to 3.5) 1.5 (0.9 to 2.8) 0.9 (0.4 to 2.0) 
Chondrocytes 4 (2 to 4) 4 (2 to 4) 2 (1 to 3) 
 
1.1 (0.4 to 3.2) 2.7 (1.5 to 5.1)** 2.6 (0.9 to 7.4) 
Proteoglycans 3 (2 to 4) 3 (1 to 4) 2 (1 to 2) 
 
1.0 (0.3 to 3.5) 3.3 (1.4 to 7.5)** 3.4 (1.0 to 11.4)* 
Collagen 2 (1 to 3) 2 (1 to 3) 1 (1 to 2) 
 
1.1 (0.4 to 2.9) 2.8 (1.5 to 5.1)** 2.5 (0.9 to 6.8) 
Tidemark 1 (0 to 2) 0 (0 to 2) 0 (0 to 2) 
 
1.8 (1.2 to 2.8)** 1.7 (1.1 to 2.8)* 1.0 (0.6 to 1.4) 
Bone 1 (0 to 3) 0 (0 to 3) 3 (0 to 3) 
 
1.1 (0.6 to 2.4) 0.7 (0.2 to 2.1) 0.6 (0.2 to 1.8) 
OATS, osteochondral autograft transfer system; CTL, no dexamethasone supplementation group; DLMS, 
dexamethasone-loaded microsphere implant group; INJ, dexamethasone injection group 
 
Table 3.3 OC scores. 
 
Median (95% CI) 
Measurement OATS-CTL (N=5) OATS-DLMS (N=6) OATS-INJ (N=5) 
OC (Total) 2 (1 to 4) 2 (1 to 3) 2 (1 to 3) 
Fill 0 (0 to 0) 0 (0 to 0) 0 (0 to 0) 
Edge Integration 1 (1 to 1) 1 (1 to 1) 1 (1 to 1) 
Surface Congruity 0 (0 to 1) 1 (0 to 1) 0 (0 to 1) 
Calcified Cartilage 0 (0 to 1) 0 (0 to 0) 0 (0 to 1) 
Fibrosis 0 (0 to 1) 0 (0 to 1) 0 (0 to 1) 
Inflammation 0 (0 to 0) 0 (0 to 0) 0 (0 to 0) 
OATS, osteochondral autograft transfer system; CTL, no dexamethasone supplementation 






3.3.6 Modulation of In Vivo Inflammatory Environment (Study 2) 
Synovial fluid IL-6 levels peaked at 1 month in each group (p<0.01) (Figure 3.7). The 
concentration of IL-6 at 1-month was significantly elevated in the OATS-DLMS group relative to 
CTL (p=0.004) and INJ (p=0.011). Significant differences were not detected in IL-8 levels.  
MMP-2 was elevated at 1 month and remained significantly elevated at 3 months in all 
groups (p<0.001). MMP-3 levels peaked at 1 month in the DLMS group only (p=0.012). By 2 
months, MMP-3 levels in DLMS had returned to baseline (p=0.78). The concentration of MMP-3 
was significantly elevated in the DLMS group relative to CTL (p=0.009) and INJ (p=0.008) at the 
1-month time point. No significant differences were observed in OARSI synovium scores, which 
were largely in the range of mild to moderate pathology (Figure 3.8, Table 3.4). 
 
 
Figure 3.7 Synovial fluid composition of IL-6, IL-8, MMP-2, and MMP-3. *p<0.05 compared 
to Day 0 (same group), †p<0.05 compared to OATS-CTL (same time point), ‡p<0.05 compared to 







Figure 3.8 Representative synovium H&E. Mild to moderate synovitis was observed in (A) 
CTL (ID-92), (B) DLMS (ID-88), (C) INJ (ID-112) animals.  
 
Table 3.4 Histological scoring of the synovium (OARSI). 
 








OARSI (Synovium Total) 7 (5 to 9) 7 (6 to 11) 8 (6 to 10) 
Lining Cells 2 (1 to 3) 2 (1 to 3) 3 (2 to 3) 
Lining Characteristics 3 (3 to 5) 4 (2 to 5) 4 (3 to 4) 
Cell Infiltration 1 (0 to 2) 2 (1 to 3) 1 (1 to 2) 
OATS, osteochondral autograft transfer system; CTL, no dexamethasone supplementation 
group; DLMS, dexamethasone-loaded microsphere implant group; INJ, dexamethasone 
injection group 
 
3.3.7 Evaluation of DLMS Implant in Donor Sites 
Micro-CT reconstructions of the DLMS implant bone bases revealed significant bone fill-in and 
ingrowth (Figure 3.9). Specifically, bone volume density (BV/TV) of the bone scaffold increased 
17 ± 23% over the implantation period (p=0.009). There was also a significant decrease in plate-





Representative histology of the graft donor site, which also served as the DLMS implant 
site, showed a degree of fibrous tissue formation in CTL and INJ groups (Figure 3.10). 
 
 
Figure 3.9 MicroCT reconstruction of autograft donor site. (A) Significant bone remodeling 
in the DLMS osteochondral implant; Bone volume density (BV/TV), plate density (pBV/TV), rod 
density (rBV/TV), plate-rod ratio (PR ratio), number of plate trabeculi (pTb.N), number of rod 
trabeculi (rTb.N), plate trabecular thickness (pTb.Th), and rod trabecular thickness (rTb.Th); (B) 
Reconstruction of DLMS bone base showing resorbed bone (pink), new bone (green), and 







Figure 3.10 Gross imaging and histological staining for selected graft donor sites. (A-C) Gross 
morphology; (D-F) H&E; (G-I) Toluidine blue; (J-L) Picrosirius red; (M-O) Polarized light 
microscopy; OATS-CTL (A, D, G, J, M; 92-FCL), OATS-DLMS (B, E, H, K, N; 88-FCL), OATS-
INJ (C, F, I, L, O; 112-FCL). 
 
3.4 Discussion  
The current study examined the influence of targeted, sustained low-dose DEX delivery, via PLGA 
microspheres embedded in an acellular agarose carrier, on suppressing synovial inflammation and 
promoting growth and repair of neighboring focal articular cartilage injuries (SA1e-f). While 
periodic intra-articular glucocorticoid injections have long been used to manage joint inflammation 





intervention aimed at dampening the inflammatory cascade following joint injury and surgical 
repair (Grodzinsky et al., 2017; Heard et al., 2015; Huebner et al., 2014). To overcome issues with 
low residence time and negative local and systemic effects, MS glucocorticoid delivery platforms 
have entered development. One product, an already FDA-approved intra-articular microsphere 
injection of triamcinolone acetonide (TA), has demonstrated extended local drug release and 
improvements in pain, however no impact on tissue integrity (Bodick et al., 2015; Kraus et al., 
2018; Spitzer et al., 2019). We anticipated that DEX, due to its elevated anti-inflammatory potency 
relative to TA (Buttgereit et al., 2002) and demonstrated strong pro-anabolic effects in cartilage 
cultures at low doses (Bian et al., 2010; Grodzinsky et al., 2017; Ng et al., 2010), would be a prime 
candidate to expedite and augment cartilage repair and restoration procedures that can be limited 
by graft durability and viability (Gomoll et al., 2012; Nover et al., 2015; Sgaglione and Kerker, 
2008) as well as iatrogenic injury (Amin et al., 2017; Hooiveld et al., 2003; Sgaglione and Kerker, 
2008). Overall, we accept our hypothesis that the DLMS implant provides chondroprotection and 
improved functional osteochondral integrity in both an in vitro cytokine-challenged environment 
(Study 1, SA1e) and a preclinical model of cartilage restoration surgery (Study 2, SA1f). However, 
results were inconclusive as to whether the DLMS implant directly affected synovial structure-
function. 
Study 1a confirmed DEX bioavailability not only to the bathing media (i.e. joint space), 
but also directly to the adjacent dense cartilage matrix. Glucocorticoid receptor binding, indicated 
by p57Kip2 expression, demonstrated a radially-dependent concentration of DEX, with cartilage 
immediately adjacent to the DLMS-laden core expressing the most intense staining that declined 
toward the edge of the construct (Figure 3.3). This local delivery rendered special targeting 





In Study 1b, engineered cartilage derived from adult canine chondrocytes reached native 
levels for Young’s modulus, dynamic modulus, and GAG content by day 42 in culture (Ng et al., 
2010). And as anticipated, EY and GAG/ww were not significantly affected by IL insult in the 
DLMS group, indicating that the carrier was chondroprotective to these mature constructs in vitro.  
Meanwhile, specimens without DEX supplementation (ULMS), a positive control for IL-induced 
cartilage degradation (Roach et al., 2016b), decreased significantly in EY and GAG content when 
subjected to IL insult. ULMS+IL specimens had significantly lower EY than ULMS, which was 
likely due to the significant decrease in GAG/ww (Figure 3.4A, C) in the periphery of the 
constructs (Figure 3.5). Cytokine treatment did not significantly decrease collagen content in IL-
treated groups, regardless of DEX treatment, which is consistent with literature studies of two-
week cytokine stimulation of engineered and explanted cartilage tissues (Lima et al., 2008c; 
Andrea R Tan et al., 2015). 
 Interestingly, constructs grown with DLMS in the absence of IL had a significant decrease 
in collagen content (%COL/ww). This was partially a byproduct of higher GAG content (i.e. wet 
weight) in the DLMS group, however absolute levels of collagen were still approximately 20% 
below pre-treatment values. In the absence of cytokines, adult cartilage explants are generally able 
to maintain mechanical and biochemical properties in culture regardless of DEX treatment (Bian 
et al., 2010). However in juvenile engineered tissues, there is evidence that collagen deposition 
later in culture can be higher without DEX (Lima et al., 2008c). It is possible that DEX levels 
accumulated too quickly in vitro and approached a deleterious level. DLMS groups ostensibly had 
variable DEX concentrations, which were dependent on release kinetics and media volume 
(estimated to be 1.6 µM DSP in the first 24 hours followed by 150 nM DSP per day) as well as 





the course of the two week culture, concentrations likely remained at least an order of magnitude 
below the peak seen in a clinical setting (7.7 mM; based on 4 mg, 1 ml injection (Cardone, 2002)). 
In Study 2, DLMS carriers were formulated to deliver an estimated burst release of 15-75 
µM DSP in the first 24 hours followed by 1.4-7.0 µM DSP per carrier per day (based on estimated 
0.5-2.5 ml synovial fluid volume). An in vitro release study of actual DLMS implants confirmed 
this estimate. While it is anticipated that in vivo release kinetics would be expedited compared to 
in vitro (Doty et al., 2017), studies have shown that extended in vivo release (at least 70 days) still 
occurs (Doty et al., 2017; Rudnik-Jansen et al., 2017). For PLGA-DEX microspheres, in vitro 
release is predictive of in vivo release kinetics (Zolnik and Burgess, 2008). Although expected to 
at times be higher than minimum values established to be chondroprotective (1 nM-10 µM) (Lu et 
al., 2011), we anticipated that concentrations would remain well below deleterious levels. The total 
dosage used in this study was estimated to be 0.63 mg DSP (3 implants per knee), whereas clinical 
injections contain 4 mg DSP. 
At the terminal time point, the OATS-DLMS group showed superior knee function based 
on return to pre-surgery gait scores and improved lameness grades. Between-group differences in 
pain were not observed, likely due to the fact that OAT procedures are generally successful in 
restoring joint function (Ma et al., 2004). Further benefits of low dose DEX were observed in 
OARSI cartilage score, with DLMS specimens more than twice as likely to be improved compared 
to controls. Examining sub-scores, DLMS were nearly three times more likely to have better 
chondrocyte scores and more than three times more likely to have better proteoglycan sub-scores 
than both CTL and INJ. This supported the results of Study 1b, which showed enhanced GAG/ww 





In our studies, DLMS and ULMS had mean diameters of approximately 25 µm and 46 µm, 
respectively, which were similar to TA-loaded PLGA MS products on the market administered via 
intra-articular injection (Kumar et al., 2012). In advanced OA patients, these TA-MS injections 
provided better pain relief and longer joint residence time than bolus TA injection (Kraus et al., 
2018; Spitzer et al., 2019). However, TA-loaded MS did not affect cartilage pathology in this 
clinical trial (Spitzer et al., 2019) or an in vivo rat model of OA (Rudnik-Jansen et al., 2017). This 
may have been a result of TA toxicity; TA has been reported to be toxic to chondrocytes (Euppayo 
et al., 2016) and to significantly decrease the proliferative rate and inhibit chondrogenic 
differentiation at an equivalent DEX level established to be chondroprotective (1 µM TA ≈ 200 
nM DEX) (Lu et al., 2011; Weiss et al., 1988). Alternatively, free floating MS in the joint space 
may have led to increased joint friction and cartilage wear (Estell, 2018). End point histological 
analyses of rats did not show visible TA-MS (Rudnik-Jansen et al., 2017), indicating that free-
floating MS may not remain in place. To prevent this, our DLMS implant was composed of 
agarose-encapsulated MS. Furthermore, DLMS carriers were constructed on a bone scaffold base 
to aid integration (Figure 3.2), ensuring that the carriers remained in place for the duration of the 
study (Figure 3.10). It is also anticipated that by suspending MS in agarose, the effect of small 
variations in MS diameter and local pH changes would be mitigated. 
DLMS were more than twice as likely to have a better collagen sub-score than both CTL 
and INJ, which was further evidenced by pronounced picrosirius red staining. While contrary to 
the results of Study 1b, DEX at 100 nM is known to promote the osteoblast phenotype and in vivo 
bone formation by transplanted human osteoblasts on collagen sponges (Yamanouchi et al., 2001). 





seeded into the construct, whereas in vivo experiments incorporated the contributions of a complex 
milieu of other joint tissues, including synovial- and bone marrow-derived stem and immune cells. 
Meanwhile, chondrocyte and proteoglycan scores were not significantly likely to differ 
from CTL in the high dose DEX group (OATS-INJ). In a rabbit PTOA model, frequent injections 
of high dose DEX were chondroprotective over three weeks but had severe systemic side effects, 
including weight loss and organ necrosis (Huebner et al., 2014). We did not observe significant 
weight gain or loss for any dog in the study and necropsy results showed no evidence for systemic 
pathology. Furthermore, neither impairment of healing nor infections were observed in our studies, 
each of which can be undesired side effects of glucocorticoids (Sherman et al., 2015). 
Micro-CT reconstructions of the DLMS implants showed significant bone fill and ingrowth 
of donor sites with increasing trabecular bone density over the implantation period. Histologic 
assessment of donor sites also revealed improved donor site tissue fill and architecture compared 
to injection and control groups. These findings have important clinical significance in terms of 
their potential for reducing donor site morbidity, which is still a significant concern associated 
with OAT (Andrade et al., 2016; Shimozono et al., 2019). As such, this apparent dual benefit of 
the DLMS implants in terms of supporting cartilage restoration while also addressing potential 
donor site morbidity further enhances the attraction for clinical use. Other DEX delivery methods, 
such as an intra-articular DLMS patch, are also feasible if concerns regarding donor site morbidity 
persist or if other cartilage restoration techniques, such as OCA, ACI, or MACI, are selected. 
Cytokine levels in the synovial fluid were inconclusive regarding a potential anti-
inflammatory effect. Counterintuitively, both IL-6 and MMP-3 concentrations were increased at 
the 1-month time point in the OATS-DLMS group relative to CTL and INJ (Figure 3.7). While 





(Gaissmaier et al., 2008; Rose and Kooyman, 2016), in our study they were paired with the relative 
absence of synovitis and improved cartilage tissue quality in DLMS groups. IL-6 has been 
implicated as an anti-inflammatory mediator in OA, showing chondroprotective and anabolic 
effects (Gaissmaier et al., 2008; Westacott and Sharif, 1996). Meanwhile, MMP-2 and MMP-3 
can be an indicator of wound healing early in repair (Rose and Kooyman, 2016). Further, MMP-3 
is mainly expressed by fibroblasts and endothelial cells (Okada et al., 1992), indicating that 
changes to the synovium are likely contributing to observations in Study 2. Previous in vitro work 
has suggested that DEX modulates synovium behavior to IL-1 insult (Stefani et al., 2018), however 
the role of MMPs on synovium function is unclear. Ultimately, additional studies will be required 
to elucidate the mechanism of DEX-induced matrix remodeling in vivo. 
It is unlikely that increased cytokine concentration was a pro-inflammatory reaction to the 
PLGA or agarose, as these are widely reported to be biocompatible at the levels used (Danhier et 
al., 2012; Selmi et al., 2008). We speculate that the bone substrate used with the DLMS carrier 
may have contributed to elevated levels, however devitalized bone has been successfully used by 
others (Tognana et al., 2005). We previously reported negative in vitro effects of bone with 
juvenile chondrocytes, but did not see any with adult chondrocytes (Lima et al., 2008a). Overall, 
conclusions based on measures of inflammation (synovitis and cytokines) were potentially limited 
by having multiple repairs per knee. If only one DLMS implant failed, one might expect to observe 
a global spike in synovial fluid cytokines while simultaneously seeing improved local tissue 
quality at other repair sites. To capitalize on the positive effects of DEX, future studies may utilize 
other porous base scaffolds such as titanium (Bal et al., 2010). 
This preliminary in vivo experiment was potentially limited by sample size, which was 





laboratory, we determined a priori that a sample size of approximately 17 repairs per group would 
be required to achieve a power of at least 0.8. In addition, the 6-month end point provides only an 
initial assessment of healing, integration, and cartilage restoration for functional outcomes with 
longer term studies needed prior to clinical application. Nevertheless, trends and significant 
between-group differences were observed for the outcome measures, providing evidence for 
expedited early repair and providing rationale for long-term studies of sustained, targeted low-
dose DEX delivery to the joint. 
 
3.5 Conclusion 
Using in vitro models (Study 1, SA1e) and confirmatory in vivo models (Study 2, SA1f) of 
cartilage restoration provide guidance for optimizing localized DEX delivery strategies to 
maximize cartilage graft survival and function. Utilizing a targeted DLMS carrier implant, we 
observed in vitro chondroprotection in the presence of IL-1-induced degradation and improved in 
vivo functional outcomes. These improved outcomes were correlated with superior histological 
cartilage scores and minimal-to-no comorbidity, but not necessarily a dampened inflammatory 
response. However, synovitis was low across groups, and synovium-associated MMPs were 
upregulated in response to DLMS, potentially indicative of increased healing rather than 
degradation. Together, the data confirms the anabolic and chondroprotective effects of DEX on 
cartilage, however a dampened inflammatory response was not observed in synovial measures. 













Electric Fields as Catabolic, Anabolic, and Migratory 
Mediators in Synovium and Cartilage 
Part II Electric Fields as Catabolic, Anabolic, 








Chapter 4 Pulsed Electromagnetic Fields Modulate the Response of Synovium Explants to Cytokine 
Challenge or Glucocorticoid Treatment 
Pulsed Electromagnetic Fields Modulate the Response 
of Synovium Explants in Culture 
 
4.1 Introduction 
In vitro studies have established PEMFs as a modulator of inflammatory signaling in isolated FLS 
from both bovine and human arthritic sources (De Mattei et al., 2009; Ongaro et al., 2012), 
however it remains unclear how this translates to explants. Complicating the matter, the 
distribution and quantity of FLS, MLS, and non-resident immune cells in the synovium changes 
dramatically based on stage of OA and donor (O’Brien et al., 2017; Utomo et al., 2016). Studies 
have characterized behavior of macrophage cell lines to various strengths and duty cycles of 
PEMFs, showing variable effects on inflammatory mediators (Akan et al., 2010; Kawczyk-Krupka 
et al., 2002). Using this as motivation, as well as the observed modulation of cell phenotype by IL-
1 and DEX (Chapter 2), clinical stimulation parameters that have also been reported to have in 
vitro, in vivo and clinical benefits for cartilage and joint health (Collarile et al., 2018; Gobbi et al., 
2014; Zorzi et al., 2007) were used to investigate the effect of PEMF on response to IL-1 and DEX 
in juvenile bovine and OA human synovium explants (SA2a). Specifically, we hypothesized that 
PEMFs would decrease markers of inflammation in healthy bovine tissues and have an 
inconsistent effect on human OA tissues. Further, we hypothesized that the effect of PEMF would 





4.2 Materials and Methods 
4.2.1 PEMF System 
The PEMF generators were custom made and calibrated to recapitulate clinical parameters by 
IGEA Clinical Biophysics (Carpi, Italy). The system consisted of electromagnetic coils made of 
copper wire and placed in a signal generator. This created a 1.5 ± 0.2 mT magnitude pulse with a 
duration of 1.3 ms and frequency of 75 Hz, yielding a duty cycle of 0.10. The magnetic peak field 
intensity was measured by the Hall probe (HTD61-0608-05-T, F.W. Bell, Sypris Solutions, 
Louisville, KY) of a gaussmeter (Walker Scientific, Auburn Hills, MI, USA) with a reading 
sensitivity equal to 0.2%. The induced electric field was measured by a standard coil probe (50 
turns, 0.5 cm internal diameter of the coil probe, 0.2 copper diameter). A digital oscilloscope was 
used to evaluate the temporal pattern of the signal (Le Croy, Chestnut Ridge, NY). The shape and 
impulse length of the produced signal were maintained constant. 
Studies were performed in a plexiglass chamber consisting of two parallel coils, also known 
as a Helmholtz pair (Figure 4.1). The paired coils created a large region with uniform field, ideal 
for use with tissue culture plates. 
 
 
Figure 4.1 In vitro PEMF chamber consisting of (A) two electromagnetic coils (green) 





4.2.2 Synovium Explant Harvest 
Fresh bovine synovial tissue was harvested, pooled, and cultured as described previously (2.2.2.1). 
Human OA synovium explants were collected (IRB #AAAQ2703) from the region adjacent to the 
medial and lateral femoral condyle of 11 subjects during total knee arthroplasty (Figure 4.2, Table 
4.1). Explants were trimmed of excess adipose and outer capsule tissue before dicing. Human 
tissue was kept separated by donor for experiments. 
 
 
Figure 4.2 Human synovium explant harvest. Tissue (arrow) harvested from human OA 













Table 4.1 Human Donor Information. 
Donor ID Gender OA Grade Age 
A M 4 78 
B M 2 65 
C F 4 68 
D F 4 63 
E F 3 60 
F M 4 80 
G F 4 69 
H F 4 71 
I F 4 72 
J F 4 66 
K F 4 72 
Human (mean ± stdev) 3.7 ± 0.6 69 ± 6 
 
4.2.3 In Vitro Chemical Stimulation with or without PEMF 
As previously described (2.2.2.3), bovine explants were cultured for two weeks in: BM (CTL), 
BM supplemented with 10 ng/ml IL-1α, or BM supplemented with 100 nM DEX. Human explants 
were cultured in identical conditions, but interleukin-1α was substituted with interleukin-1β, as it 
is a more potent isoform in adult tissues (Kuroki et al., 2005). Specimens were cultured in PEMF 
chambers (Figure 4.1) which were active for either 8 hr per day or 0 hr per day (sham)1. 
 
 






As previously described (2.2.2.6), bovine explants (3 pooled donors; n=9-11) and human OA 
explants (11 individual donors; n=4-7 replicates per donor) were frozen, digested, and assayed for 
DNA, GAG, and total collagen content. Initial content shown in Table A.1.1. 
 
4.2.5 Media Analyses 
Media samples were assayed using the HA Quantikine ELISA Kit (Cat. No. DHYAL0; R&D 
Systems), PGE2 Parameter Assay Kit (Cat. No. KGE004B; R&D Systems), and Griess Reagent 
Kit for NO determination (Cat. No. G7921; ThermoFisher). 
 
4.2.6 Histological and Immunohistochemical Characterization 
Specimens were fixed and processed for H&E, alcian blue, and picrosirius red histology, as well 
as CD-14 immunostaining as described previously (2.2.2.8). 
 
4.2.7 Statistics 
Statistical analyses were conducted as previously described (2.2.2.9). Human data was analyzed 
using two- or three-way ANOVA (repeated measures) and Tukey HSD post-hoc test. Simple 
linear regression was performed on PGE2 data using Graphpad Prism software. 
 
4.3 Results 
4.3.1 Juvenile Bovine Synovium Explants 
In the absence of PEMF, CTL and DEX specimens retained a native membrane-like morphology 





only differed in the CTL media condition; specimens partially contracted and hardened, similar to 
IL groups. Total collagen content increased in culture only in the CTL media group without PEMF 
(p=0.018) (Figure 4.4). Histological staining showed generally porous ECM in CTL and DEX 
groups, whereas IL specimens had a greater degree of matrix compaction (Figure 4.5). Comparing 
H&E of IL±PEMF specimens (Figure 4.5B, E), IL+PEMF had a lower degree of intimal 
hyperplasia more similar to CTL and DEX specimens. 
 
 
Figure 4.3 Gross morphology of bovine synovium explants exposed to CTL, IL, or DEX 
media in combination with PEMF stimulation for either: 0 hr (-PEMF) or 8 hr (+PEMF) per day 
for two weeks. 
 
 








Figure 4.5 Histology of PEMF-treated bovine synovium explants. (A-F) H&E, (G-L) Alcian 
Blue, and (M-R) Picrosirius Red for (A, G, M) CTL-PEMF, (D, J, P) CTL+PEMF, (B, H, N) IL-
PEMF, (E, K, Q) IL+PEMF, (C, I, O) DEX-PEMF, (F, L, R) DEX+PEMF. 
 
Total NO secretion was significantly decreased by PEMF treatment in CTL culture 
conditions (p<0.0001) (Figure 4.6). Meanwhile, PEMF treatment non-significantly lowered NO 







Figure 4.6 Total nitric oxide (NO) secretion in PEMF-treated bovine synovium explants. 
*p<0.0001 
 
4.3.2 Human OA Synovium Explants 
Gross morphology varied widely between donors and treatment groups, with synovial contractures 
and residual adipose tissue observed in many specimens (Figure 4.7). DNA content was 
significantly affected by both media (p=0.027) and PEMF (p=0.011) (Figure 4.8). In the CTL 
media group, PEMF treatment significantly decreased DNA content compared to no PEMF 
treatment (p=0.009). Overall, specimen dry weight was not significantly affected by PEMF 
(p=0.12), however there was a modest ~11% overall decrease with PEMF treatment across all 
groups. Significant PEMF effects were not observed in GAG or collagen content. Histological 
staining was similarly variable; however, matrix compaction was least apparent in the 
DEX+PEMF group (Figure 4.9E, Q). Low intensity alcian blue staining was observed across all 
groups. In the absence of PEMF, CD14-positive cells were observed in all groups, however 







Figure 4.7 Gross morphology of selected OA human synovium explants exposed to CTL, 
DEX, or IL media in combination with PEMF stimulation for either: 0 hr (-PEMF) or 8 hr 
(+PEMF) per day for two weeks; (A) Donor H, (B) Donor I, (C) Donor J, and (D) Donor K. 
 
 
Figure 4.8 DNA, Dry weight, GAG, and collagen content in PEMF-treated human OA 







Figure 4.9 Histology of PEMF-treated OA human synovium explants. (A-F) H&E, (G-L) 
Alcian Blue, (M-R) Picrosirius Red, and (S-X) CD14 immunohistochemistry (red-brown DAB 
stain with purple hematoxylin counterstain, arrows point to CD14+ positive cells, negative control 
inset in panel S) for Donor A; (A, G, M, S) CTL-PEMF, (D, J, P, V) CTL+PEMF, (B, H, N, T) 






In the absence of PEMF, both HA and NO secretion were significantly decreased by DEX 
and increased by IL during the second week (p<0.05) (Figure 4.10). Similarly, PGE2 secretion 
was decreased by DEX and increased by IL at both week 1 and week 2 (p<0.0001). There was not 
a significant effect of PEMF treatment on HA, NO, or PGE2 secretion. Post hoc linear regression 
analysis of donor age and PGE2 secretion yielded a significant positive correlation in IL+PEMF 
group only (Week 2, Slope=4.8, r2=0.53, p=0.012) (Figure 4.11). 
 
 
Figure 4.10 Hyaluronic acid, nitric oxide, and PGE2 secretion from PEMF-treated human OA 
synovium explants. All values are normalized to mean starting dry weight (g) for the respective 







Figure 4.11 Linear regression of PGE2 secretion vs. donor age in IL-treated groups. Age had a 
significant positive correlation with PGE2 secretion in week 2. 
 
4.4 Discussion 
The presented studies characterized the response of healthy and OA synovial explants to PEMFs 
in control and chemical-stimulated culture conditions (SA2a). As hypothesized, a differential 
response to PEMF was observed in juvenile bovine and OA human synovium explants, and 
response was dependent on media treatment. PEMF treatment modulated collagen content, NO 
secretion, and gross morphology of bovine explants in CTL media conditions. Meanwhile, PEMF 
treatment had an effect on DNA and possibly CD14 content in human OA specimens, however 
other measures remained unchanged. Interestingly, secretion of NO from human OA explants 
followed a familiar pattern of decreased levels with DEX and increased with IL-1 that was 
previously observed in juvenile bovine explants (2.2). However, HA secretion deviated from this 
behavior in that DEX treatment lowered levels compared to CTL (Figure 4.10) rather than 
increased (Figure 2.6).  
In the absence of PEMF, bovine CTL and DEX specimens retained a native-like membrane 





indicative of a fibrotic phenotype (Remst et al., 2015), and was also apparent in histological 
staining, where IL specimens had a greater degree of matrix compaction compared to CTL and 
DEX (Figure 4.5A-C). A potent anti-inflammatory effect (i.e. decreased NO secretion) was 
observed in PEMF-stimulated CTL specimens, a nonsignificant effect in IL specimens, and no 
effect in DEX specimens (Figure 4.6). It is possible that this was due to changing cell phenotype 
in IL and DEX-treated bovine explant cultures, as observed in Chapter 2. 
Meanwhile, regardless of media condition, there was not a significant effect of PEMF 
treatment on HA or NO secretion in human OA tissues. This is in contrast with literature reports 
of reduced inflammatory signaling in bovine isolated bovine and human arthritic FLS (De Mattei 
et al., 2009; Ongaro et al., 2012). However, although an overall effect of PEMF on PGE2 secretion 
was not observed, there was a significant correlation with donor age in IL+PEMF specimens only 
(Figure 4.11). In this group, specimens from older donors were more likely to have higher PGE2 
secretion. This result warrants further study, as it is possible that the anti-inflammatory effect 
previously ascribed to PEMF is only present in a subset of specimens (possibly lower age). If such 
an effect were present, this would have obvious clinical implications and could also explain 
conflicting results for PEMF treatment in the literature. 
In our study, human tissues showed qualitative evidence of an anti-inflammatory effect; in 
the absence of PEMF, CD14+ cells were observed in all groups, however CD14+ cells were absent 
in CTL+PEMF and DEX+PEMF specimens (Figure 4.9S-X). Future studies should include flow 
cytometry analysis to robustly quantify potential changes in CD14 due to PEMF. Flow cytometry 
data for passaged synovial cells from selected donors is shown in Table A.1.2, however no 





Nevertheless, it is likely that variable quantities of FLS were present in the OA specimens, 
with a higher proportion of starting cells being MLS or lymphocytes (1.3.1.2). The effect of PEMF 
on synovial immune cells has not been well characterized, however one study reported 
downregulation of TNFα and nuclear factor kappa B (NFκB) in a murine macrophage cell line 
(Ross and Harrison, 2013). NFκB serves critical immune system functions, including transcription 
of cytokines and regulation of cell differentiation, proliferation, and viability (Hayden et al., 2006). 
PEMF has also been shown to increase NO production in THP-1 cells, a human monocyte cell line 
(Akan et al., 2010). Therefore, it is quite possible that PEMF had counteracting effects in FLS and 
MLS, contributing to the inconclusive results in human OA explants. 
In human specimens, PEMF treatment did have an effect on DNA content, leading to 
significantly decreased DNA content compared to no PEMF treatment. Similarly, there was a 
modest ~11% overall decrease in specimen dry weight with PEMF treatment across all groups. 
Together, these may be indicative of a reduction in synovial hyperplasia and/or fibrosis, however 
the clinical significance of this small effect, without concomitant reduction in inflammatory 
mediators, is unclear. Overall, these results support the Part II global hypothesis, however this 
comes with the caveats that PEMF did not have a consistent anti-catabolic effect in human OA 
tissues nor did it have an additive effect with DEX.  These results are likely to have significant 
implications for selecting optimal patient populations for PEMF therapy. 
 
4.5 Conclusion 
Overall, the current studies (SA2a) support the Part II global hypothesis by demonstrating that 
PEMF modulates inflammatory signaling in bovine explant tissues, in agreement with previous 





anti-catabolic effect of PEMF was not observed. This was likely due to the advanced disease state 
of these tissues and the variable cell content, with a significantly lower proportion of FLS cells 
compared to healthy tissue. A key limitation of this study was that we could not quantify exactly 
which cells in the tissue were responding to PEMF. It is likely that increased MLS and T 
lymphocytes within human OA specimens interact with PEMF in very different ways from FLS, 
likely also compounded by cellular communication/gap junctions. This motivates further 
evaluation of PEMF in synovial tissue obtained from healthy or early disease patients, where 







Chapter 5 Pulsed Electromagnetic Fields Enhance 
Osteochondral Repair using Engineered Constructs 
Pulsed Electromagnetic Fields Enhance Osteochondral 
Repair using Engineered Constructs 
 
5.1 Introduction 
Clinical studies of PEMFs have shown improvements in function following microfracture, OCA, 
MACI®, and bone marrow-derived stem cell transplantation (Cadossi et al., 2014; Collarile et al., 
2018; Iwasa and Reddi, 2018). However, while these initial studies were promising, PEMFs have 
remained controversial for cartilage repair due to inconclusive clinical evidence of robust efficacy 
and few mechanistic studies on the matter (Bjordal et al., 2007; Gobbi et al., 2014). We suspect 
that the sometimes-conflicting data may stem from differences in methods and strengths/duty cycle 
of applied electric fields, anatomic geometry, repair type, and contributions from surrounding 
tissues.  
Motivated by promising initial in vitro and clinical studies (1.3.4.1) and our own in vitro 
data supporting an anti-catabolic response in non-pathologic synovium explants (Chapter 4), 
these studies aim to optimize parameters of PEMF stimulation in order to provide insights into 
successful clinical translation for engineered cartilage repair (SA2b-c). As engineered cartilage is 
especially susceptible to impacts from sub-optimal implantation properties and pro-inflammatory 
cytokines (Djouad et al., 2009; Hunter and Levenston, 2004; Obradovic et al., 2001b; Spalazzi et 





role of stimulating cartilage anabolism and suppressing synovial-mediated catabolism following 
joint repair, leading to better post-operative outcomes using engineered cartilage. 
To this end, we first assessed the effect of timing (Study 1) and orientation (Study 2) of 
PEMF stimulation on engineered cartilage growth and integration, two often cited factors 
contributing to clinical graft failure (Hunter and Levenston, 2004; Obradovic et al., 2001a). Study 
1 and 2 were conducted in vitro, to serve as a best-case scenario permitting the evaluation of the 
intrinsic response of engineered cartilage to PEMF stimulation. Next, tissue quality and functional 
outcomes were assessed following an in vivo engineered osteochondral graft repair (Study 3). The 
adult canine preclinical model was selected for its similarities to humans in patellofemoral joint 
pathology and presentation of pain and discomfort via changes to gait (Bendele, 2001). To the 
author’s knowledge, PEMFs have not previously been investigated in a preclinical engineered 
cartilage model or as a method for improving engineered cartilage growth and integration. 
 
5.2 Materials and Methods 
5.2.1 PEMF System 
The PEMF system was configured as previously described (4.2.1). In vitro studies (Study 1-2) 
were performed in a plexiglass chamber consisting of two parallel coils (Figure 4.1, Figure 5.1A). 
Modeling of the PEMF-induced electrical field within engineered cartilage constructs was 
performed by means of COMSOL Multiphysics 5.4 software. The in vivo portion (Study 3) was 
performed using a single electromagnetic coil, which was strapped to the cranial (anterior) portion 







Figure 5.1 Schematic of in vitro PEMF application and push-out mechanical testing. (A) 
Magnetic field lines (modified from commons.wikimedia.org, labeled for reuse) with engineered 
constructs in perpendicular (┴) or parallel (═) orientations; (B) Study 1 specimens were stimulated 
with PEMF starting at day 0 (continuous PEMF, C-PEMF), starting at day 28 (delayed PEMF, D-
PEMF), or no PEMF (CTL) and cultured for a total of 42 days (all study 1 PEMF samples in 
perpendicular orientation). Study 2 specimens were pre-cultured for 42 days and then sub-cored, 
re-implanted, and stimulated with either perpendicular (┴) or parallel (═) orientation or no PEMF 
(CTL) for an additional 1 month; (C) Schematic of push-out testing of engineered core/annulus 
units (Study 2) showing side view and deconstructed oblique view with construct holder (i.), 
indenter (ii.), construct annulus (iii.), and construct core (iv.); (D) Representative load-







Figure 5.2 Schematic of in vivo osteochondral repairs and PEMF stimulation. (A) Two 
engineered osteochondral grafts (out of a total of 3 per joint, trochlear repair not shown) were 
implanted in the femoral condyles (Study 3); (B) Two microfracture procedures (total of 3 per 
joint, trochlear defect not shown) in the femoral condyles (Study 3); (C) Single electromagnetic 
coil (green) used for in vivo pilot allowed full range of motion (Study 3). 
 
5.2.2 Preparation and Culture of Engineered Constructs 
TE cartilage was prepared from adult canine cartilage and cultured as previously described (3.2.2). 
 
5.2.3 Effect of PEMF Timing on Engineered Cartilage Growth (Study 1) 
Engineered constructs (∅ 3 mm x 2.4 mm thick) were placed in the PEMF device starting from 1 
of 3 different times: 1) continuous PEMF starting from day 0 (C-PEMF), 2) delayed PEMF starting 
from day 28 (D-PEMF), and 3) no-PEMF (CTL) (Figure 5.1A-C). PEMF was applied for 8 hr/day, 
7 days/week, and a total culture time of 6 weeks. CTL specimens were cultured in adjacent sham 









5.2.4 Effect of PEMF Orientation on Engineered Cartilage Integration (Study 2) 
Cartilage constructs were prepared (∅ 8 mm x 2.4 mm thick) and cultured to maturity (42 days). 
At maturity, constructs were sub-punched using a 3 mm biopsy punch (Integra Miltex). The 3 mm 
cores were then randomly re-inserted into each annulus to create an implant-defect model. The 
core-annulus units were placed in 1 of 3 conditions: PEMF stimulation with electromagnetic coils 
oriented either perpendicular (┴ PEMF) or parallel (═ PEMF) to the construct surface and no-
PEMF controls (CTL) (Figure 5.1A-C). As in Study 1, PEMF was applied for 8 hr/day, 7 
days/week. 
Specimen biochemical properties were evaluated at 42 days (start of implantation) and 72 
days (1-month post-implantation) (n=8-12). Integration of the core-annulus unit was evaluated 
using an indentation “push-out” test at the terminal time point (Figure 5.1D-E). Briefly, an 
indenter was visually centered over the core before loading at a rate of 10 µm/sec (Lima et al., 
2008a; van de Breevaart Bravenboer et al., 2004). The stiffness (slope of linear portion of force-
displacement curve; Figure 5.1E, v.), failure load (maximum observed force; Figure 5.1E, vi.), 
and energy to failure (area under the load-displacement curve to the peak load and normalized to 
interface area; Figure 5.1E, vii.) were computed for each specimen. After the cores were separated 
from the annuli via this destructive mechanical testing, individual core/annulus specimens were 
solubilized using proteinase K and assayed for DNA, GAG, and COL, as before. 
 
5.2.5 Preclinical Model of Engineered Osteochondral Repair with PEMF (Study 3) 
Osteochondral grafts (∅ 6 mm x 6 mm thick) were prepared and cultured as previously described 
(Lima et al., 2008a). Briefly, bovine trabecular bone cores (∅ 6 mm x 5 mm thick) were devitalized 





cells/ml) to produce layered osteochondral constructs with a 1 mm gel-only region, 1 mm gel bone 
interface, and 4 mm bone-only. Constructs were pre-cultured until the cartilage layer reached 
maturity (42 days).  
Purpose-bred adult mongrel dogs (0.9 ± 0.07 yr, 24.0 ± 1.78 kg, all female) were 
anesthetized and prepared for aseptic surgery of the right stifle (University of Missouri-Columbia 
IACUC #9167). Mature osteochondral constructs (n=8 animals, n=3 grafts per animal) were press-
fit into defects created using a 6 mm OATS® reamer with power pick (Figure 5.2A, trochlear 
repair not shown). Specifically, one defect each was created in the trochlear groove (TG), femoral 
condyle-medial (FCM), and femoral condyle-lateral (FCL) of the stifle joint. A parallel set of 
repairs were performed in defects (∅ 6 mm x 1 mm thick) using the microfracture (power pick) 
technique (n=8 animals, n=3 repairs per joint) (Figure 5.2B, trochlear repair not shown). 
Starting on the first post-operative day, all animals were fitted with PEMF devices which 
were then worn for 6 hr/day, 7 days/week for 3 months. The stimulation time was shortened from 
the 8 hr/day used for in vitro experiments to 6 hr/day for the in vivo study due to practical reasons. 
Half of the devices were active (+ or PEMF, n=4) and the other half were sham control devices (- 
or CTL, n=4). 
 
5.2.6 Clinically Based Assessments (Study 3) 
Animals were examined, assessed, and had synovial fluid assayed as described in Chapter 3.2.5, 






5.2.7 Histological Scoring (Study 3) 
At the terminal 3-month time point, animals were sacrificed and tissue harvested for 
histopathology assessment, as previously described (3.2.6). Additional immunohistochemical 
staining of osteochondral repair units was performed using collagen type II primary antibody 
(ab34712; Abcam) and DAB staining kit (ab64264; Abcam).  
 
5.2.8 Statistics 
Statistical analyses of in vitro data and power analysis were performed as previously described 
(3.2.7). In vivo functional measures were compared using three-way ANOVA (repair type, PEMF, 
time) with time as a repeated measures factor and Tukey post-hoc test (α=0.05). These normally 
distributed data were presented as mean (95% Confidence Interval (95% CI)). 
Modified OARSI scores and corresponding sub-scores were analyzed using a Generalized 
Linear Model. Specifically, data were fit to an ordinal multinomial probability distribution and 
cumulative logit link function with generalized estimating equations correction for repeated 
measures (location, scorer). The dependent (response) variable was the score (or sub-score) and 
the independent variables (predictors) were the categorical factors: repair type, PEMF, and/or 
repair location. Total OARSI scores were grouped into ordered categories for regression analysis 
in order to increase the number of observations per level of the dependent variable. Odds ratios 
(OR) and corresponding 95% CI were computed from the model’s parameter estimates. OCA 
scores were evaluated using the Mann-Whitney test. Averages of non-normal datasets were 








5.3.1 Finite Element Modeling of Electric Field Distribution 
In the perpendicular PEMF coil orientation, the induced electric field was predicted to peak at 
opposite ends of the construct resulting in an irregular charge distribution on the outer surface 
(Figure 5.3). The parallel PEMF coil orientation generated an electrical field and consequent 
charge distribution peaking along the outer circumference of the cartilage construct. In this case, 




Figure 5.3 Finite element analysis of PEMF-stimulated engineered cartilage. Charge 
distribution changed dramatically dependent on PEMF orientation. 
 
5.3.2 Effect of PEMF on Maturation of Engineered Cartilage (Study 1) 
At day 42, delayed PEMF (D-PEMF) had significantly greater cell content (DNA/ww; 0.05 vs. 
0.03 %ww; between-group difference, 0.01 %ww; p=0.022) and GAG content (GAG/ww; 2.8 vs. 
2.3%; between-group difference, 0.5 %ww; p=0.031) compared to no-PEMF (CTL) (Figure 5.4). 





PEMF) compared to no PEMF (2.6 vs. 2.0 %ww; between-group difference, 0.7 %ww; p=0.046) 
(Figure 5.4C). Meanwhile, there were no significant between-group differences in either 
GAG/DNA or COL/DNA at any time point. 
 
 
Figure 5.4 Biochemical properties of PEMF-stimulated engineered cartilage maturation. (A) 
DNA/ww, (B) GAG/ww, and (C) COL/ww in engineered constructs subjected to no PEMF (CTL), 
continuous PEMF (C-PEMF), or delayed PEMF (D-PEMF) (Study 1); *p<0.05 compared to CTL 






5.3.3 Effect of PEMF on Repair of Mature Engineered Cartilage Model (Study 2) 
Repair stiffness was significantly greater in the parallel PEMF orientation compared to CTL (3.1 
vs. 2.4 N/mm; between-group difference, 0.73 N/mm; p=0.012) and compared to perpendicular 
PEMF (3.1 vs. 2.4 N/mm; between-group difference, 0.71 N/mm; p=0.026) (Figure 5.5A). 
Additionally, there was a significant increase in failure load for the parallel PEMF orientation 
relative to CTL (Figure 5.5B; 6.4 vs. 4.6 N; between-group difference, 1.7 N; p=0.017) and a 
nonsignificant increase in energy to failure (Figure 5.5C; 310 vs. 197 J/m2; between-group 
difference, 113 J/m2; p=0.074) of the core-annulus unit. 
 
 
Figure 5.5 Mechanical properties of core-annulus repairs subjected to PEMF. (A) Stiffness 
(N/mm) was determined from the slope of the load-displacement curve, (B) failure load (N) from 
the peak load, and (C) energy to failure (J/m2) from the area under the curve normalized to interface 
area. Each parameter was enhanced in the parallel (═PEMF) orientation relative to no PEMF 
(CTL); *p<0.05 compared to CTL, #p<0.05 compared to ┴PEMF. 
 
DNA content was not significantly affected by PEMF treatment in either the construct 
cores or annuli (Figure 5.6A). Annuli in the perpendicular PEMF group had significantly greater 
GAG content compared to CTL (5.6 vs. 4.0 %ww; between-group difference, 1.6 %ww; p=0.010) 
(Figure 5.6B). GAG content was similarly increased in parallel PEMF compared to CTL (5.6 vs. 





differences in collagen content, perpendicular PEMF had a non-significant increase over parallel 




Figure 5.6 Biochemical properties of core-annulus repairs subjected to PEMF. (A) DNA/ww, 
(B) GAG/ww, and (C) COL/ww for the engineered construct cores (left) and annuli (right) in 
perpendicular (┴) and parallel (═) PEMF groups compared to no PEMF (CTL) (Study 2); *p<0.05 






5.3.4 Clinically Based Assessments of In Vivo PEMF-Stimulated Repairs (Study 3) 
In animals with tissue-engineered repairs, five out of six parameters (gait, CROM, TPI, pain, 
effusion) were not significantly changed from baseline (Table 5.1). At the same time, animals with 
microfracture repairs had significantly worse gait, CROM, and TPI scores. Tissue-engineered 
repairs led to less lameness than microfracture repairs in both no PEMF (1.3 vs. 2.0; between-
group difference, 0.8; 95% CI, 0.01 to 1.5) and PEMF (1.3 vs. 2.0; between-group difference, 0.8; 






Table 5.1 Clinical outcome scores of OC repairs at 3 months; *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 
 
Mean (95% CI) 
 
Mean (95% CI) 
 
Mean (95% CI) 
 
TE (Change from Baseline) Difference in 
Change (TE- vs. 
TE+) 
 





Change (TE- vs. 
MF-) 
Difference in 
Change (TE+ vs. 




Gait -1.5 (-3.6 to 0.6) -1.7 (-3.8 to 0.4) -0.2 (-2.7 to 2.4) 
 
-2.9 (-5.0 to -0.8) ** -3.9 (-5.9 to -1.8) *** -0.9 (-3.4 to 1.6) 
 
-1.4 (-3.9 to 1.1) -2.2 (-4.7 to 0.3) 
CROM -7.5 (-20.2 to 5.2) -10.8 (-23.4 to 1.9) -3.3 (-18.4 to 11.9) 
 
-17.5 (-30.2 to -4.8) ** -23.8 (-36.4 to -11.1) *** -6.3 (-21.4 to 8.9) 
 
-10.0 (-25.2 to 5.2) -13.0 (-28.2 to 2.2) 
TPI -2.8 (-6.7 to 1.2) -2.1 (-6.1 to 1.8) 0.7 (-4.1 to 5.4) 
 
-4.4 (-8.4 to 0.5) * -6.0 (-9.9 to -2.1) ** -1.6 (-6.3 to 3.1) 
 
-1.7 (-6.4 to 3.1) -3.9 (-8.6 to 0.8) 
Lameness 1.3 (0.6 to 1.9) *** 1.3 (0.6 to 1.9) *** 0.0 (-0.7 to 0.7) 
 
2.0 (1.4 to 2.6) **** 2.0 (1.4 to 2.6) **** 0.0 (-0.7 to 0.7) 
 
0.8 (0.01 to 1.5) * 0.8 (0.01 to 1.5) * 
Pain 1.3 (-0.6 to 3.2) 1.1 (-0.8 to 3.0) -0.2 (-2.5 to 2.1) 
 
1.5 (-0.5 to 3.4) 2.6 (0.7 to 4.5) ** 1.2 (-1.1 to 3.5) 
 
0.2 (-2.1 to 2.4) 1.6 (-0.7 to 3.8) 
Effusion 1.3 (-1.7 to 4.3) 1.7 (-1.3 to 4.7) 0.5 (-3.1 to 4.0) 
 
3.8 (0.8 to 6.8) ** 2.6 (-0.4 to 5.5) -1.2 (-4.8 to 2.3) 
 
2.5 (-1.1 to 6.1) 0.8 (-2.7 to 4.4) 
TE-, tissue-engineered osteochondral repairs without PEMF; TE+, tissue-engineered osteochondral repairs with PEMF; MF-, microfracture repairs without PEMF; MF+, microfracture 






5.3.5 Histological Assessment of PEMF-Stimulated Repairs (Study 3) 
PEMF-treated tissue-engineered osteochondral repairs (TE+) were approximately 70% less likely 
than those without PEMF (TE-) to have a worse (ie. higher) combined OARSI cartilage score 
(p=0.028) (Table 5.2). Specifically, TE+ samples were about 80% less likely to have greater 
proteoglycan pathology (p=0.013) and 60% less likely (p=0.051) to have greater chondrocyte 
pathology than TE-. This was reflected by toluidine blue staining, which was homogenously 
distributed in TE+ specimens and almost nonexistent in the superficial zone of TE- specimens 
(Figure 5.7I-J). 
 
Table 5.2 OARSI cartilage scores and sub-scores. *p<0.05, ****p<0.0001 
 
Median (95% CI)  
 
Median (95% CI)  





Odds Ratio          
(95% CI) 
OARSI (Cartilage, combined) 19 (14 to 20) 18.5 (12 to 19) 0.3 (0.1 to 0.9) * 
 
16 (13 to 19) 16.5 (15 to 20) 1.8 (0.6 to 5.7) 
Structure 4 (2 to 4) 4 (1 to 4) 0.7 (0.2 to 2.0) 
 
3.5 (2 to 4) 3 (2 to 4) 0.9 (0.2 to 3.6) 
Chondrocytes 4 (2 to 4) 3.5 (1 to 4) 0.4 (0.1 to 1.0) 
 
3 (2 to 4) 3 (2 to 4) 0.9 (0.2 to 4.5) 
Proteoglycans 3 (2 to 4) 3 (1 to 3) 0.2 (0.1 to 0.7) * 
 
3 (3 to 3) 3 (3 to 4) 0.8 (0.1 to 5.0) 
Collagen 3 (3 to 3) 3 (3 to 3) N/A 
 
3 (3 to 3) 3 (3 to 3) N/A 
Tidemark 2 (2 to 2) 2 (2 to 2) N/A 
 
2 (2 to 2) 2 (2 to 2) N/A 
Bone 3 (3 to 3) 3 (3 to 3) N/A 
 
2 (1 to 3) 3 (3 to 3) 55.3 (9.4 to 326) **** 
TE-, tissue-engineered osteochondral repairs without PEMF; TE+, tissue-engineered osteochondral repairs with PEMF; MF-, 
microfracture repairs without PEMF; MF+, microfracture repairs with PEMF 
 
There were no significant differences in repair quality at the graft-host junction (OC score; 
p=0.31) (Table 5.3). However, H&E staining showed evidence of increased matrix fill-in for TE+ 
specimens compared to TE- (Figure 5.7E-F). 
Histologically, tissue-engineered repairs had superior deposition of both GAG (Figure 





significant effect of PEMF in determining overall cartilage pathology in microfracture (p=0.31). 
However, picrosirius red staining intensity was more intense in non-PEMF groups for both tissue-
engineered and microfracture repairs (Figure 5.7M-P). 
 
 
Figure 5.7 Gross imaging and histological staining for selected grafts sites. (A-D) 
Representative gross morphology, (E-H) H&E, (I-L) toluidine blue, (M-P) picrosirius red, and 
(Q-T) type II collagen immunohistochemistry of TE- (ID 90-FCM; A, E, I, M, Q), TE+ (ID 101-
FCM; B, F, J, N, R), MF- (ID 105-FCM; C, G, K, O, S), and MF+ (ID 110-FCM; D, H, L, P, T) 
at 3-month time point (Study 3); Tissue-engineered osteochondral repairs without PEMF (TE-) 








Table 5.3 OC TE graft-host junction scores. 
 
Median (95% CI) 
Measurement TE- TE+ 
OC (Total) 7 (6 to 8) 6 (5 to 8) 
Fill 2 (2 to 2) 2 (2 to 2) 
Edge Integration 1 (1 to 1) 1 (0 to 2) 
Surface Congruity 2 (1 to 2) 1 (0 to 2) 
Fibrosis 1 (1 to 2) 1 (1 to 1) 
Inflammation 1 (1 to 1) 1 (1 to 1) 
TE-, tissue-engineered osteochondral repairs without PEMF; TE+, tissue-
engineered osteochondral repairs with PEMF 
 
5.3.6 Modulation of In Vivo Inflammatory Environment (Study 3) 
TE- repairs had significantly elevated IL-6 (p=0.0031) and IL-8 (p=0.012) at the 1-month time 
point (Figure 5.8). With PEMF treatment, TE+ repairs did not have significantly elevated levels 
of IL-6 (p=0.32) or IL-8 (p=0.62) at the same time point. Meanwhile, KC was elevated after 1 
month for TE+ (p=0.010) but not for TE- (p=0.35). There were no between-group differences in 
MCP-1, MMP-1, MMP-2, or MMP-3. 
For microfracture repairs, there were no significant increases above baseline for IL-6, IL-
8, KC, or MMP-3. Microfracture with PEMF had significantly elevated MCP-1 at both 1-month 
(p<0.001) and 2-months (p=0.0072) but repairs without PEMF did not (p=0.36 and p=0.82, 







Figure 5.8 Synovial fluid panel of OA-related cytokines. (A) IL-6, (B) IL-8, (C) KC, (D) 
MCP-1, (E) MMP-1, (F) MMP-2, and (G) MMP-3; *p<0.05 compared to Day 0. 
 
TE+ repairs were approximately 1.6x more likely than TE- to have greater overall 
synovium pathology (p=0.043) (Table 5.4). Specifically, TE+ repairs were about 4x more likely 





in synovium histology, which showed synovial villous hyperplasia (Figure 5.9, arrows). No 
significant differences were observed in number of lining cells or degree of cell infiltration. While 
synovium in microfracture repairs was not significantly affected by PEMF, TE groups were 
approximately 3x more likely to present cell infiltration than microfracture groups (p=0.021). 
 
 
Figure 5.9 Representative H&E of synovium in PEMF-stimulated repairs showing increased 









Table 5.4 Histological scoring of the synovium (OARSI). *p<0.05 
 
Median (95% CI)  
 
Median (95% CI)  
Measurement TE- TE+ Odds Ratio (95% CI) 
 
MF- MF+ Odds Ratio (95% CI) 
OARSI (Synovium Total) 5 (3 to 7) 6.5 (4 to 8) 2.6 (1.0 to 6.4) * 
 
4 (3 to 7) 4.5 (4 to 6) 1.1 (0.4 to 3.2) 
Lining Cells 2 (1 to 2) 2 (1 to 3) 1.7 (0.8 to 3.7) 
 
2 (1 to 3) 2 (1 to 3) 1.1 (0.5 to 2.3) 
Lining Characteristics 2 (1 to 3) 3 (2 to 4) 4.0 (1.3 to 11.9) * 
 
2 (1 to 3) 2 (1 to 3) 0.9 (0.3 to 2.8) 
Cell Infiltration 1 (0 to 1) 1 (0 to 2) 1.3 (0.6 to 3.0) 
 
0 (0 to 1) 0 (0 to 1) 0.8 (0.2 to 3.1) 
TE-, tissue-engineered osteochondral repairs without PEMF; TE+, tissue-engineered osteochondral repairs with PEMF; MF-, microfracture 
repairs without PEMF; MF+, microfracture repairs with PEMF 
 
5.4 Discussion 
Although not currently the standard of care, engineered cartilage repair techniques (e.g. MACI) 
are increasingly gaining clinical acceptance. By improving strategies for preparation and 
implantation of tissue engineered cartilage, their full potential can be more fully realized. The 
current studies examined the influence of PEMF on engineered cartilage fabricated from an 
agarose hydrogel with passaged adult canine chondrocytes (SA2b-c). Overall, PEMF enhanced 
engineered cartilage repair by modulation of growth (Study 1, SA2b) and integration (Study 2, 
SA2b) in vitro. Specifically, delayed PEMF application improved DNA and GAG content while 
the parallel PEMF orientation was superior for integrative repair. Furthermore, PEMF significantly 
improved functional outcomes and cartilage tissue quality in vivo (Study 3, SA2c), despite also 
increasing synovial hyperplasia and only modestly decreasing inflammatory cytokines. As a result 
of the inconclusive synovial measures, we can only partially accept the hypothesis. 
In Study 1, delayed PEMF stimulation led to significantly greater cell content and GAG 
deposition in immature engineered constructs (Figure 5.4). While GAG/DNA was not also 





have been implicated in stimulating FGF-2 production (Tepper et al., 2004), which may have 
contributed to chondrocyte growth and survival in culture. 
The time-dependent effect of PEMF suggested a role of cell-matrix adhesions, which had 
not yet formed at the onset of stimulation in the continuous PEMF group. Previous studies have 
established that isolated chondrocytes were only responsive to PEMFs in the presence of serum, 
which is necessary for forming such adhesions (Pezzetti et al., 2014). Furthermore, PEMFs have 
been shown to stimulate chondrocyte proliferation and GAG synthesis in mature cartilage explants 
(De Mattei et al., 2007; Ongaro et al., 2011).  
PEMF had a similar robust effect on GAG deposition when applied to mature engineered 
constructs, however the difference was only observed in the construct annuli (Study 2; Figure 
5.6). No differences were observed in constructs cores, perhaps due to shielding by the annuli. 
This theory was supported by finite element modeling, which showed that charge density was 
concentrated in the annuli for both PEMF orientations (Figure 5.3). 
While the increase in GAG deposition was not orientation dependent, parallel PEMF 
outperformed perpendicular PEMF and CTL in terms of repair stiffness and ultimate failure load 
(Figure 5.5). This was potentially a result of the more uniform charge density created by the 
parallel PEMF orientation, particularly at the core-annulus junction (Figure 5.3). Increased 
collagen content in the perpendicular group may have played a role as well, as it would counteract 
GAG-induced tissue swelling in the annulus thereby lowering the perceived integration strength. 
EF-induced cell migration at the core-annulus interface was another potential contributor 
to improved graft integration in parallel PEMF specimens. Endogenous EFs are known to guide 
cell migration and proliferation in developing embryos (Robinson, 1985). Analogous to their role 





adult animals (Baker et al., 1974; Lippiello et al., 1990; Nessler and Mass, 1987) and cause in vitro 
directed movement of musculoskeletal cells (Chao et al., 2007; O’Connell et al., 2015; Sun et al., 
2004). The PEMF system used in this study created a relatively low intensity induced EF of 
approximately 0.071 V/cm (Benazzo et al., 2008), however it was applied over an extended time 
period. The EF, which is perpendicular to the magnetic field lines (Figure 5.1), would be offset 
by 90° in the two orientations, likely causing different patterns of migration. Although migration 
behavior was not analyzed in this study, future experiments could examine this potential 
mechanism by tracking cell migration using labeling techniques. 
In vivo (Study 3), PEMF-stimulated tissue-engineered repairs were significantly less likely 
than no PEMF controls to have cartilage pathology (OARSI cartilage score, Table 5.2). 
Specifically, PEMF-treated specimens were less likely to have proteoglycan- and chondrocyte- 
related pathology than control, which was also apparent from comparatively diffuse toluidine blue 
staining in the superficial zone of control specimens (Figure 5.7). A similar result was observed 
in a guinea pig model of OA (Veronesi et al., n.d.); this may have been due to increased TGFβ 
expression (Aaron and Ciombor, 2004) and chondrogenesis (Ciombor et al., 2002; De Mattei et 
al., 2007; Ongaro et al., 2011). 
In apparent agreement with the results of Study 2, tissue-engineered repair integration was 
improved by PEMF (Table 5.3), although not significantly. H&E staining of the graft-host 
junction was more intense in PEMF-treated repairs (Figure 5.7). It is possible that only a weak 
effect was observed in OC sub-scores due to inconsistent PEMF orientation, which was likely 
dependent on degree of knee flexion and repair location (TG vs. FCL or FCM). Due to coil 
placement and animals being allowed to walk freely, we speculated that repairs would primarily 





inherently difficult, limiting orientation-related conclusions that could be drawn from Study 3. 
Furthermore, while the animals were all the same size and gender, clinical PEMF dosing is 
complicated by the varied conductance of different tissue types and different patient sizes 
(Petrofsky, 2008).  
In contrast to cartilage scores, PEMF slightly increased synovial pathology. TE+ repairs 
were significantly more likely than TE- to have villous hyperplasia (Figure 5.9, Table 5.4). PEMF 
has been shown to increase collagen I expression and VEGF (de Girolamo et al., 2013), which 
may have led to the observed synovial pathology. While no differences in lining thickness or 
inflammatory cell recruitment were observed, PEMF is known to increase FGF-2 production 
(Tepper et al., 2004), which may have had the unintended effect of stimulating synovial fibroblast 
proliferation. 
Interestingly, the increased synovial pathology did not coincide with increased synovial 
fluid inflammatory markers (nor worse clinical outcomes). For example, TE- repairs had 
significantly elevated IL-6 and IL-8 at the 1-month time point (Figure 5.8), whereas levels in TE+ 
repairs were not significantly elevated over baseline. PEMF has been shown to increase adenosine 
receptor activity in synovial cells and chondrocytes, resulting in the inhibition of pro-inflammatory 
cytokines (De Mattei et al., 2009; Vincenzi et al., 2013). 
 Overall, disparate effects of PEMF were observed in microfracture and tissue-engineered 
osteochondral repairs. Microfracture repairs had a significantly increased likelihood of having 
subchondral bone pathology in PEMF compared to no PEMF control. The bone pathology 
presented as increased subchondral bone density, which was apparent in picrosirius red staining 





in osteoblasts (Bodamyali et al., 1998; Zhuang et al., 1997), as well as increased osteoblast 
proliferation and reduced osteoclast formation (Chang et al., 2005; Otter et al., 1998). 
Increased bone growth has also been observed at the transplant-host junction of the 
subchondral bone in an in vivo autograft model (Benazzo et al., 2008). While it was considered 
beneficial for early graft stabilization and preventing bone resorption, it is possible that PEMF 
dosage would need to be modified (i.e. lowered) in microfracture repairs to prevent this pathologic 
bone thickening. It is further speculated that due to tissue density and maturity, OCA repair, the 
current standard of care, would perhaps require an elevated PEMF dose in order to observe similar 
integrative benefits to cartilage that were seen in tissue-engineered constructs. 
Microfracture repair tissue is often described as sub-optimal in quality (Mithoefer et al., 
2009), and this was reflected in the improved functional outcome of engineered vs. microfracture 
repairs in Study 3. Microfracture had significantly worse scores at 3 months, compared to baseline, 
for gait, CROM, and TPI (Table 5.1). Meanwhile, these parameters were not significantly different 
from baseline in tissue-engineered groups, indicating a near absence of functional limitations. 
Engineered repairs outperformed microfracture in lameness score as well. This was likely due to 
superior cartilage tissue quality, as demonstrated by increased deposition of both GAG and type II 
collagen (Figure 5.7). 
Despite the positive clinical outcome measures, elevated baseline cytokine levels (Figure 
5.8) were observed in engineered construct groups. This may have been indicative of increased 
overall metabolic activity and tissue healing, as proposed in the discussion of Chapter 3. 
Alternatively, we speculate that the observed differences between microfracture and engineered 
cartilage repairs may have been a result of the allogenic cells in the engineered constructs. In vitro 





whereas in vivo experiments incorporated the contributions of a complex milieu of other joint 
tissues, including synovial- and bone marrow-derived stem and immune cells. The cell content and 
matrix structure of synovium is altered dramatically in different stages of disease (Stefani et al., 
2018), and likely changing the overall effects of PEMF as well.  
Although the devitalized bone bases did not elicit an immunogenic response in 
biocompatibility tests (data not shown), future studies may choose to utilize a more robust porous 
titanium scaffold (Bal et al., 2010). Overall, we anticipate that engineered cartilage is analogous 
to allogeneic cartilage allografts, which have been used clinically for decades and not thought to 
pose a significant immunogenic risk (Bugbee et al., 2016). 
To the authors knowledge, this is the first report of PEMF for improved engineered 
cartilage growth and integration, both in vitro and in vivo. This preliminary in vivo experiment was 
potentially limited by sample size, which was improved by creating multiple defects per knee. 
Based on previous canine studies in our laboratory, we determined a priori that a sample size of 
approximately 17 repairs per group would be required to achieve a power of at least 0.8. 
Nevertheless, trends and significant between-group differences were observed for many of the 
outcome measures. While some success in alleviating pain has been reported in previous clinical 
PEMF studies, our preclinical model provides a valuable platform for optimizing focal defect 
repair protocols based on individual mechanisms of action. It will be important to determine if 
benefits to growth translate to improved long-term clinical repairs. 
 
5.5 Conclusion 
The current studies, which utilized clinically relevant parameters associated with the IGEA device, 





cartilage growth and healing. And while it is possible that increased synovial hyperplasia observed 
here, in the absence of increased inflammatory cytokines, was indicative of non-catabolic changes 
to synovium structure-function, additional studies will be required to confirm this. Therefore, the 
presented data is partially supportive of the global hypothesis outlined for Part II. In order to 
capitalize on potential anti-inflammatory behavior in synovium, further evaluation of structure-
function in response to PEMF will be needed, perhaps utilizing the engineered model described in 
Chapter 2. 
Using in vitro models (Study 1 and 2, SA2b) and confirmatory in vivo models (Study 3, 
SA2c) of cartilage restoration provide guidance for optimizing PEMF strategies to maximize 
clinical cartilage graft survival and function. Engineered osteochondral grafts were pre-cultured 
for 42 days prior to implantation and initiation of PEMF stimulation (Study 3), mimicking the 
delayed PEMF protocol evaluated in Study 1. Furthermore, the PEMF coil was oriented on the 
frontal plane to maximize time spent in a “parallel” orientation during normal movement. Moving 
forward, we hypothesize that PEMF dosage can be further optimized to target improved pre-
implantation cartilage properties and decreased catabolic activities post-implantation, leading to 
better long-term clinical outcomes. Although not currently the standard of care, engineered 
cartilage repair techniques are increasingly gaining clinical acceptance. By improving strategies 
for preparation and implantation of tissue engineered cartilage, the full potential of tissue 







Chapter 6 Direct Current Electric Fields Increase Mobilization 
of Synovial Cells 
Direct Current Electric Fields Increase Mobilization 
of Synovial Cells 
 
6.1 Introduction 
In addition to being key effector cells within the synovium in both IL and DEX-treated (Chapter 
2) and PEMF-stimulated (Chapter 4) conditions, synovial cells have also been directly implicated 
in cartilage repair (Bilgen et al., 2007; Rui et al., 2010; Sampat et al., 2011a). FLS are recruited to 
the site of partial thickness defects in vivo, however the efficiency of their migration into the wound 
site is generally insufficient for effective healing (Hunziker and Rosenberg, 1996). Meanwhile, 
proliferation of resident MLS and infiltration of peripheral blood mononuclear cells (PBMCs) 
contribute to the pro-inflammatory environment and further joint degeneration (O’Brien et al., 
2017; Utomo et al., 2016). Development of a method to direct migration of one or more cell types 
of interest may facilitate the natural healing process or serve as a method for repopulating 
devitalized allogenic and xenogeneic tissues. 
DC EFs, which have been shown to induce galvanotaxis in vitro (1.3.4.2), may allow the 
selective homing of repair cells (Chao et al., 2000; Finkelstein et al., 2007; Tan et al., 2011) and 
exclusion of immune cells (Douglas et al., 2019; Orida and Feldman, 1982). Furthermore, 
migration behavior likely differs based on biological substrate or culture within three-dimensional 
matrices. Galvanotaxis of FLS and MLS (or adherent PBMCs) has not been explored in a 3D repair 





Such an in vitro model will be crucial in translating findings to a preclinical system that will 
ostensibly require implanted electrodes. 
Below, we explore strategies to enhance and direct cell migration in the joint to be used to 
amplify the intrinsic repair process of cartilage as well as to support cell-based therapies of 
cartilage repair. First, we evaluated potential galvanotactic behavior of adherent PBMCs in the 
existing 2D experimental chamber used by our laboratory (SA2d). Next, we modified this chamber 
in order to view migration of FLS within a collagen repair matrix (SA2e). Finally, we designed 
and validated a new culture chamber capable of applying DC EFs to 3D tissues in a sterile and 
biomimetic culture configuration (SA2f). Overall, we hypothesized that adherent PBMCs and FLS 
exposed to DC EFs, in 2D and 3D, respectively, would exhibit directed migration. Furthermore, 
development of new bioreactor approaches would facilitate application of DC EFs to three-
dimensional synovium and cartilage specimens in biomimetic configurations. 
 
6.2 DC EFs Increase Migration Speed of Adherent Inflammatory Cells 
6.2.1 Introduction 
Under DC EF stimulation, macrophages have been shown to migrate towards the anode (Orida 
and Feldman, 1982), whereas FLS may migrate in the opposite direction (i.e. cathode) at certain 
passage numbers (Tan et al., 2011). Although the exact mechanism of galvanotaxis is not known, 
it is thought to be dependent on cell adherence and therefore not an electrophoretic phenomena 
(Finkelstein et al., 2007). Monocytes and macrophages are major constituents of PBMCs (Ulmer 
et al., 1984) that invade the joint, and they can easily be separated and isolated via their ability to 
adhere to substrates (Bennett and Breit, 1994). This study aimed to investigate DC EF-induced 





important role of MLS in driving structural changes in synovium (2.3), the ability to direct 
migratory behavior of inflammatory cells may impact the progression of OA symptoms and 
synovial hyperplasia. 
 
6.2.2 Materials and Methods 
6.2.2.1 2D Galvanotaxis Chamber 
The galvanotaxis chamber (Figure 6.1) was based on a modified flow chamber assembly (A. R. 
Tan et al., 2015b). Briefly, silver–silver chloride electrodes were fabricated from silver wire 
soaked for one hour in a hypochlorite solution (Clorox Bleach) and interfaced with ports on each 
side of the galvanotaxis channel via a pair of 30-cm long, 2% agarose–PBS bridges. These bridges 
prevented contamination of the cells from electrolysis products generated during current 
application using a power supply (Keithley Instruments). The conductive media was DMEM 
supplemented with 5% FBS, which had adequate protein concentration for cellular adherence and 
ion concentrations for current flow. The chamber also consists of a glass window, facilitating real-
time microscopic analysis. 
 
 
Figure 6.1 Schematic of classic 2D galvanotaxis system. Cells are plated on a glass slide and 






6.2.2.2 Preparation, Culture, and DC EF Stimulation of Adherent PBMCs 
A leukopak, obtained from a healthy blood donor (n=1, Type O+), was purchased from New York 
Blood Center (New York, NY). PBMCs were isolated via density centrifugation with Ficoll-Paque 
(GE Healthcare, Cat. No. 17144002) (Ulmer et al., 1984). 
Prior to assembling the galvanotaxis chamber, PBMCs were precultured for 2 hours at 
37°C in DMEM supplemented with 5% FBS on un-coated glass slides with removable silicone 
wells (105 cells/cm2). Silicone wells were then removed and non-adherent cells were thoroughly 
rinsed from the slides before placing in the galvanotaxis chamber. Subsequently, a current of 3.33 
mA was applied, resulting in an EF = 6 V/cm, for 3 hours at room temperature. Control slides were 
cultured in parallel chambers with no EF stimulation. 
 
6.2.2.3 Image Analysis 
Photomicrographs (10x magnification with phase contrast filter on an Olympus IX-70 inverted 
microscope) were collected at 10-min intervals during the 3-hour stimulation period. Resulting 
images  were manually analyzed using custom MATLAB code in order to extract overall speed, 
incremental speed, migration direction, and directed velocity (A. R. Tan et al., 2015b). Briefly, 
coordinates of each cell’s centroid were tracked, using the initial starting position as the origin. 
Overall speed was derived from the overall net displacement (i.e. magnitude of the vector starting 
at the origin and ending at the final cell position) divided by the 3-hr experimental period. 
Incremental speed was computed at each individual 10 min interval. Migration direction was 
defined based on the position of the migration vector, whereby the cathode (-) and anode (+) were 





speed directed toward the cathode (90°). Mean angle was computed as the average of unit vectors 
for each cell. A total of 19-20 cells were evaluated for each run (n=3-4). 
 
6.2.2.4 Statistics 
Statistical comparisons were made with the Mann Whitney test (α = 0.05). Values were presented 




6.2.3.1 Adherent PBMC Migration 
Mean incremental speed computed over the three-hour stimulation period was significantly 
decreased by DC EF application (19 vs. 15 µm/h; between-group difference, -4 µm/h; p=0.0017) 
(Figure 6.2). There was no statistical difference in overall migration speed (p=0.20) or directed 
velocity (p=0.12). Mean migration angle was 272° for EF and 177° for CTL. 
 
 
Figure 6.2 Effect of DC EFs on incremental speed, overall speed, and directed velocity of 
adherent PBMCs in 2D. *p<0.01 compared to CTL (no EF); Total cells analyzed for CTL (n=59) 







Infiltration of PBMCs from the vasculature is a hallmark of OA synovium (O’Brien et al., 2017; 
Utomo et al., 2016). A majority of these infiltrating mononuclear cells have been identified as 
CD14+ monocytes and macrophages (Moradi et al., 2015; Pessler et al., 2008), which are unique 
among PBMCs in that they adhere to substrates in culture (Bennett and Breit, 1994). In the 
preceding experiments, DC EF-induced migration of the adherent subpopulation of PBMCs was 
explored (SA2d). We observed increased kinetic activity in response to a DC EF, however no 
preferential migration direction (Figure 6.2). Therefore, the presented data does not support our 
hypothesis. 
 Both incremental and overall speed were evaluated in this study. Incremental speed was 
derived from the cell displacement observed in each individual 10-min interval. Overall speed, 
however, considers only the start and end point of each cell over the 3-hr stimulation. The increase 
in incremental speed without a corresponding increase in overall speed was characteristic of 
increased random cell motility. This was also evident from the lack of difference in directed 
velocity between groups. This result was unanticipated, based on previous research showing 
preferential migration of macrophages in culture (Douglas et al., 2019; Orida and Feldman, 1982). 
However, it should be noted that the mean angle of migration in EF-stimulated samples was 272°, 
almost exactly towards the anode. While this may have been by chance, it possibly indicates an 
extremely low level of direction preference. 
Although likely not useful for excluding these cells from the joint (i.e. the original 
hypothesis), increased overall kinetic behavior may have other implications. Additional work will 
be required to assess any concurrent changes in PBMC function and viability. PBMCs are thought 





clinical benefit. Induced EFs have also been shown to affect the immunogenic response of 
macrophages to bacterial infection (Akan et al., 2010). Modulation of PBMC behavior may also 
be used to complement other modes of joint repair; PBMCs have been shown to enhance migration 
of chondrocytes both in vitro and in vivo (Hopper et al., 2015b, 2015a).  
 
6.3 DC EFs Induce Migration of FLS within a Collagen Repair Matrix 
6.3.1 Introduction 
Galvanotaxis of FLS has been demonstrated on 2D substrates, however the preferential migration 
direction was dependent on passage number (Tan et al., 2011). It is anticipated that migration 
behavior may differ on biological substrates or within three-dimensional matrices, and 
understanding this phenomenon will be critical for eventual clinical translation. Directed migration 
may also be useful in populating or re-populating scaffolds for tissue engineering applications 
(Rajabi et al., 2015). 3D collagen- or Matrigel- based migration assays have been described using 
Transwells or culture dishes (Timpson et al., 2011), however to our knowledge these systems have 
not been used to evaluate galvanotaxis of FLS. In this study, we modified the classic galvanotaxis 
chamber (Figure 6.1) in order to view migration of FLS within a collagen hydrogel (SA2e), similar 
to (Sun et al., 2004). 
 
6.3.2 Materials and Methods 
6.3.2.1 Cell Isolation and Culture 






6.3.2.2 Galvanotaxis Chamber Assembly and Application of DC EF 
The galvanotaxis chamber and parameters described in the previous section (6.2.2.1) were used. 
However, instead of culturing cells directly on glass slides, FLS (105 cells/ml) were encapsulated 
directly in a type I collagen hydrogel (2 mg/ml; ThermoFisher, Cat. No. A1064401). This resulted 
in a thin collagen gel with the exact geometry of the channel. Briefly, concentrated collagen was 
diluted, osmotically balanced with 10x PBS, and neutralized with 1 N NaOH prior to thoroughly 
mixing in cells, on ice. This FLS-seeded collagen gel (100 µl per chamber) was allowed to solidify 
directly in the chamber for 2 hours at 37°C prior to DC EF stimulation (6 V/cm) at room 
temperature for 4 hours. Control samples without applied DC EF were performed in parallel. 
 
6.3.2.3 Image Analysis 
Photomicrographs were collected and analyzed as previously described (6.2.2.3). A total of 20-24 
cells were evaluated for each run (n=1). 
 
6.3.2.4 Statistics 
Statistical analyses were performed as previously described (6.2.2.4). 
 
6.3.3 Results 
DC EF-application led to significantly increased incremental speed (6.9 vs. 1.9 µm/h; between-
group difference, 5.0 µm/h; p<0.0001), overall migration speed (2.5 vs. 1.4 µm/h; between-group 
difference, 1.0 µm/h; p<0.0001), and directed velocity towards the anode (1.9 vs. 0.5 µm/h; 









Figure 6.3 Effect of DC EFs on overall speed, incremental speed, and directed velocity of 
bovine FLS in 3D. *p<0.001 compared to CTL (no EF); Total cells analyzed for CTL (n=20) and 
EF (n=24); Median and IQR shown in plots. 
 
 
Figure 6.4 Individual migration paths for FLS in 3D collagen gel. (A) E- (n=20), (B) E+ 








Galvanotaxis of bovine FLS within a 3D collagen hydrogel was explored (SA2e) through the 
modification an established system for evaluating 2D migration (Chao et al., 2007, 2000; 
O’Connell et al., 2015; Tan et al., 2011). In the collagen substrate, FLS exhibited cathodal-directed 
migration as well as an increase in overall and incremental speed. Therefore, we accept the 
hypothesis that FLS exhibit directed migration in 3D culture conditions. 
In our hands, P2 FLS had a cathodal-directed velocity of 1.9 µm/hr when exposed to a 6 
V/cm EF (Figure 6.3). This was similar to previous work from our laboratory, which showed that 
P4 FLS demonstrated cathodal-directed velocity of up to 5 µm/hr in 2D (Tan et al., 2011). In one 
study of human fibroblasts embedded in 0.58 mg/ml collagen and exposed to 0.1 V/cm, cells 
migrated at a velocity of 13.8 µm/h, however the same cells did not migrate in 2D or in 1.08 mg/ml 
collagen (Sun et al., 2004). The clinical relevance of such a low collagen concentration is dubious, 
due to the extremely low mechanical properties. In a follow-up study by the same group, human 
fibroblasts in 2 mg/ml collagen and exposed to 10 V/cm did not migrate, but did realign 
perpendicularly to the EF (Sun et al., 2006).  
The mode of cell tracking, via the centroid, may have underestimated migration distance 
in our experiment. Mesenchymal cells typically migrate via dendritic outgrowths (Friedl and Wolf, 
2010), which may not have been observed using an inverted microscope with brightfield 
illumination. It is also likely that cells formed additional focal matrix adhesions in the collagen 
gel, which can complicate migration (Qu et al., 2019; Sun et al., 2006). This, along with the 
porosity of collagen hydrogel, may have contributed to slower directed migration observed here. 
In anticipation of this, the collagen concentration used in the current work (2 mg/ml) was chosen 





mg/ml collagen hydrogels have an average pore size of 2 µm2 (Miron-Mendoza et al., 2010). Cells 
and their nuclei can constrict to fit through pores as small as 3 µm2, but cell translocation becomes 
limited at pore sizes below 25 µm2 (Qu et al., 2019). 
 
6.4 Development of a 3D Bioreactor Capable of Modeling FLS Migration 
within a Cartilage Defect 
6.4.1 Introduction 
In this study, migration of synovial repair cells was demonstrated in situ on cartilage explants using 
a custom, versatile galvanotaxis chamber (SA2f). The chamber was designed with the goal of 
applying DC EFs to 3D specimens to simulate the migration of endogenous and/or exogenous 
repair cells into a substrate or defect. To demonstrate the capabilities of the system, EFs were 
directionally applied through a piece of synovium overlaid in apposition with cartilage explants 
(Ng et al., 2010). This tissue configuration was chosen to mimic the proximity of the synovium 
and cartilage in the diarthrodial joint and provide a route for FLS to contribute to the limited repair 
of cartilage observed after injury (Bhattaram and Chandrasekharan, 2016; Hunziker and 
Rosenberg, 1996). FLS migration into the mock defect was quantified and long-term viability of 
EF-exposed cells was confirmed. Finally, to characterize the electrokinetic conditions associated 
with the applied EF in our custom chamber, we employed finite element modeling to describe the 






6.4.2 Materials and Methods 
6.4.2.1 Chamber Design 
Using an established flow-chamber based galvanotaxis system (Figure 6.1) as a basis, a novel 3D 
galvanotaxis chamber (Figure 6.5B) was designed using CAD software (Solidworks, Waltham, 
MA). The upper and lower chamber is separated by an O-ring and held together with screws, 
thereby accommodating cylindrical specimens while preventing current leakage. As such, a sealed 
cylindrical channel with a 5-mm diameter and a 1-mm height was formed to accommodate the 
specimen. The well-defined chamber geometry permitted the electric field strength (E) and current 
density (J) to be calculated using Ohm’s Law. The resistance of the chamber was 35.8 kΩ, which 
was consistent with theoretical calculations. 
The anode (+) and cathode (-) were positioned above and below the sample chamber, 
respectively. The power supply, electrodes, and salt bridges were prepared as before (6.2.2.1). The 
total chamber volume was approximately 2.5 ml, allowing sufficient media supplementation for 
large constructs and ion concentration to conduct current. 
 
  
Figure 6.5 Schematic of novel 3D galvanotaxis system. The chamber allows application of 
EF gradients (electrode positions denoted (+ and -) to 3D tissues and constructs (blue arrow 





6.4.2.2 3D Printing of Chamber 
The chamber was 3D printed using an Ultimaker S5 (Cura v4.2.1; Utrecht, Netherlands) with 
Taulman Nylon 680 filament. Nylon filament was selected due to FDA approval and compatibility 
with autoclaving and ethanol sterilization (“Nylon 680 Spec,” 2016). The main parameters 
necessary for good results are 100% infill with modified: printing speed, temperature, ironing 
setting, layer height, build plate temperature, retraction speed/distance, fan speed, build plate 
adhesion, and support material (Table A.2.1). 
After printing, the support material was removed by soaking in warm water. Then the 
chamber assembly was tapped and drilled. Once all of the holes are threaded and drilled, the final 
the clear acrylic cap for the bottom chamber of the bioreactor was prepared. The acrylic cap was 
laser cut from an acrylic sheet between 1.2 mm to 1.6 mm in thickness and adhered to the assembly 
with Loctite® 4902 cyanoacrylate adhesive. 
 
6.4.2.3 Finite Element Analysis of Chamber 
FEBio (v. 2.6.0) was used to model the current flow within a the cartilage explant system (Maas 
et al., 2012).  The cartilage and bath were modeled as multiphasic materials with neo-Hookean 
solids. Na+ and Cl- solutes were permitted to transport throughout the system  as this framework 
maintains electroneutrality throughout all of the material phases (Ateshian et al., 2013). The 
material properties and solute transport properties is supplied in the supplemental materials (Table 
A.2.2). 
Geometries were based on: a PBS bath with a 5 mm  2 mm cartilage ring with a central 
(a) 1 mm  2 mm defect, (b) 1.5 mm  2 mm defect, (c) 2.0mm  2 mm defect, or (d) 





current density was imposed (in a manner similar to the experimental procedure) using an effective 
prescribed solute flux to represent the flow of Cl- based on the Ag-AgCl kinetics. Models were 




within the middle 
of the collagen gel, in the middle of the analysis. Axisymmetric boundaries were imposed to reduce 
model size while maintaining the experimental cylindrical geometry. 
 





= 150 𝑚𝑀; 𝑝 = 0 𝑀𝑃𝑎;  𝑐𝑎𝑟𝑡𝑖𝑙𝑎𝑔𝑒 𝑓𝑖𝑥𝑒𝑑 − 𝑐ℎ𝑎𝑟𝑔𝑒 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 =  −200 𝑚𝑀 
 
6.4.2.4 Tissue Harvest and Culture 
Fresh bovine cartilage and synovial tissue was harvested and maintained as before (2.2.2.1). ∅5mm 
full thickness osteochondral cores were harvested from the femoral condyles and trimmed to 
remove subchondral bone. 
 
6.4.2.5 FLS Migration into a Cartilage Defect 
To create a cartilage defect, Ø1mm cores were removed from each cartilage explant with a biopsy 
punch. An intact section of juvenile bovine synovium (~5 mm × 5 mm × 1 mm thickness) was 
then labeled with a lipophilic membrane dye (Vybrant DiI, Life Technologies) and placed in direct 
apposition to the cartilage explant prior to EF stimulation (Figure 6.6). Explants were pre-cultured 
overnight in DMEM supplemented with 5% FBS. Explants were placed in the chamber and current 
was applied for three hours, generating an applied field strength E= 6 V/cm (E+). Control samples 







Figure 6.6 Schematic of cartilage-synovium defect-repair model. The chamber’s anode (+) 
and cathode (-) were positioned above and below the specimen, respectively. DiI-labeled 
synovium (1, yellow) was placed in direct contact (2) with DAPI-labeled cartilage (3, blue). 
Synovium removed for confocal z-stack imaging (4), leaving migrated cells on cartilage specimen. 
Scale bar = 100 µm 
 
6.4.2.6 Confocal Imaging 
A subset of samples was set aside and immediately analyzed for viability in each condition 
(Live/Dead kit, Thermofisher).  The remainder of samples were fixed in 4% paraformaldehyde 
overnight. The synovium was then removed from the explant, leaving migrated cells behind.  
Specimens were subsequently stained with DAPI (Sigma Aldrich) for co-localization of 
endogenous cartilage cells with the migrated synovial cells (stained with DiI) on the cartilage 
explant. A confocal microscope (Zeiss) was used to visualize cell accumulation at the cartilage 
surface and cartilage defect site. Additionally, z-stacks with a 40 µm step-size were used to 
characterize the migration distances within the constructs (Figure 6.6). This step size was chosen 
to ensure that no FLS were missed or double counted in the subsequent image analysis. Only FLS 
that had adhered to the cartilage explant were evaluated. These were identified by co-localization 
of DAPI and DiI stains on the cartilage surface. Cells were classified as either “transferred” or 





first z-stack image) or visible at ≥40 µm depth, respectively. The number of migrated cells was 
normalized to the total number of transferred plus migrated cells. Directed velocity was computed 
assuming constant cell migration over the 3-hour experiment, and non-migrating cells (i.e. 
transferred to cartilage surface only) were considered to have a velocity of 0. 
 
6.4.2.7 Statistics 
The proportion of migrated vs. transferred cells was analyzed via Fisher’s Exact Test (p<0.05). 
Transferred and migrated cells were counted and pooled from N=3 constructs in each EF condition, 
yielding 237 total FLS in the E+ condition and 132 total FLS in the E- condition. Directed velocity 
of transferred cells was analyzed using the Mann Whitney Test (p<0.05) and values were expressed 
as mean ± standard deviation. 
 
6.4.3 Results 
6.4.3.1 Chamber Validation and FEBio Modeling 
Finite Element Analysis Showed Distinct Current Gradients Dependent on Specimen Geometry 
and Material. At equilibrium, current density (Figure 6.7) was concentrated at the defect site, as 
expected from electrical computations. The highest concentration of current was seen at the inner 
cut surface of cartilage defect, throughout its entire depth.  The empty chamber had a homogeneous 
current density profile. Electrical computations and FEBio outputs were validated by taking 
measurements of the chamber with varying sized cartilage (conductive) and rubber (insulative) 







Figure 6.7 Estimated current density as estimated with FEBio. (A) The system was modeled 
in FEBio as two bathing solutions (green) above and below the cartilage explant (purple), with a 
biopsy punch defect in the center (blue). To simplify computations, the symmetric sample and 
chamber was modeled as a wedge. (B) Current density at equilibrium was concentrated in the 
defect. Gradients were sensitive to small changes in defect size (3.33 mA applied). 
 
Table 6.1 Theoretical and actual specimen voltage drop in galvanotaxis chamber. 
Defect Diameter 
(mm) 




1.0 4.8 6 ~34-40 
1.5 4.1 4 ~31-34 
2.0 3.4 3 ~28-31 
5.0 (Empty) 1.1 - ~16-19 
Voltage drop (E, V/cm); Current density (J, mA/cm2); Theoretical Ohm’s Law values were predicted 
using Ohm’s Law and an applied current of 3.33 mA, media resistivity of 0.6579 Ωm, cartilage resistivity 
of 3.268 Ωm (Binette et al., 2004), and 2.2 mm sample thickness. FEBio-predicted values were 






6.4.3.2 FLS Migration in Wound Repair Model 
EF-Stimulation Increased Both Cell Recruitment and Average Migration Velocity in an Explant 
Model. EF specimens (E+) showed enhanced migration into the defect site and a larger number of 
adherent FLS overall (Figure 6.8).  Approximately 89% of adherent cells had migrated at least 40 
µm into the defect in the EF group, compared to 45% in controls (E-). Additionally, EF increased 
directed velocity of FLS into the defect relative to control (Figure 6.9). 
 
 
Figure 6.8 Representative confocal reconstructions of FLS migrating into cartilage defect. (A) 
top and (B) side view of control (E-) showing minimal FLS migration. (C) Top and (D) side view 
of explant exposed to DC EF for 3 hours (E+) showing migration to a depth of up to 200 μm. 







Figure 6.9 Cell migration affinity and directed velocity. (A) Effect of EF on FLS migration 
into the cartilage defect. Significantly more FLS migrated in the E+ (6 V/cm) group, compared to 
E- (p<0.05). (B) Effect of EF on FLS directed velocity into a cartilage defect. FLS had significantly 
greater velocity towards the cathode in E+ groups compared to E- (p<0.05). N reported on each 
bar, pooled across triplicate samples. 
 
6.4.4 Discussion 
A custom galvanotaxis chamber was designed, tested, and characterized to evaluate cell migration 
on a biological substrate due to applied EF strengths of magnitude similar to those reported to 
promote galvanotaxis in 2D (SA2f). The system was modeled and validated using finite element 
analysis, basic circuit computations, and multimeter measurements. In a pilot study using the 
system, cathodal migration of synovial repair cells was observed in a cartilage explant defect repair 
model. Passaged SDSCs have been shown to migrate preferentially towards the anode (+) or 
cathode (-) at early or late passages, respectively (A. R. Tan et al., 2015b; Tan et al., 2011). While 
our current experiments did not allow for examination of bi-directional migration, the system can 
be easily modified to do so by culturing labeled cells on multiple surfaces of the construct. Overall, 
we accept the hypothesis that development of novel bioreactors can facilitate application of DC 
EFs to tissue specimens and subsequent cellular analysis. 
FLS have been shown to have a speed of up to 10 µm/hr (E=6 V/cm) and 25 µm/hr (E=10 





an average directed velocity of 26.7 ± 15 µm/hr with an estimated E=6 V/cm and J=73 mA/cm2 
(Figure 6.9). These high field strengths are on par for what chondrocytes may see in vivo, with 
magnitudes of up to 15 V/cm and current densities of up to 100 mA/cm2 (Mow and Huiskes, 2005). 
Higher EFs and current densities than those seen in vivo may be necessary to stimulate more 
significant and robust migration, but must be balanced with any detrimental effects on cell health, 
such as Joule heating. Our pilot studies confirmed that cells remained viable under the conditions 
tested. In future studies, it will be important to parse out mechanisms that mediate differences in 
cell attachment and interaction between the substrates examined (i.e. 2D glass slide vs. 2D 
cartilage vs. 3D). The effect of EFs can also be studied where a collagen gel (or other cell carrier) 
is superimposed with the cylindrical cartilage explant to study integrative properties of cartilage 
repair (Hunter and Levenston, 2004; Obradovic et al., 2001a). Results of Section 6.3 provide a 
foundation for these experiments. Some studies have reported perpendicular migration of MSCs 
and fibroblasts in 3D matrices, however these reports utilized either very small continuous DC EFs 
(Sun et al., 2004) or low duty cycle pulsed EFs (Yuan et al., 2014).  
While the present system is unable to perform real-time cell tracking, it does permit for 
maintenance of aseptic conditions, multiple treatments over time, and subsequent cell, tissue and 
media analyses. The applied current necessary to achieve a desired electric field strength can be 
calculated from Ohm’s Law and knowledge of the impedance of the current path.  Our FE model 
is able to faithfully determine the average current density as calculated from measurements of 
chamber impedance and electrokinetic properties of the electrolyte. Moreover, it is able to describe 
the spatially-varying current density distribution in the experiments not able to be determined 
experimentally. The latter may support efforts to better understand the mechanisms that mediate 





This model can serve as the basis of future efforts to describe electrokinetic conditions where more 
complex geometries and tissue properties (such as may be found with OA tissue) are considered. 
As a singular example, we envision modeling cellular migration into varying degrees of damaged 
and porous arthritic tissue. In this study, the chamber was used successfully to direct FLS migration 
out of 3D synovium tissue onto cut 2D cartilage surfaces.  
 
6.5 Conclusion 
Together with successful applications of applied DC EFs for bone fractures and spinal fusion 
(Veronesi et al., 2015), our findings (SA2e-f) suggest that galvanotaxis may be a promising tool 
for encouraging and promoting the migration of both endogenous and exogenously-delivered FLS 
repair cells to sites of articular cartilage injury (Ng et al., 2010). However, directed migration of 
adherent PBMCs was not observed (SA2d), and additional studies will be required to elucidate 
any potential benefits of the observed kinetic response. Therefore, the results are supportive of the 
Part II global hypothesis with regard to FLS but not necessarily other cell types present in the 
synovium. It is envisioned that future iterations of applied EFs could include modifying the time 
course of stimulation. After directing migration of cells via galvanotaxis imposed by DC EFs, 
time-varying EFs, such as PEMFs (Chapter 4 and Chapter 5), may be applied using field 
parameters reported to stimulate biosynthesis of chondrocytes and repair cells (Ongaro et al., 2011; 
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Chapter 7 Conclusions and Future Directions 
Conclusions and Future Directions 
 
The overall aim of this dissertation is two-fold: 1) characterize synovium structure-function in 
response to pro-inflammatory cytokine insult and glucocorticoid treatment (Part I); 2) investigate 
electrotherapeutic strategies for modulating synovium behavior and cartilage repair (Part II). 
Towards this goal, this dissertation uncovered new findings related to synovium structure-function 
and shed light on potential glucocorticoid and electrotherapeutic strategies that may support 
cartilage repair via modulation of the synovium. The studies described here utilized both tissue 
engineering and explant culture techniques to elucidate specific mechanisms of altered synovial 
structure-function as well as preclinical animal models and new bioreactor culture systems to 
explore translation of findings and new strategies targeting synovial-mediated repair. Together, 
these models allowed us to capture the complexity of synovium behavior in health and disease and 
the potential for synovial-based therapies in joint repair. In conclusion, we first present a summary 
of experimental findings in the context of the global hypotheses. Finally, future studies motivated 
by this work are suggested. 
 
7.1 Conclusions 
7.1.1 Dexamethasone is a Metabolic Mediator in Synovium and Cartilage 
In Part I, we began by describing a functional tissue engineered synovium model that was 





structural and functional characteristics of synovium, including protein expression, intimal lining 
formation, solute transport, and friction coefficient. Additionally, engineered synovium behavior 
mirrored that of explants when treated with IL-1 or DEX. Notably, IL-1 and DEX treatment both 
induced a hyperplastic response that was correlated with reduced solute permeability, despite both 
treatments otherwise eliciting the expected secretory response. The engineered synovium model 
was then expanded to include resident MLS, demonstrating the key role that these cells play in 
structural reorganization of synovium. An exaggerated IL-1-induced hyperplastic response and co-
localization of FLS and MLS was observed, highlighting the importance of MLS in synovium 
structure-function. Finally, the model was translated to a human system with co-cultured T 
lymphocytes. We observed reduced intimal hyperplasia in engineered synovium co-cultured with 
T lymphocytes that correlated with increased specimen dry weight, suggesting an alternative T 
cell-mediated mechanism of hyperplasia and/or pannus formation. Overall, these studies highlight 
the complexity of the response to IL-1 and DEX as well as the interaction of cell types present at 
different stages and presentations of OA, with specific impact on synovium structure-function. 
Finally, in part motivated by insights into solute transport in the synovium as well as its 
strong anti-inflammatory response to DEX, we developed a sustained low-dose DEX delivery 
platform for mitigating synovial inflammation while simultaneously stimulating cartilage growth 
(Chapter 3). We observed in vitro chondroprotection in the presence of IL-1-induced degradation 
and improved in vivo functional outcomes following a preclinical model of OAT repair. These 
improved outcomes were correlated with superior histological cartilage scores and minimal-to-no 
comorbidity, but not necessarily a dampened inflammatory response. However, synovitis was low 
across groups, and synovium-associated MMPs were upregulated in response to DLMS, 





anabolic and chondroprotective effects of DEX on cartilage, however a dampened inflammatory 
response was not observed in synovial measures. Therefore, the global hypothesis for Part I was 
accepted, in part. Together, these results support a strong role for IL-1 and DEX in altered 
synovium structure-function in vitro, however in vivo preclinical data did not strongly support a 
connection between the improved outcomes and altered synovial function. 
 
7.1.2 Electric Fields as Metabolic & Migratory Mediators in Synovium & Cartilage 
In Part II, we evaluated synovium behavior and cartilage repair in response to two different modes 
of electrical stimulation. For the first time, we characterized the biological response of both healthy 
bovine and OA human synovium explants to PEMFs, showing distinct anti-inflammatory behavior 
in bovine tissues, in agreement with literature reports of isolated bovine FLS (Chapter 4). 
However, the response of human OA tissues was far more variable and a robust anti-catabolic 
effect of PEMF was not observed. This was likely due to the advanced disease state of these tissues 
and the variable cell content, with a significantly lower proportion of FLS cells compared to 
healthy tissue. A correlation was observed between age and PGE2 secretion in response to PEMF, 
suggesting a potential avenue of future research with immediate clinical implications. A key 
limitation of this study was that we could not quantify exactly which cells in the tissue were 
responding to PEMF. It is likely that increased MLS and T lymphocytes within human OA 
specimens interact with PEMF in very different ways from FLS, likely also compounded by 
cellular communication/gap junctions. 
Motivated by the potent anti-inflammatory effect seen in normal tissue and previous work 
demonstrating a pro-anabolic and anti-catabolic effect on cartilage, the PEMF system was then 





Using clinically relevant stimulation parameters, we demonstrated that PEMFs can enhance 
engineered cartilage repair through modulation of cartilage growth and healing. 
Counterintuitively, increased synovial hyperplasia was also observed, however this was in the 
absence of increased inflammatory cytokines. Additional studies, perhaps utilizing the engineered 
synovium described in Chapter 2, will be required to elucidate the mechanism of this seemingly 
contradictory synovial behavior. Finally, we investigated the potential for direct synovial cell-
mediated cartilage repair via induced migration with DC EFs (Chapter 6). Results suggested that 
galvanotaxis may be a promising tool for promoting the migration and transfer of FLS repair cells 
within ECM or to sites of articular cartilage injury. The novel tissue-scale bioreactor was capable 
of applying well-defined DC EFs in sterile culture conditions to three-dimensional constructs, 
providing a crucial tool in translating culture findings to a preclinical system. Overall, the global 
hypothesis for Part II was accepted, in part. Together, these results support the role of 
electrotherapeutic strategies in promoting metabolic and migratory behavior of FLS in vitro, and 
metabolic behavior of engineered cartilage both in vitro and in vivo. However, despite positive 
overall outcomes, a complex role of synovium-mediated in vivo repair was evident. 
 
7.2 Future Directions 
7.2.1 Computational Modeling of Synovium Transport 
To complement structure-function data from solute transport studies (2.2.3.3), we are working to 
develop constitutive models of the Transwell system (Figure 7.1) and synovium (Figure 7.2). The 
computational analyses, based on the mixture theory constitutive framework (Ateshian et al., 2013, 





In the current solute transport analysis (2.2.2.4), extraction of solute permeability 
coefficient relies on assumptions that the top reservoir remains at a constant concentration and the 
bottom reservoir concentration is negligible. However, these assumptions do not hold true for our 
Transwell-based system, as the three compartments (top reservoir, tissue, and bottom reservoir) 
all have comparable volumes. Therefore, we plan to use finite element analyses (FEBio, febio.org) 
to determine the time-evolution of solute concentration in the bottom well, and fit the model to 
experimental data (Figure 2.9). A representative finite element mesh for an axisymmetric analysis 
of the tissue inside a Transwell of known dimensions is shown in (Figure 7.1a). At the initial time 
t=0, the solute concentration is uniform in the top well; as the solute diffuses through the specimen 
to the bottom well, the concentrations in the top and bottom well evolve, demonstrating that the 
assumption of constant concentrations in the top and bottom reservoirs is erroneous (Figure 7.1b). 
We plan to generate parametric curves for the bottom well concentrations at specific time 
points, taking into account that the bottom well is refreshed at each sampling time point (i.e. the 
bottom concentration will be reset to zero at those intervals). These curves will be generated for a 
range of permeability values and sample thicknesses, and used to fit the experimental data to find 
the optimal permeability coefficient for each tissue sample. Additionally, fluorescence recovery 
after photobleaching (FRAP) may be used to assess spatial variations (Albro et al., 2008) that may 
occur between the highly cellular intimal lining and more acellular subintimal lining. 
Compartmental modeling of the synovial joint has been used by others to describe how the 
synovium modulates synovial fluid composition in disease and therapeutic conditions (Blewis et 
al., 2010a; Hui et al., 2012). Our findings can provide information that may help to further refine 
the model, such as by defining parameters that are influenced by tissue loading and deformation. 





transport is affected by both tissue geometry (i.e. thickness) and cellular compaction, which both 
increase the effective diffusion distance for solutes (Figure 7.2). 
 
 
Figure 7.1 FEBio modeling of solute transport assay in Transwell. (a) Finite element mesh for 
axisymmetric model of tissue sample (∅4.26 mm × 1.75 mm) in Transwell. Subsequent panels 
show the time evolution of dextran concentration as it diffuses across the tissue sample down to 
the bottom reservoir; (b) The temporal evolution of dextran concentration in the bottom reservoir 
may be fitted to experimental data to extract the dextran permeability. 
 
 
Figure 7.2 FEBio modeling of solute transport within the synovium. (a) Finite element mesh 
of synovium intima and subintima, including cells; (b) Solute concentration (color contours) and 
solute molar flux (arrows) showing transport from the synovial cavity into the sub-intima; (right) 
Drawing of potential route (L) of solute transport across synovium in normal versus OA tissue 





7.2.2 Advanced Cell Tracking and Isolation 
In Chapter 2, lipophilic membrane dyes were used to track the individual contributions and 
phenotype of individual cell populations. Lipophilic membrane dyes are convenient and do not 
alter cell behavior, but have the potential for dye transfer and do not persist after 1-2 population 
doublings (Lassailly et al., 2010). Another option for robust, long-term cell tracking is through 
constitutive labeling with lentiviral trackers. In preliminary work, human OA FLS were 
successfully transfected with ILV-EF-1α-tdTomato (Vectalys, Toulouse, France) to constitutively 
express tdTomato fluorescent protein (Figure 7.3). After one additional passage (P3-P4), 
transfection efficiency was assessed to be nearly 100% at a multiplicity of infection (MOI) of 20 
and 100% at MOI of 40. This lentivirus was reported by the manufacturer to label primary 
fibroblasts at 100% efficiency and MSCs at least 90% efficiency. These results demonstrate our 
ability to culture and robustly track isolated human OA FLS from multiple donors. These cells 
remained viable in 2D. Additional work needs to be completed to assess functional aspects of these 
cells and to optimize labeling for other synovial cell types. 
Further, in our studies, Dynabead sorting was utilized to isolate and count cell populations 
of interest. A more efficient and accurate method is through multicolor flow cytometry sorting. 
This will allow precise donor matching of immune cell populations, through isolation directly from 
synovial explant tissues. This will be especially useful for further translating the engineered 
synovium model to the human system, where normal tissues may consist of tiny fragments with 
few cells. Initial optimization has begun to take place in our laboratory through collaborations with 
Columbia Stem Cell Initiative flow cytometry core facility. Alternatively, matching donor tissues 
and cell types may be obtained from tissue procurement facilities such as the National Disease 






Figure 7.3 Confocal images, transmitted light with overlaid fluorescence signal. Human OA 
FLS were isolated by CD14 Dynabead negative isolation and subsequently transfected to 
constitutively express tdTomato. (A) MOI 20; (B) MOI 40; (C) Control cells. Transfection was 
stable over at least one passage and multiple weeks of culture. Scale bar = 10 µm  
 
7.2.3 Cartilage-Synovium Cross-Talk  
As the ultimate goal of studying the synovium is to more accurately predict and influence whole-
joint outcomes, our engineered synovium model will ostensibly require addition of additional 
tissue types. This was apparent in Chapter 3 and Chapter 5, where it was difficult to decouple 
the effects of DEX and PEMF on the synovium vs. cartilage or bone. Others have conducted 
simplistic co-culture studies with synovium and cartilage (1.3.2), however functional analyses 
were limited. In a more complex system, the Tuan lab group proposed a lab-on-a-chip inspired 
model composed of bone, cartilage, synovium, and fat cells (Li et al., 2019). However, this system 
also lacks analyses of synovium structure-function, relying instead on modeling secretory behavior 
of isolated FLS only. Our laboratory has begun to perform cartilage-synovium co-culture studies 







Figure 7.4 Transwell-based synovium-cartilage co-culture system. 
 
7.2.4 Modeling Synovium-related Pain 
The normal synovial sub-lining is highly vascularized and innervated (Smith, 2011), and nerve 
and vascular density have been observed to increase with OA (Ghilardi et al., 2012). Inflammation 
caused by cartilage and synovium injury influence dorsal root ganglion (DRG) neurons and 
sensitize pain perception (i.e. nociception) (Felson, 2005). Alterations in the functional properties 
of sensory neurons are a key determinant of the severity of OA pain (Li et al., 2011). Interestingly, 
the density of calcitonin gene-related peptide (CGRP)-positive sensory nerve fibers was higher in 
OA than in RA, and density of substance P-positive nerve fibers tended to be higher in RA 
(Dirmeier et al., 2008). While both are considered to be pro-inflammatory (Wang et al., 2015), this 
data suggests alternate mechanisms of pain transmission.  
Substance P is produced by FLS from patients with RA and OA (Inoue et al., 2001). In 
initial work, we have observed substance P in human OA synovium and engineered synovium, 
respectively (Figure 7.5). These findings suggest that IL-1 and TNF-α regulate nerve growth 
factor (NGF) expression and production in MLS and FLS in OA joints (Stoppiello et al., 2014; 
Takano et al., 2017). Importantly, the influence of FLS on DRG neurons is dependent on their state 





contribute to the pain response through expression of neuropeptide markers in response to FGF-2 
(Liu et al., 2011). In preliminary work, we have shown that FGF-2-treated FLS express 
neurofilament-M+H (Figure 7.6A-B). Additionally, IL-treated FLS in three-dimensional culture 
have the capacity to express β3-tubulin (Figure 7.6C-D), which is considered a robust marker of 
neuronal cells (Takeshita et al., 2012). 
 
 
Figure 7.5 Immunohistochemistry of pain marker in synovium. Substance P staining of human 
OA synovium (a: no-antibody control, b: positive DAB staining). 
 
 
Figure 7.6 Neurofilament-M+H and β3-tubulin immunohistochemistry of FLS. P3 juvenile 
bovine FLS were cultured on a collagen-coated dish at a density of 3000 cells/cm2 in (A) CTL or 
(B) FGF-2-treated (25 ng/ml) conditions for 10 days. Robust positive expression of neurofilament-
M+H (FITC, green) was observed in FGF-2-treated FLS. Separately, P3 juvenile bovine FLS were 





or (D) IL-treated (10 ng/ml) conditions for 10 days. Positive expression of β3-tubulin (FITC, 
green) was observed in a subset of IL-treated FLS (arrows). 
 
Anti-NGF treatments have shown some promise in animal models (Lascelles et al., 2015), 
however clinical investigations have revealed significant downsides such as increased OA 
progression, higher incidence of joint replacement, and neurological side effects (Seidel et al., 
2013). A sophisticated in vitro model (Chapter 2) may be useful in supplementing clinical pain 
studies, where outcomes are difficult to interpret and compare as they often lack standard protocols 
(Chu et al., 2019) and can be confounded by placebo effect (Saltzman et al., 2017). We propose a 
modification to the engineered synovium model whereby DRG neurons are encapsulated within a 
Matrigel matrix and layered above or below the synovial intima (Figure 7.7). A preliminary 
version of the co-culture system demonstrated axon formation by DRG cells that were placed in 
apposition with engineered synovium. 
 
 
Figure 7.7 Schematic of layered co-culture of DRG neurons and synovium in Transwell. 
Immunohistochemistry of β3-tubulin (green) and DAPI counterstain showing axon formation by 







7.2.5 Developing Drug Delivery Strategies Targeting Synovium 
In Chapter 3, we described intra-articular delivery of DEX via an acellular osteochondral implant 
in OAT repairs. While promising, this delivery method is incompatible with repairs that do not 
leave behind an empty graft donor site, such as OCA, ACI, or microfracture procedures. Further, 
depending on the drug and mode of action, osteochondral delivery may not be ideal. For example, 
SB-431542 (SB), a selective small molecule inhibitor of TGF-β/activin type I receptor kinase 
activity developed by GlaxoSmithKline, has been shown to reduce rotator cuff fibrosis after injury 
in a mouse model (Davies et al., 2016). Osteochondral delivery of a TGF-β inhibitor would likely 
impede cartilage healing.  
Elevated levels of TGF-β1 during various stages of the wound response leads to 
differentiation of resident synovial fibroblasts to activated myofibroblasts (Bauer et al., 2006). 
Studies suggest that myofibroblastic differentiation represents a potential mechanism by which 
TGF-β1 enhances the arthrofibrotic process (Unterhauser et al., 2004). Our preliminary data shows 
that SB can inhibit synovium contraction and myofibroblast differentiation of synovial fibroblasts 
(Cai et al., 2018; Lee et al., 2020).  
By instead incorporating drug-loaded microspheres into a biocompatible vitrified collagen 
(Takezawa et al., 2004) patch, which can be sutured directly to the synovial intima (Figure 7.8), 
precisely targeted intra-articular drug delivery can be accomplished. However, robust in vitro 
models will still be necessary to assess potential unforeseen changes in synovium structure-







Figure 7.8 Schematic of proposed synovial patch for targeted drug delivery. (A) Model of 
idealized knee joint showing possible location of synovial patch. (B) Microspheres embedded 
within the patch release drug into the joint space. (C) A synovial patch composed of high-density 
collagen vitrigel is capable of being sutured. Fluorescently labeled microspheres can be seen on 
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This appendix provides additional results to supplement studies described in this dissertation. A 
related second-author publication is also provided to show tangential work being performed in our 
laboratory using synovium-based models. 
Appendix A Supplementary Results 
A.1 Supplementary Human Donor Data 
 
Table A.1.1 Initial biochemical content for human and bovine synovium explants. 
Donor Info  Initial Biochemical Content* 
Donor Gender OA Grade Age  DNA/DW (%) GAG/DW (%) GAG/DNA (µg/µg) COL/DW (%) COL/DNA (µg/µg) 
A M 4 78  0.17 ± 0.18 0.71 ± 0.38 6.38 ± 3.8 43.73 ± 12.6 458.6 ± 262.6 
B M 2 65  0.30 ± 0.11 1.02 ± 0.18 3.72 ± 1.0 54.11 ± 7.88 210.1 ± 94.3 
C F 4 68  0.14 ± 0.06 0.82 ± 0.36 5.68 ± 1.0 38.69 ± 14.9 282.1 ± 39.4 
D F 4 63  0.27 ± 0.13 0.93 ± 0.30 3.75 ± 1.1 64.24 ± 9.57 317.7 ± 133.9 
E F 3 60  0.47 ± 0.26 1.10 ± 0.61 2.35 ± 0.7 35.25 ± 15.5 89.8 ± 44.1 
F M 4 80  0.43 ± 0.20 1.19 ± 0.56 2.69 ± 0.6 51.32 ± 13.7 135.9 ± 46.7 
G F 4 69  0.13 ± 0.06 0.60 ± 0.23 5.11 ± 2.6 42.35 ± 14.6 366.6 ± 179.8 
H F 4 71  0.20 ± 0.13 0.19 ± 0.17  0.86 ± 0.5 28.15  ± 16.4 354.1 ± 677.9 
I F 4 72  0.45 ± 0.50 0.46 ± 0.55  1.03 ± 0.5 42.23 ± 46.7 109.4 ± 59.8 
J F 4 66  0.26 ± 0.07 0.58 ± 0.22  2.52 ± 1.7 74.42 ± 23.0 333.7 ± 218.2 
K F 4 72  0.26 ± 0.25 0.34 ± 0.22  1.56 ± 1.1 33.90 ± 19.1 208.2 ± 91.8 
Human Average 
(11 donors) 
3.7 ± 0.6 69 ± 6  0.28 ± 0.1 0.72 ± 0.3 4.24 ± 1.5 48.02 ± 13.1 260.6 ± 119 
Bovine Average (4 
donors) 
0 Juvenile  0.53 ± 0.1 1.27 ± 0.2 2.52 ± 0.7 51.71 ± 11.1 105.5 ± 46.4 










Inflamed synovium Endothelial Leukocytes Macrophages HSC 
Donor CD73 CD90 CD105 CD106 CD31 CD11B CD45 CD14 CD34 
A 90.3 52.6 10.7 50.7 16.6 1.01 1.1 1.39 2.25 
B 99.5 89.7 48.2 51.6 17.5 0.653 0.653 0.917 1.58 
C 82.2 56.6 12.2 82.2 15.2 1.02 1.02 2.12 2.03 
D 65 35.8 34.2 59.5 9.77 0.22 0 1.01 3.01 
E 94.2 75 52.2 57 8.95 1 0.32 1.2 3.27 
F 96 62.5 61 77 17.1 0.5 0 2 5.14 






















A.2 Galvanotaxis Chamber Parameters 
 
Table A.2.1 Optimal 3D printing settings. 
Setting Optimal Value* 
Precision 20 µm 
Extrusion Speed Slow, ~35 mm/sec 
Extrusion Temperature 255°C +/- 5°C 
Fan Speed 40% 
Optional Cura Settings Ironing 
Layer Height 0.2 mm 
Nozzle Size 0.4 mm 
Build Plate Temperature 45°C 
Retraction Distance 3.5 mm 
Retraction Speed 25 mm/sec 
Build Plate Adhesion Method Brim (support material extruder) 
*Ultimaker S5 model printer, Cura version 4.2.1  
 
Table A.2.2 Material properties of the finite element analysis. 
Property Cartilage Collagen Bath 
Neo-Hookean 𝐸 (𝑀𝑃𝑎) 0.4 0.01 0.1 
𝜐 (−) 0 0 0 
𝜑𝑠 (−) 0.002 0.21 10-6 
𝐹𝐶𝐷 (𝑚𝑀) 0 -200 0 
𝑘 (𝑚𝑚4 × 𝑁 × 𝑠−1) 0.28 0.0035 1 
Na+ 𝐷𝑤 (𝑚𝑚2𝑠−1) 1.15  10-3 1.15  10-3 1.15  10-3 
𝐷𝑠𝑤 (𝑚𝑚2𝑠−1) 4.6  10-4 7.5  10-4 1.15  10-3 
𝜅 (−) 1 1 1 
Cl- 𝐷𝑤 (𝑚𝑚2𝑠−1) 1.18  10-3 1.18  10-3 1.18  10-3 
𝐷𝑠𝑤 (𝑚𝑚2𝑠−1) 7.2  10-4 9  10-4 1.18  10-3 
𝜅(−) 1 1 1 
Temperature (K) 310 310 310 
E = Young’s modulus, 𝜐 = Poisson’s ratio, 𝜑𝑠 = solid volume fraction, FCD=fixed-charge 
density, k = permeability, 𝐷𝑤 = solute diffusion through PBS solution, 𝐷𝑠𝑤 = solute diffusion 
through mixture matrix, 𝜅 = partition coefficient 
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1063-4584/© 2017 Osteoarthritis Research SocietyObjective: Arthroscopy with lavage and synovectomy can remove tissue debris from the joint space an
the synovial lining to provide pain relief to patients with osteoarthritis (OA). Here, we developed a
in vitro model to study the interaction of cartilage wear particles with fibroblast-like synoviocytes (FLS
to better understand the interplay of cartilage particulates with cytokines on cells of the synovium.
Method: In this study sub-10 mm cartilage particles or 1 mm latex particles were co-cultured with FL
±10 ng/mL interleukin-1a (IL-1a) or tumor necrosis factor-a (TNF-a). Samples were analyzed for DNA
glycosaminoglycan (GAG), and collagen, and media samples were analyzed for media GAG, nitric oxid
(NO) and prostaglandin-E2 (PGE2). The nature of the physical interaction between the particles and FL
was determined by microscopy.
Results: Both latex and cartilage particles could be phagocytosed by FLS. Cartilage particles were inter
nalized and attached to the surface of both dense monolayers and individual cells. Co-culture of FLS wit
cartilage particulates resulted in a significant increase in cell sheet DNA and collagen content as well a
NO and PGE2 synthesis compared to control and latex treated groups.
Conclusion: The proliferative response of FLS to cartilage wear particles resulted in an overall increase i
extracellular matrix (ECM) content, analogous to the thickening of the synovial lining observed in O
patients. Understanding how cartilage particles interface with the synovium may provide insight int
how this interaction contributes to OA progression and may guide the role of lavage and synovectomy fo
degenerative disease.












Tissue wear occurs as the result of articulation between loa
bearing surfaces1. Increased cartilage wear, leading to formation o
loose particles in the joint space, has been linked to aging, overus
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International. Published by Elseviehave investigated the use of synovial fluid aspirates to diagnose O
by characterizing cartilage wear particles in the synovial joint3e
Clinically, it has been observed that cartilage and bone debris ar
bound to the surface or embedded deep within the synovia
membrane of patients suffering from capsular synovial hyperplasi
and metaplasia6. It has been hypothesized that the fibrotic short
ening of the synovial capsule and synovitis result in OA-associate
pain and contribute to further degradation of cartilage6,7. To pro
vide pain relief to patients with OA, surgeons often use arthroscop
with lavage and synovectomy to remove tissue debris from the join
space and the synovium, however its success as a preventativ
measure has beenwidely debated8,9. Characterizing the interactio
between cartilage particulates and the synovium is important fo
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212it may also explain how increased concentrations of cartilage debri
may contribute to the progression of osteoarthritic changes via th
synovium. Despite mounting in vitro and in vivo evidence of th
deleterious effects of cartilage particulates on joint health, th
mechanisms that mediate their negative interactions with synovia
cells remain poorly understood.
In vivo studies have investigated the biological effects of carti
lagewear particles on synovial joint health and disease progression
in animal models10e12. For the latter, animals developed synoviti
shortly after joint injection with particulates, which persisted and
was accompanied by the infiltration of mononuclear cells and
capsular, fibrotic thickening of the synovium10. Notably, the injec
ted particles were still present and embedded within the synovium
months later10,11.
Monolayer cell and particulate co-cultures have previousl
been used to study the effects of biologic and synthetic particle
on cells. While the most common method of determinin
particle-induced effects is to apply a specific number of particle
per cell13e15, measuring particulate mass per number of cells i
also commonly used16,17. Adding wear particles of any material t
cells can change cellular viability, metabolic activity, function and
expression of OA specific markers. Specifically, treatment of hu
man fibroblast-like synoviocytes (FLS) or chondrocytes with
cartilage particles results in increased proteinase activity16 and
tumor necrosis factor-a (TNF-a) gene expression17. Lacking th
availability of techniques to measure precisely the number or siz
of particles being used for treatment, previous studies examined
biologic wear particles by mass, with an undefined size distri
bution. As such, it has been difficult to determine if the mecha
nism involved in driving the response of FLS to cartilag
particulates is mediated by phagocytosis, cell surface contact or
combination of both.
Studies typically use synthetic particles that are 0.2e7 mm in
size13e15,18,19, as particles <15 mm in diameter, are readily phago
cytosed by chondrocytes, macrophages, FLS and mesenchyma
stem cells (MSCs)20,21. Compared to these non-biologic (metal o
plastic) wear particles, biologic (cartilage) wear particles are mor
complex to study because they are composed of extracellular ma
trix (ECM) proteins that can be phagocytosed or degraded by, o
bound to cells. This study aims to better understand the interplay o
cartilage particulates with cytokines on cells of the synovium t
foster the development of effective strategies to mitigate the in
flammatory effect of cartilage particulates in OA.
Methods
Experimental design
Three studies are discussed in this paper (outlined in Fig. 1)
Study 1 optimized the treatment dosage of sub-10 mm cartilage o
1 mm latex particles. Particle concentrations up to 1000 particle
per cell were cultured for 5 days with confluent FLS monolayers t
determine a dose that would elicit a cellular response withou
compromising cell viability (n ¼ 3e4/group). The lowest particl
dose that resulted in significantly altered metabolic activity, a
determined by the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphe
nyltetrazolium Bromide) assay, while preserving cell viability, wa
selected for subsequent experiments. A dosage of 250 particles pe
cell was selected for future experimentation for both latex and
cartilage particles.
In study 2, cells were co-cultured for 5 days with ±250 cartilag
particles (CART) per cell in the presence or absence of 10 ng/mL o
interleukin-1a (IL-1a, Life Technologies, Carlsbad, CA) or TNF-
(Life Technologies) (n ¼ 6e8/group). These concentrations ar
previously established for studies of cytokine effects on jointissues . FLS were also cultured ±250 latex particles per cell t
establish a baseline non-biologic particle response. In study 3
designated donor cultures were maintained in media in the pres
ence (FLS þ CART) or absence (FLS only) of 250 cartilage particle
per cell for 5 days. In parallel, cell-free cultures with (CART only) o
without particles (media only) were maintained for 5 days unde
the same conditions. Conditioned media was removed from th
four donor culture groups (media only, CART only, FLS only
FLS þ CART), and particles were removed via filtration with
0.22 mm filter in the particle groups. This conditioned media wa
split with fresh growth media and added to the recipient FL
monolayers for 5 days (n ¼ 5e8/group).
Isolation and culture of FLS and cartilage explants
Synovial tissue was harvested from three freshly slaughtere
juvenile bovine knee joints (2e4 weeks old) and digested in
collagenase type II (Worthington Biochemical Corporation, Lake
wood, NJ) for 2 h with stirring at 37C. Digested cells (FLS) wer
filtered through a 70 mm porous nylon mesh. Viable cells wer
counted and plated at a density of 1.76  103 cells/cm2. To obtain
pure cell population, FLS were expanded for two passages in a
Minimal Essential Medium (a-MEM, Life Technologies) containin
10% fetal bovine serum (FBS), 1% antibiotic-antimycotic and bFGF-
(Life Technologies)25,26. Articular cartilage explants were cored
using a disposable biopsy punch (10 mm diameter, Acuderm® Inc
Fort Lauderdale, FL) and cultured in cartilage explant media2
supplemented with 1% antibiotic-antimycotic, 1% non-essentia
amino acids (SigmaeAldrich, St. Louis, MO), 1 mg/mL bovin
serum albumin (BSA), 50 mg/mL ascorbic acid (SigmaeAldrich)
0.01 mg/mL hydrocortisone (SigmaeAldrich) and 0.002 mg/mL in
sulin (BD Biosciences, San Jose, CA) until use.
Creation and characterization of in vitro synovium model
Confluent FLS were trypsinized, counted, re-suspended and
plated at a density of 50  104 cells/cm2 in a-MEM (10% FBS, 1%
antibioticeantimycotic) supplemented with 50 mg/mL ascorbi
acid to allow the formation of a dense cell monolayer. After
days, confluent monolayers were fixed in 4% paraformaldehyd
(PFA, SigmaeAldrich) overnight at 4C before being washed in
phosphate buffered saline (PBS, Life Technologies). Cell mono
layers were stained to determine the presence of Type I collagen
(rabbit polyclonal anti-collagen I, Abcam, Cambridge, MA)
lubricin (rabbit polyclonal anti-lubricin, Abcam) and DNA
(40,6-Diamidino-2-Phenylindole, Dihydrochloride, DAPI, Lif
Technologies).
Particulate preparation and characterization of particles
Cartilage particles were generated aseptically from the super
ficial and middle zones by manually abrading cartilage submerged
in phosphate buffered saline (PBS) with waterproof 120 grit sand
paper (McMaster-Carr, Elmhurst, IL). Potential residual sandpape
particulates were removed gravimetrically and via sub-sequen
filtration, as was confirmed through microscopic inspection of th
particulate solution. The resulting cartilage particle solution wa
sequentially filtered with 70 mm, 40 mm, and 10 mm porous nylon
mesh filters to achieve a sub-10 mm particulate size. An aliquot o
either cartilage particles or 1 mm latex particulates (SigmaeAldrich
was further diluted in PBS, counted and sized using a Multisizer
Coulter Counter (Beckman Coulter, Brea, CA) to determine th
concentration of both the cartilage particulate and latex particl
solutions28. An average of four aliquots was used to determine th



















































Fig. 1. Schematic of the experimental study design. In study 1, FLS were cultured for 5 days with increasing concentrations of latex or cartilage particulates (up to 1000:1 parti-
cles:cells). In study 2, FLS were cultured for 5 days in the presence or absence of 250 latex or cartilage particles per cell and 10 ng/mL IL-1a or TNF-a. In study 3, FLS were cultured in
the presence (FLS þ CART) or absence (FLS) of 250 cartilage wear particles (CART) per cell for 5 days. Concurrently, media alone (media only) and particles alone (CART only) were
also cultured. Conditioned media from each donor group was combined with fresh media and added to recipient cultures for 5 days.
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213particulate size. Toxicity of sandpaper exposure to the cartilag
surface was evaluated by co-culturing suspended pieces of 120 gr
sandpaper with passage 2 FLS plated at a density of 50  104 cells
cm2 in a-MEM (10% FBS, 1% antibiotic-antimycotic) supplemente
with 50 mg/mL ascorbic acid. Viability and metabolic activity wer
assessed after 30 min, 60 min and 24 h using the LIVE/DEAD
Viability/Cytotoxicity kit (Life Technologies) and MTT assa
(SigmaeAldrich)29. Cell monolayers were incubated for 4 h wit
0.5 mg/mL MTT in growth media. The media was replaced and th
dye was solubilized in a 1:1 solution of isopropanol and dimethy
sulfoxide.
Microscope analysis of cell-particle interactions
To better characterize the interactions between latex an
cartilage particles, cartilage particulates were labeled with 20 mM
dichlorotriazinylaminofluorescein (DTAF, SigmaeAldrich)28. FL
were plated at either a low or high density overnight befor
treatment with 250 fluorescently labeled cartilage particles, green
yellow or unlabeled latex beads (SigmaeAldrich) per cell for 2 day
on glass coverslips. Prior to imaging, synovial cells were staine
with CellTrace™ Calcein Red-Orange AM (Life Technologies) t
identify if particles were internalized or in contact with the ce
surface. Alternatively, cells were cultured and fixed in 4% PF
overnight, permeabilized with 0.1% Triton X (SigmaeAldrich) an
washed with PBS. After blocking with 1% BSA in PBS, cells wer
stained with TRITC-conjugated Phalloidin (EMDMillipore, Billerica
MA) and counterstained with DAPI. Z-stack images were taken an
reconstructed using a Zeiss LSM700 Confocal microscope (Zeis
Oberkochen, Germany). For actin-DAPI stained images with lateparticles, non-fluorescent latex beads were used to eliminate th
effects of channel bleed-through. For quantification of cell-particl
interactions and spatial characterization, three blinded reviewer
each counted 170 cells and 108 cells cultured with cartilage an
latex particles, respectively.
Biochemistry
Confluent cell sheets and media samples were frozen at 20
until use. Frozen monolayers and cartilage particulates wer
lyophilized prior to digestion for 16 h at 56C in 0.5 mg/mL o
proteinase K (MP Biomedicals, Santa Ana, CA) in 50 mM Tri
buffered saline containing 1 mM EDTA, 1 mM iodoacetamide an
10 mg/mL pepstatin A (SigmaeAldrich)30. Samples were analyze
using the Picogreen (Life Technologies), 1,9 dimethylmethylen
blue (DMMB, SigmaeAldrich) dye-binding31, and orthohy
droxproline (OHP) assays to determine DNA, glycosaminoglyca
(GAG) and collagen content using, respectively. For the OHP assay
the proteinase K digested sample was hydrolyzed with 12 N HCl a
110C for 16 h and dried before re-suspension in assay buffer. OH
content was determined after reacting chloramine T with dime
thylaminobenzaldehyde (SigmaeAldrich) and quantified using
1:7.64 OHP-to-collagen mass ratio32. GAG content in the medi
was analyzed using the DMMB assay and normalized by DNA
Nitric oxide (NO) and prostaglandin-E2 (PGE2) released into th
media was determined using the Greiss Reagent Kit for nitrit
quantification (Life Technologies) and the PGE2 Parameter Assa
Kit (R&D Systems Inc., Minneapolis, MN), respectively. Biochem
ical content or media product concentrations of particles alon
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214synovial sheet with particles to determine the contribution o
treated FLS alone.
Statistical analysis
Data sets were tested for normality and homogeneity using th
KolmogoroveSmirnov Test and Levene's test, respectively. Non
normal and non-homogeneous data were adjusted using a lo
transformation prior to analysis. For MTT dosage studies and
conditionedmedia studies, a one-way analysis of variance (ANOVA
with Tukey's post-hoc test was performed. For cartilage biochem
ical analyses, a two-way ANOVA with Tukey's post-hoc tests with
main factors set to cytokine and particle treatment was utilized. Fo
latex biochemical analyses, student's unpaired t-test with unequa
variances was used. Statistical analyses were performed in Statis
tica (Statsoft, Tulsa, OK) and R version 3.3.2 with a¼ 0.05. Each dat
point represents the mean and 95% confidence interval.
Results
Characterization of FLS synovium culture
After 5 days, FLS organized into a multi-layer cell sheet tha
stained positive for collagen type I and lubricin (Fig. 2). Collagen
staining indicated the synthesis of a dense fibrous networ
whereas lubricin staining was primarily co-localized intracellularly
Optimization of particle treatment dose
Latex and cartilage particles had average diameters o
1.05 ± 0.0002 mm and 0.85 ± 0.002 mm, respectively. Exposure t
sandpaper up to 60 min had no toxic effects on the FLS as deter
mined by viability or metabolic activity (not shown). To identify an
effective treatment dose of cartilage particles, dense monolayer
were co-cultured with up to 1000 particles per cell (Fig. 3)
Increasing the dose of cartilage particles had no effect on cellula
viability, as confirmed by increasing metabolic activity observed in
the MTT assay. Metabolic activity significantly increased compare
to controls for all doses 250 particles per cell (P ¼ 0.002; 250:1 v
0:1 particles per cell, Fig. 3(A)). Thus, a dosage of 250 particles pe
cell was chosen for future experimentation, as it was the lowes
dose that increased metabolic activity without compromisin
viability.
Only a dose of 1000 latex particles per cell resulted in signifi
cantly decreased metabolic activity and viability (P ¼ 0.003
compared to no-particle controls [Fig. 3(B)]. 250 latex particles pe
cell resulted in a significant increase in metabolic activity (P¼ 0.04
vs 0:1 particles:cells, Fig. 3(B)), while maintaining cell viability
Thus, 250:1 particles:cell was chosen for subsequent experimentsFig. 2. Collagen I (green, A) and lubricin (green, B) vs negative (C) staining of a FLFor both latex and cartilage particles, 250 particles per ce
comprised a dose that was <0.002%v/v.Characterization of the interaction between particles and synovium
Both latex and cartilage particles were phagocytosed by FL
[Figs. 4, 6(A) and 6(B)]. Latex particles were readily phagocytosed
by FLS (73± 7%), with 5e20 particles internalized per ce
[Fig. 6(A)]. Meanwhile, cartilage particles were selectively phago
cytosed by FLS, with positive cells only internalizing 1e5 particle
[Fig. 4(A) and (B)]. Z-stack reconstructions revealed two potentia
mechanisms of action: cartilage particle internalization or attach
ment to the surface of both dense monolayers and individual cell
(Fig. 4). 79 ± 7% of FLS were associated with a particle (eithe
phagocytosis or surface contact). Of these, 72 ± 11% of cells had
cartilage particles within their cell boundaries (i.e., as a result o
phagocytosis) while 32 ± 5% of the cells had cartilage particles in
contact with the surface. 24 ± 5% of the cells had particles both
within the cell boundary and in contact with the cell. Actin cyto
skeleton staining revealed nuclear (internal) and cortical (external
remodeling of the actin cytoskeleton around cartilage particle
[Fig. 4(C) and (D)], compared to only nuclear (internal) remodelin
of latex particulates [Fig. 6(B)].Effect of cytokines and cartilage or latex particles
Exposure to IL-1a or TNF-a had no effect on FLS proliferation
(P ¼ 0.56, Fig. 5(A)), however, cytokines modulated the total ECM
composition of the FLS sheets as well as the release of ECM com
ponents and inflammatory markers to the media. Cytokine treat
ment had a significant effect on GAG (P < 0.00001) and collagen
synthesis (P < 0.00001). TNF-a treatment resulted in a decrease in
GAG content (P ¼ 0.003, Fig. 5(B)), while both IL-1a (P < 0.00001
and TNF-a (P < 0.00001) resulted in a significant decrease in
collagen content compared to non-cytokine controls [Fig. 5(C)
Overall, cytokine treatment resulted in a significant increase in
media GAG (P < 0.00001), NO (P < 0.00001), and PGE
(P < 0.00001) when normalized by DNA content [Fig. 5(DeF)]. IL-1
had the greatest impact on PGE2 synthesis (P ¼ 0.0001; vs n
cytokine control), while TNF-a had the greatest effect on NO syn
thesis (P ¼ 0.0001; vs no cytokine control). Total GAG synthesi
(sum of FLS GAG þmedia GAG) was increased in IL-1a (P ¼ 0.0003
vs no cytokine control) and TNF-a stimulated cultures (P ¼ 0.0003
vs no cytokine control).
Co-culture of FLS with cartilage particulates resulted in a sig
nificant increase in DNA content of the cell sheet (P < 0.00001
Fig. 5(A)). The DNA content of the cartilage particles themselve
constituted <1% that of the DNA of the cell monolayer (not shown)







































Fig. 3. MTT assay for assessing the effect of increasing concentrations of cartilage (A) and latex (B) particles on cellular metabolic activity. Data presented as mean and 95%
confidence interval. *P < 0.05 vs control (0:1 particles:cell), **P < 0.05 vs 100:1 cartilage particles:cell, ***P < 0.05 vs 250:1 cartilage particles:cell. #P < 0.05 vs control 0:1, 500:1,
750:1 and 1000:1 latex particles:cells, ##P < 0.05 vs 0:1, 100:1, 250:1, and 500:1 latex particles:cells.
Fig. 4. (A) Z-stacks of a synovial cell (red) cultured without (CTL) and with (CART) cartilage wear particles (yellow/green). (B) 3D reconstruction. Top (C) and side (D) views of the 3D
reconstructions of actin staining from the cartilage particles are found on the cell surface (a) and internalized by the cells (b). Particles indicated by white arrows. Scale bar ¼ 20 mm.
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215proliferative behavior of FLS treated with cartilage particle
(P ¼ 0.46, Fig. 5(A)). In the absence of cytokine insult, co-cultur
with cartilage particles had no effect on GAG content (P ¼ 0.09
Fig. 5(B)) and resulted in a significant change collagen conten
(P < 0.00001, Fig. 5(C)) of the cell sheet. Cartilage particles an
cytokines together significantly reduced the GAG (P ¼ 0.01) an
collagen content (P ¼ 0.02).
Overall, GAG content in the media was modulated by cytokine
and particles together (P < 0.00001, Fig. 5(D)). NO levels wer
elevated as a result of cartilage particle (P ¼ 0.00003) and cytokin
(P < 0.00001) treatments, as well as the combined cartilage particl
and cytokine treatment (P ¼ 0.003). Cell sheets treated with TNF-
had NO levels equivalent to their cartilage particle treated coun
terparts (P ¼ 0.83, Fig. 5(E)). Lastly, cartilage particle treatment ha
an effect on the release of PGE2 compared to control cell
(P < 0.00001). Cytokine and cartilage particles together als
resulted in a significant increase in PGE2 media concentration
compared to non-treated controls (P < 0.00001, Fig. 5(F)).
Treatment with latex particles alone had no effect on FLS pro
liferation (P ¼ 0.37, Fig. 6(C)). Co-culture with latex particle
resulted in a decrease in the overall collagen synthesis by FL
(P < 0.00001, Fig. 6(D)). NO synthesis was not altered by cultur
with latex particles (P¼ 0.39, Fig. 6(E)). PGE2was detectable only i
latex particle treated samples, after pooling. No PGE2 was detectein control samples compared to 27.6 ± 42.4 pg of PGE2/mg of DNA i
latex treated samples (P ¼ 0.11).
Conditioned media study
FLS treated with Media only and CART only conditioned medi
proliferated to a greater extent than FLS treated with FLS onl
conditionedmedia (P¼ 0.0005) and FLSþ CARTconditionedmedi
(P ¼ 0.01, Fig. 7(A)), respectively. No differences were observe
between media only and CART þ media groups (P ¼ 0.90) an
FLS þ media only and CART þ media þ FLS (P ¼ 0.70, Fig. 7(A)). N
differences were detected in GAG synthesis (P ¼ 0.17, Fig. 7(B)) an
collagen synthesis across all groups (P¼ 0.20, Fig. 7(C)). As such, th
response of FLS to cartilage particles appears to require particulat
surface binding and/or phagocytosis.
Discussion
Previous research has identified the deleterious effects o
cartilage wear particles on FLS and suggested that they play a
important role in the pathogenesis of OA and degenerative join
changes16. Here, we adopted FLS monolayer cultures as a two
dimensional synovium model to further characterize the interac
tion of cartilage particles with FLS. The in vitro FLS system wa
Fig. 5. Analysis of FLS cells sheets cultured ± IL-1a or TNF-a and ± cartilage wear particles (CART). The DNA, ECM synthesis and media NO and PGE2 of the particles alone was
subtracted from the total to determine the final values. DNA (A), FLS cell sheet GAG (B), FLS cell sheet collagen (COL) (C), media GAG/DNA (D), media NO/DNA (E) and media PGE2/
DNA (F). Data presented as mean and 95% confidence interval. ND ¼ not detected. *P < 0.05 vs non-particle treated control (CTL) with same cytokine treatment. #P < 0.05 vs IL/
TNF, ##P < 0.05 vs þIL/TNF within CTL or CART treated samples respectively.
Fig. 6. (A) Z-stacks of a synovial cell (red) cultured with latex wear particles (yellow). (B) Actin (red)-DAPI (blue) staining showing remodeling of the cytoskeleton around the
ingested latex beads. Scale bar ¼ 20 mm. Analysis of FLS cell sheets cultured ± latex particles for DNA (C), FLS cell sheet COL (D) and media NO/DNA (E), all normalized by cor-
responding control (CTL) values. Data presented as mean and 95% confidence interval. *P < 0.05 vs non-particle treated control (CTL).






















































































Fig. 7. DNA (A), FLS cell sheet GAG/DNA (B), and COL/DNA (C) for the conditioned media experiment. Data presented as mean and 95% confidence interval. *P < 0.05 vs Media only.
#P < 0.05 vs CART only.
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217comprised of a dense cell sheet that was a few cells thick an
positively expressed both collagen I and lubricin, similar to th
native synovial lining33e35. The results of this study demonstrat
the inflammatory response of FLS to sub-10 mm cartilage particle
cartilage debris in vitro and evaluates two potential mechanisms o
action: phagocytosis and surface contact.
The particulate doses (up to 1000:1 particles per cell) examine
and used in this study may be compared to the range of values use
for previous wear particles studies on various adult cell type
involving cartilage16, latex19, polyethylene15,18 and titanium14,19,3
that quantified dose in terms of weight/cell16,17, volume percent
age14,18,36 and particles per cell13,19. Similar to other non-biologi
particles such as titanium, the viability of the synovial sheet cul
tureswas decreased by increasing concentrations of latex particles1
Microscopy confirmed that sub-10 mm cartilage particle
interact with FLS through both phagocytosis and surface contac
Both latex control and cartilage particles showed re-arrangement o
the actin cytoskeleton around the wear particulate [Figs. 4(C,D) an
6(B)], as has been previously observed for osteoprogenitors an
MSCs14,19 treated with titanium particles. Here, we observed
remodeling of the actin cytoskeleton at the surface to form a U
shaped organization at the cell-cartilage particulate contact sit
[Fig. 4(D)].
Treatment of the synovium model with IL-1a and TNF-a
commonly utilized cytokines for in vitro modeling of OA37, modu
lated ECM composition and increased secretion of inflammator
factors. Specifically, FLS treated with cytokines demonstrated
marked drop in cell sheet collagen content and increased medi
concentrations of NO and PGE2, indicative of an inflammator
response. Previous research on the effect of human FLS cells ha
shown that inflammatory cytokines increase cell proliferation
perhaps explaining the thickening of the synovial capsule observe
in OA-associated synovitis23,38,39. The previously observed prolif
erative stimulus provided by these pro-inflammatory cytokine
may have inhibited by the presence of growth factors in FBS used t
supplement the culture media in the present study40,41. Cytokin
stimulated FLS have been shown to produce a number of inflam
matory factors involved in OA and RA, including IL-6, IL-8, NO, an
PGE223,38,39,42 that can lead to matrix degradation, as observe
here. PGE2 is known to activate MMP expression leading to carti
lage degeneration43, reinforcing the role of the synovium i
continued cartilage matrix degradation.
Co-culture of FLS with cartilage particles resulted in prolifera
tion of FLS that was not further modulated by the addition o
inflammatory cytokines [Fig. 5(A)]. Moreover, exposure t
cartilage particles alone resulted in increased production of keinflammatory factors (i.e., NO, PGE2) and thickening of the ce
sheet through increased collagen content [Fig. 5(B) and (C)]. Thes
in vitro findings confirm the results of previous animal mode
studies showing that cartilage particles alone can lead to synoviti
and increased capsular thickening10,11. Supplementation of carti
lage particle treated FLS cell sheets with inflammatory cytokine
did differentially modulate the ECM composition, suggesting tha
the response of cartilage wear particles may have differing effect
on synovial tissue health and cartilage degradation in late stage O
when cytokine levels are significantly upregulated.
Cells with media only and particle conditioned media prolifer
ated greater than cells treated with FLS or FLS þ Particle condi
tioned media, likely due to the depletion of nutrients in ce
conditioned media. Conditioned media studies with media from
cartilage particles alone and cartilage particle treated cells showe
that the particles themselves are not leaching factors driving th
rapid proliferative or inflammatory response of treated fibroblast
Accordingly, contact is required for the mechanisms of action t
have an impact on cellular response. Cartilage is composed pri
marily of type II collagen and proteoglycan44, thus particulat
binding to FLS surface receptors via integrins has the potential t
activate a number of pathways and increase expression of matri
metalloproteinases45. Numerous studies have looked at cellula
activation through ECM binding to FLS integrins46 using ECM
(collagen, fibronectin, etc.)-coated beads. These studies have show
that integrin engagement through collagen binding increase
cellular proliferation and decreases collagenase synthesis. Thes
results support the outcomes reported here for cartilage particl
treatment (Fig. 5). Further, treatment of activated cells with TNF-
was able to increase collagenase synthesis46, observed via treat
ment of FLS with cartilage particles and TNF-a (Fig. 5).
The change in ECM composition and release of products into th
media of FLS co-cultured with latex particles was used as a non
biologic control to isolate the effects of phagocytosis alone on th
observed responses. Latex particles did not affect the proliferatio
of particle treated FLS, as has been shown previously in FLS47 an
MSCs19. Latex particulates did induce decreased synthesis o
collagen. Previous studies on the effects of sub-15 mm latex par
ticulates in rabbits have shown increased synthesis of collagenas
and neutral proteinases20,47. These studies have also shown tha
cells in the same culture as cells that have phagocytosed late
particulates also synthesize greater concentrations of collagenase
suggesting that phagocytosis results in the release of an activ
stimulatory factor.
Cartilage particles inducedmore proliferation and inflammatio
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218surface contact and presumably activation of integrins in th
response of FLS to cartilage particles. Phagocytosis, cell surfac
binding and actin reorganization together may affect how FL
synthesize other molecules beyond the ECM proteins or inflam
matory factors studied here in response to physical stimuli pre
sented to FLS in the synovial joint environment (e.g., fluid shear o
mechanical stretch)48e50.
The work presented here provides a platform to study how th
synovium responds to cartilage wear particulates in vivo. Targetin
the interaction of cartilage particles by phagocytosis or surfac
binding may provide a means to slow the onset and progression o
OA by mitigating the deleterious effects of cartilage particle
mediated synovitis. Future work will further investigate the exac
mechanisms (e.g., integrin activation) responsible for rapid FL
proliferation and determine how cellular activation by cartilag
wear particles influences cellecell communication47. These insight
may guide the optimization of arthroscopic lavage and debride
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